List of Vendor Companies in United States - 2849

Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team to fuel new scientific discovery, no matter how challenging. And we won’t stop until all of the cells’ secrets are revealed.

16S Technologies delivers actionable, cost-effective and pain-free information using advanced DNA science to the oil and gas and industrial markets. Employing advanced DNA sequencing and proprietary data analytics, we offer a range of genomics diagnostics, biocide selection and consultancy services for microbial challenges faced by the oil and gas industry. In addition, 16S offers DNA-based oil and water tracers that have significant advantages when compared to legacy tracer technology. Specifically, DNA tracers are cheaper, more plentiful and not disproportionately affected by downhole environments. Please contact us directly to talk more about our tracer or biocorrosion application.

20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Our headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which we have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into two categories: Personalized Medicine: Our patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.

The 2bPrecise platform integrate genomic data withclinical knowledge and genomic research to identify relevant information for clinical care.

3BarBio offers increased profitability to discovery companies, bulk suppliers, and distributors by addressing the major hurdle to further adoption of biologics by designing innovative packaging to deliver viable microbes to the ag market. With its proprietary LiveMicrobe® Design. Develop. Deliver. process, 3Bar delivers on demand for partners around the world.

3D Biotek, LLC is a high tech biomedical engineering company located in the state of New Jersey, USA. Using its Precision 3D Micro-fabrication Technology and Advanced Bio-manufacturing Technology, 3D Biotek is a leader and the industry's only dedicated driving force in the research and development of novel 3-dimensional cell culture devices for stem cell/tissue engineering, drug discovery and broad cell biology applications.

We are North America's premier HLVd testing company and tissue culture licensing technology all over the US and world. From Washington to Germany, we are here to help cultivators de-risk their operations, scale their production safely, and reap the benefits of this exciting crop. Almost every clonally-produced crop has moved to tissue culture plant starts for a reason. Plants that are starting disease-free tend to be highly vigorous throughout their life cycle and focus more energy on growth and secondary metabolite production, augmenting the performance of the crop and economic return. We work with established breeders in every region to ensure that our genetics will keep you compliant and help you succeed where you grow.

410 Medical is a medical device company dedicated to developing innovative products that enable clinicians to improve care for critically ill patients. LifeFlow® PLUS, 410's recently approved product, is designed to enhance the speed and efficiency of volume resuscitation, improving care for patients with life-threatening conditions such as sepsis, hemorrhage and cardiac arrest.

4G Clinical’s suite of innovative RTSM and clinical supply optimization software provides the right-sized support for any phase or trial complexity. At 4G Clinical, all studies are supported by a team of RTSM experts to advise trial teams on the best path forward. Our operations team distinguishes itself through their extensive industry expertise and deep understanding of trial designs and mid-study adjustments. 4G Clinical is committed to helping sponsors and CROs follow the science, wherever it may lead, as quickly and as safely as we can. While we will not discover the next novel compound in the lab, we are doing our part by leveraging our extensive experience and technological innovations to bring speed and agility to clinical trials. As a critical partner throughout clinical development, we can help you seamlessly transition and scale your trials through both protocol and supply complexities to help bring crucial medicines to those who need them, faster. To learn more about how we are tackling the bottlenecks in clinical trials through our innovative solutions, Prancer RTSM® and 4C Supply®, visit us at www.4gclinical.com.

908 Devices is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. The Company’s devices are used at the point of need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in bioprocessing, pharma/biopharma, forensics, life sciences research and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of complementary analytical technologies, microfluidic sampling and separations, software automation, and machine learning.

Aanika Biosciences, Inc. provides food security services for large food and agricultural companies. We use synthetic biology to ensure the integrity of supply chains and reduce potential losses.

AAT Bioquest®, Inc. (formerly ABD Bioquest, Inc.) develops, manufactures and markets bioanalytical research reagents and kits to life sciences research, diagnostic R&D and drug discovery. We specialize in photometric detections including absorption (color), fluorescence and luminescence technologies. The Company's superior products enable life science researchers to better understand biochemistry, immunology, cell biology and molecular biology. AAT Bioquest offers a rapidly expanding list of enabling products. Besides the standard catalog products, we also offer custom services to meet the distinct needs of each customer. Our current services include custom synthesis of biological detection probes, custom development of biochemical, cell-based and diagnostic assays and custom high throughput screening of drug discovery targets. AAT Bioquest® is committed to constantly meet or exceed its customer’s requirements by providing consistently high quality products and services, and by encouraging continuous improvements in its long-term and daily operations. While we continue to rapidly expand, our core value remains the same: Innovation and Customer Satisfaction. We are committed to being the leading provider of novel biological detection solutions. We promise to extend these values to our customers during the course of our service and to continue to support our customers with new products and services.

AAVnerGene Inc is an innovative company specialized in AAV technologies. It is founded by a group of AAV gene therapy enthusiasts who dream to serve the community, promote and lead the future of gene therapy. Our passion is to solve the bottleneck problems in AAV gene therapy and find more and better cures for all the patients. We believe that hard core technologies are the key to achieve it. With 20 years of frontline gene therapy experience, our team develops novel AAV vectors, methods and strategies that can efficiently produce, deliver and express high quality vectors into specific cells. Our goal is to increase AAV gene therapy efficacy and decrease the cost, making it accessible and affordable to patients. Our highly complex AAV capsid libraries allow us to efficiently select the best AAV capsid for each cell type in a high-throughput manner.

Abaxis develops and commercializes medical device and innovative technology and services that support best medical practices, enabling practitioners to respond to the health needs of their patients, while operating point of care, onsite diagnostics for human and animal health.Abaxis is now part of Zoetis.

Our Mission To create best niche antibody-based biologics for fulfilling the research and development needs in biomedical and biopharmaceutical communities. Our long range goal is to develop therapeutic and diagnostic entities. Core Competence ABB's core competence is in protein designs of biologics for diagnostic and therapeutic applications of immuno-oncological disorders. Specifically, our R&D for therapeutics is focused on biologics that are capable of modulating activities associated with antigenic targets and effector molecules. In addition, ABB has designed and produced a panel of immune related protein reagents that are available to biomedical researchers as investigational tools. History Founded in 2007, AB Biosciences (ABB) has been dedicated to the engineering of therapeutic biologics and research protein reagents. With decades of combined experience in research and development, ABB's scientists have built an efficient platform for the development of these two protein classes. The recombinant replacement of the traditional IVIG (PRIM program) is a great example of our engineering expertise in R&D of an unique protein drug for replacing the traditional serum-derived IVIG. Our Community Massachusetts provides a vibrant and nurturing environment for life science ventures like ABB, in terms of training grants and tax benefits, as well as an abundant talent pool possessing a wide range of expertise. Discovering breakthrough biotechnology and exploring biologics for biomedical study is our mission at AB Biosciences. As part of our commitment to science education, we open our doors to intern students, who can experience firsthand the R&D employment possibilities in the Biotech Industry. More than 15 students/interns have visited our laboratory since 2009.

As researchers are focusing their efforts on determining the biological functions, interactions and regulation of the human proteome, Abbiotec is dedicated to developing cell biology-based research tools that assist scientific discoveries. Besides custom services, Abbiotec offers over 12,000 antibodies, proteins, peptides, lysates and kits to assist researchers in understanding human biology and diseases at the cellular and molecular levels.

AbboMax is a biotechnology company that offers high quality, diagnostic-grade products and professional custom services for research purposes.

Abeomics Inc. is founded by scientists for the scientists. Our immunologists, cell biologists and business professionals have contributed for over 25 years to the growth and success of global companies including BD Biosciences, eBioscience and IMGENEX Corporation. We bring our experiences to develop well-validated and specific antibodies by traditional hybridoma technology and by genetic engineering to produce recombinant mouse and rabbit monoclonal antibodies.

Abcepta is a biotechnology company that specializes in developing primary antibodies and custom services for research and drug discovery.

Based in Danvers, Massachusetts, USA, Abiomed, Inc., part of Johnson & Johnson MedTech, is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit www.abiomed.com. Important Safety Info: https://bit.ly/39kvb47

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world's most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients' team – helping them advance today's ideas into tomorrow's medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.

Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL acquired all the patents and IP rights from TherapyEdge, Inc. in 2005 and in 2013 acquired the rights to all viral hepatitis B & C related assets from EVIVAR MEDICAL, respectively. ABL has a comprehensive suite of healthcare management products, including TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, HepatiC™ and the DPM which are used for data and patient management, monitoring and personalized reporting applications. COVID-19: CE mark (07/2020)

Ablexis offers the AlivaMab® Mouse platform, a suite of transgenic mouse strains for human therapeutic antibody discovery. AlivaMab Mouse strains are uniquely designed to be better for human therapeutic antibody discovery and development, for applications across antibody drug discovery including highest quality IgGs, singe-domain VH, multispecifics, ADCs, CARs, TCRm, and other modalities. The AlivaMab Mouse strains are well-documented for generating drug-like antibodies with broad combinatorial and somatic diversities, high affinities, specificity, and excellent developability properties. Users of AlivaMab Mouse include the world’s largest pharmas, public and private biotechs, and leading academic institutions. AlivaMab Mouse-derived antibodies in clinical development span formats including IgG, multispecific, ADC, and CAR. Many partners use AlivaMab Mouse at Ablexis’ sister company, AlivaMab Biologics, a leading provider of services in antibody drug discovery, engineering, and protein sciences. Visit us at www.ablexis.com to learn more. For inquiries about licensing the AlivaMab Mouse, contact us at info@ablexis.com.

Absolute Biotech specializes in antibody reagents, kits and services, adding value to existing antibodies through annotation, validation, sequencing, engineering and recombinant manufacturing. Our company unites multiple antibody-centric brands to offer customers worldwide the full breadth of antibody-related products, services and expertise for research, diagnostic and therapeutic applications. Our mission is to serve as “antibody curators” for customers worldwide, treating each antibody like a work of art to deliver unique and absolutely defined reagents that empower scientists. Brands within the Absolute Biotech family include: - Absolute Antibody, experts in antibody engineering and recombinant antibody technology - LSBio, leaders in IHC validation with a comprehensive catalog of antibodies, proteins and ELISAs - Kerafast, which makes unique laboratory-made research tools easily accessible to the global scientific community - Nordic Mubio, which develops antibody and flow cytometry reagents according to ISO 9001 guidelines - Everest Biotech, specialists in anti-peptide and antigen affinity purified goat polyclonal antibodies - Exalpha, which offers cutting-edge antibodies, reagents, kits and custom IgY services

ABT 360 manufactures media for embryo transfer. The media is used to collect, store and transfer embryos from cattle and horses and is used for the veterinary assisted reproduction industry.

Abterra Biosciences is reimagining antibody discovery and sequencing by harnessing the latest next-generation sequencing, mass spec, machine learning. Abterra Biosciences is enabling the next-generation of antibody therapeutics. Our technologies use the latest in next-generation sequencing.

AbTherx is advancing medicine with revolutionary technologies that accelerate and enable therapeutic antibody discovery. Through an exclusive partnership with Gilead Sciences, AbTherx has released Atlas™ Mice, a suite of novel transgenic technologies designed for unmatched performance and FTO. For over 20 years, AbTherx’s passionate, innovative, and collaborative team has pushed the boundaries of antibody discovery technologies, leading to over 1,000 successful antibody discovery campaigns and 13 marketed therapeutics. AbTherx’s industry-leading team creates transformative solutions to overcome the most demanding challenges in delivering innovative medicines. Committed to making its technologies accessible to all, AbTherx offers flexible partnering models that meet the needs of drug developers of all sizes.

Abveris is a world leader in in vivo antibody discovery and a division of Twist Bioscience. We partner with leading biopharmaceutical scientists across diverse organizations to discover and develop antibodies for diverse pharmaceutical and industrial applications.

Austin Community College is a nationally recognized two-year college serving Central Texas. ACC is focused on student success and providing affordable, flexible pathways to help students reach their education goals, learn new job skills, or advance their career. Check out our students'​ inspiring stories at austincc.edu/iamacc

AcceGen Biotech proudly develops innovative technologies for the pharmaceutical, biotech and specialty ingredients markets. We are committed to supplying the best products and services with global manufacturing, development expertise and advanced technologies to enhance the overall quality of life. AcceGen Biotech developed significant expertise in cell and genomic research. We provide a variety of high-quality human/animal cells, cell media/kits, cell-derived molecular biology products, gene-based assay kits, Clones, Fish probes and Sequencing products for research use. AcceGen Biotech offers custom cell line generation, microRNA sponges and microRNA Agomir/Antagomir services to simplify the gene research. The aim is to accelerate scientific discovery related to genetic analysis available to academic researchers as well as commercial enterprises. AcceGen Biotech has permanent facilities in Fairfield (New Jersey). We take care of our customers and their global, regional or local requirements. We welcome potential partners and distributors to explore our business all over the world.

The company providesmolecular biology services includingproduction of antibodies, GPCRs, kinases, nuclear receptors, and many other classes of drug targets and therapeutic proteins

Accel Diagnostics is medical diagnostic company developing proprietary point-of-care diagnostic assay for the diagnosis, monitoring and management of a wide variety of medical conditions. We are dedicated to making a difference in the quality of life of millions of patients through technology and innovation. AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests anytime and anywhere. The Company's patented platform technology transforms the patient blood testing paradigm, from lab-centered to near-patient. The technology bringing significant advantages in terms of simplicity, time to result, care delivery, and cost over current standard lab-based diagnostics. During COVID-19 pademic Accel Diagnostics began to operate the ADX Diagnostic Lab to provide high quality COVID testing in Houston, TX.

Accelergy uses advanced catalysts and state-of-the-art process technologies to transform natural gas, biomass, and/or coal into clean specialty products and transportation fuels. Accelergy’s state-of-the-art Hydroconversion to X (where X = solvents, lubricants, performance fluids, or fuels) "HDX" technologies economically convert abundant natural resources into clean, low carbon products.

Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room temperature stable cartridge. Accellix will continue to identify markets where its platform and assay migration expertise can be best combined to create meaningful opportunities.

Access Genetics, LLC is a privately held Minnesota-based company founded in 2001 by Dr. Ronald McGlennen, an internationally recognized molecular diagnostics expert with over a decade of experience in implementing and developing molecular genetic laboratories. As a medical technology service company, we offer turnkey solutions to assist laboratories in the implementation of molecular genetic testing by recommending a tailored, cost-effective and state-of-the-art suite of hardware, software, prepackaged materials and supplies, process guides, custom tools, staff training, technical support, telemedicine interpretations, and other optional consultative services. This comprehensive service package makes Access Genetics unlike other companies in the genetic testing market that may only provide a piece of the testing puzzle. Our Mission is to improve the availability and utility of diagnostic genetic testing through a base of laboratory providers using our Web-Enabled DNA Testing Model. We partner with qualified clinical labs to enable them to build a quality in-house molecular genetics program that is simple, fast, economical and complete.

Access Vascular is offering our suite of vascular access solutions designed to help clinicians address common catheter complications that afflict patients while helping save hospitals time and money.

AccuBreak Pharmaceuticals is a pharmaceutical company that specializes in creating tablets that can be easily divided into smaller, exact doses, aiming to make it safer for patients to adjust their dosage.

AccuGenomics is a biotechnology company that specializes in a unique spike-in control technology to enhance the accuracy of clinical sequencing tests for low abundance biomarkers and infectious pathogens.

Since its inception in 2013, AccuraGen has pioneered the development of liquid biopsy technology to facilitate more personalized cancer treatment. Our international team of scientists brings together the best of industry with the best of academia. We currently operate from two locations: Menlo Park, California and Shanghai, China.

Accu Reference Medical Lab is a state-of-the-art medical testing laboratory service that provides a complete range of tests for diagnosis, screening or evaluation of diseases and health conditions. We are certified under the federal government’s Clinical Laboratory Improvement Amendments (CLIA) and operate in compliance with all governmental regulations. We use the latest diagnostic technology. As new medical tests become available, we update our list of services. Our laboratory technicians are well trained and have many years of experience, providing the most accurate and precise testing results. We also continuously strive to improve the quality of our testing, data handling and reporting through integrating robust technique and technological advancements. Accu Reference Medical Lab is an equal opportunity employer.

Accuryn Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence. Currently, Accuryn Medical is developing a predictive health platform to help medical teams better predict adverse outcomes in critical care settings. The Accuryn® Monitoring System is not cleared for prediction of disease states or clinical conditions.

AcelaBio, wholly owned by The Alimentiv Health Trust, was incorporated in 2020 and aims to meet the growing clinical research demand for quality and efficiency in laboratory service. Our state-of-the-art facility, located in San Diego, California, is built on deep expertise in clinical and precision medicine research and our scientific and operational experts are dedicated to delivering reliable, high-quality data.

Calspan is an industry-leading research and testing partner to the great innovators of the aerospace and automotive industry. We assist both industries in overcoming developmental and technical challenges to ensure their creative concepts become viable commercial products. Calspan's business units work with integrity, collaboration, and years of experience to accelerate the world's greatest innovations on land or into the sky. Our operations span across the United States. Calspan's corporate headquarters are in Buffalo, NY and the headquarters for Calspan Flight are in Niagara Falls, NY. Additional test pilot training is conducted at Patuxent River, MD and Edwards Air Force Base, CA. Our main automotive testing campus is in Buffalo, NY with breakout locations in NY, PA, NJ, MD, MI, FL, NC and TN. Calspan Test Solutions provides aerodynamic testing, including hypersonics, and aerodynamic model solutions is in St. Paul, MN. Lastly, Calspan Test Systems provides R&D, T&E engineering and manufacturing solutions with locations in Newport News, VA, Hampton, VA, San Diego, CA, and Ronkonkoma, NY.

Acidophil is an innovation company that uses technical and business information together with bio-chemical capabilities to create, manage and co-finance new products and biotechnology businesses in human health, agriculture, and animal health. With operations in both the United States (Lutherville, MD) and United Kingdom (Cambridge), Acidophil takes a global approach to innovation, management and investment that reflects the international perspective of its team and founders. Acidophil exploits a virtual business development model to enable capital efficient innovation in collaboration with scientists, entrepreneurs, corporations and investors who are interested in addressing global market needs.

Aclairo's experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Aclairo advantage is our experience-based approach to providing strategic, scientific and regulatory services. This has proven to be our greatest asset in focusing and streamlining our clients' development efforts, reducing both time and costs.

Aclid is a security and safety platform for synthetic biology. The company's DNA screening solution for biosecurity, export control compliance, and EH&S keeps researchers safe and protects national security.

ACON Laboratories is an international diagnostic and medical device company with our corporate headquarters in San Diego, California USA. For more than 15 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world. The ACON name is well known in over 130 countries. Headquartered in San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility is ISO 13485:2003 certified, FDA registered and has been inspected by US FDA. Our current product lines include Diabetes Care, Clinical Chemistry (including Urinalysis and Point of Care Tests) and Immunoassay EIA/ELISA. We also have a number of new products in the pipeline for introduction in the future.

3D ultrasound therapy

ACRC, with locations in Austin, Carrollton, Frisco, Grapevine & Plano, conducts clinical trials with award-winning physicians. Our doctors are recognized by their peers, year after year, as D Magazine's "Best Doctors." Our team of physicians and research nurses provide convenient, accessible and high-quality patient care, all under one roof. Our goal is to advance medical knowledge and help introduce new and improved medications to the general public via pharmaceutical sponsored clinical research trials. We maintain an unwavering commitment to the highest level of ethical standards and safety. Participants go through a thorough medical checkup to determine qualification into a research study.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics. ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics. Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.

ActivMed Practices & Research, LLC. was founded in 1994 and is headquartered in Methuen, Massachusetts. The Company operates 4 clinical research offices. Methuen, Massachusetts headquarters, Beverly Massachusetts and in 2 in Portsmouth, New Hampshire. The proximity of the offices gives ActivMed Practices & Research access to nearly 1.7 million potential patients. Having successfully completed over 900 clinical trials, nationally recognized ActivMed Practices & Research has developed the staff, processes, recruitment practices and facilities to exceed performance expectations for Phase I, II, III and IV clinical trials. Our goal is to offer a compassionate, friendly, and positive research experience for our patients while gathering information that may benefit all of mankind. Awards & Citations: CorporateLiveWire Innovation & Excellence Awards, 2019 & 2018 Top 25 Places to Work, North of Boston, 2014 Business of the Year, Greater Haverhill Chamber of Commerce, 2012 Business of the Year, Greater Haverhill Healthcare, 2011 US House of Representatives Special Congressional Recognition, 2011 Massachusetts State Senate Health Award Citation, 2011 Office of the Mayor of Haverhill Official Citation, 2011 Our President and CEO Terry Stubbs has received the following awards and recognition: eWomen's "Made It To A Million"​ 2009 Women's Mentoring Award, Finalist Greater Haverhill Chamber of Commerce, Woman of the Year, Finalist, 2010 Who's Who in America, 2000-2004 Board of Director's Greater Haverhill Chamber of Commerce, 2000-2016 Public Speaker for Clinical Research Industry, 2007-Present

At Activ Surgical, our mission is for every surgical imaging system to deliver intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety. Having completed the world’s first autonomous robotic surgery of soft tissue in 2018, the company is focused on enhanced, real-time visualization capabilities for surgeons that combine advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Our vision is to transform the collective surgical experience by leveraging emerging technologies and data into insights that make world-class surgery accessible for all.

Actuated Medical has quickly emerged as a leader in the design and development of medical devices and components. Using proprietary actuation technologies, our innovations address a wide variety of medical challenges ranging from clearing occlusions to easing tissue penetration to enabling MRI assisted procedures. From start to finish, our team designs, develops and manufactures under an ISO-certified quality control system. In addition, we continually seek feedback from domain experts to ensure our products not only solve real problems but also are readily accepted by clinicians. With a proven track record of receiving federal grants to support research and development, the company has built a successful business model that takes medical devices from conception to regulatory approval to market.

ActX, Inc. is a dynamic venture that is focused on making patient genomic information truly useful in everyday medical practice. We are currently seeking a Linux System Administrator/DevOps Specialist to work in a unique, small team environment where innovative new processes assist everyone's productivity. Join our team and help us make personalized medicine a reality rather than a dream!

Actylis is a chemicals company that specializes in acetates and provides pharmaceuticals, fine chemicals, and industrial chemicals.

Founded in 1998 and based in Plainview, NY (Long Island), Acupath is a nationwide provider of sub-specialized anatomic pathology services focused on the following specialties; Urology, Gastroenterology, Hematology / Oncology, Dermatology, Breast, Gynecology, Otolaryngology, Podiatry, and Oral. Acupath offers an extensive test menu on both a global and TC/PC basis, has well over 500 active clients, processes well over 150,000 specimens annually, and is one of the leading providers of cutting edge FISH testing for the detection of bladder cancer (UroVysion™), prostate cancer (PTEN ERG), and esophageal cancer (Barrett's esophagus FISH).

Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies that provide physicians and patients with improved results. AcQMap, AcQRef and AcQGuide devices are CE Marked and FDA cleared. Please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test; and Amgen to develop a therapeutic to prevent or treat COVID-19. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has a translational collaboration with AstraZeneca to investigate the use of immunoSEQ T-MAP. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.

Adaptive Clinical Systems, a global life sciences technology company, offers a simple, secure, validated, compliant and cost-effective solution for data interoperability as well as reporting and visualization for clinical trials. Adaptive Clinical offers the Adaptive eClinical Bus and Adaptive DataVIEW. The Adaptive eClinical Bus®, a cloud-based hosted service, will integrate with any EDC, eCOA, CTMS, ePRO/IWRS, Medical Imaging, IRT, Analytics, Data Acquisition Systems as well as RWD, EHR/EMR to reduce error and speed data management for any size study. With the Adaptive eClinical Bus, patient- centric clinical trials can ensure interoperability and full compliance from the many diverse eSources generated from the explosion of data from Digital Health Technologies (DHTs), such as wearables and remote patient monitoring (RPM) solutions. Key benefits of the Adaptive eClinical Bus include: ✔️ Fully-validated Platform with Detailed Audit Logs and Reports ✔️ Fully compliant with HHS 45 CFR Part 64, FDA 21 CFR Part 11, GxP and other regulatory guidelines ✔️ Standards-based for Interoperability ✔️ Easily Implement an eSource Data Capture Workflow ✔️ Adaptive Rules Engine offers Built-in Clinical Intelligence ✔️ Reusable components for Quick Installation ✔️ Full training and 24/7 support Adaptive DataVIEW provides a robust solution for visualizing and analyzing data from disparate sources quickly and efficiently. It provides real-time, bi-directional data from many disparate sources into comprehensive dashboards. Purpose built for clinical trial operational key performance indicators and dashboards. Reports can be created at the patient, site, study or program level, including across studies. Adaptive DataVIEW enables "single click-back" from any widget or dashlet to the data source regardless of eClinical tool.

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the Pharmaceutical industry. Adare's specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

Develops a rapid leukocyte differential instrument is used to screen for infections, allergies, and blood-related cancers including leukemia.

AddexBio is a global provider of quality services and products in basic research and development for the academia, pharmaceutical, and biotechnology industries. Our headquartered is based in San Diego, California, USA , we are in a solid position to provide quality services and products which are both cost-effective and time-efficient. Our products include biological and chemical research tools.

Addison Biological Laboratory, Inc. is a Fayette, MO based manufacturer and marketer of exclusive veterinary technologies. For over a third of a century, J. Bruce Addison, president and founder, has been recognized as a leader in veterinary diagnostics and herd specific bacterin production. The reputable MAXI/GUARD® product line is best known for its M. bovis (pinkeye) cattle bacterin among bovine veterinarians and Nasal Vac (intranasal respiratory) baby pig vaccine among swine practitioners. Both technologies are recognized as efficacy leaders and privately labeled for large multinational biological manufacturer/marketers. Companion animal product offerings in veterinary dental home care, dermatology, otology, and wound care provide medical researched technologies that define today’s zinc-based product standards. Marketing accomplishments include a successful export history to over 25 countries and recognition as Missouri’s Exporter of the Year. The U.S. Chamber of Commerce selected Addison Biological Laboratory, Inc. as the recipient for its prestigious Regional Blue Chip Enterprise Initiative Award. “Our mission is to be the premier provider of exclusive and innovative technologies to assist the global betterment of animal care by solving problems for veterinary professionals, animal producers, and pet owners.”

We're thrilled to announce the launch of Adecco Search- The solution you need when your business seeks permanent, mid-level and leadership talent. To learn more, please reach out to your local Adecco representative or visit: https://tinyurl.com/yx9awhyx

Aderans has developed artificial hair with artificial cuticles called "Cyber Hair" which in 2006, evolved into "Vital Hair." A wig made from this material can retain a natural texture after taking a bath or a dip in the pool and can be styled freely with a hair drier due to its natural texture and response to air, allowing for more styling options.

Adesis Inc. is a premier chemistry solution company backed by expert chemists and partnering with biotech and pharma industries to accelerate their research and manufacturing goals. Through the years, we've retained our original culture anchored in ethics, integrity, values, family, transparency, speed, safety and trust. We are one of the few companies that can turn a difficult whiteboard chemistry concept into a physical product. We specialize in organic and organometallic synthesis and deliver organic chemistry services in three areas: early-stage research, scale-up and development, and specialty manufacturing. Our turnaround times are recognized as among the fastest in the industry – a direct result of minimizing red tape, maximizing lab time and quick, efficient decision-making. When clients say ‘let's begin,' we've already started. The companion to this remarkable speed is our commitment to safety. The Adesis Facility Safety Program is designed to constantly raise the level of awareness of safe work practices. Our vigilance extends to the protection of client patents and intellectual property. Backed by the effective use of systems, security and formalized processes, client confidentiality is always a priority. We pride ourselves on our chemists being respected for their brilliance and enthusiasm to collaborate and adapt. If a client needs to shift, we pivot quickly to provide the necessary facilities and specialist brainpower to address any challenge and keep the project moving. The compounds we develop for clients have found use in life-enhancing oncology, anti-infective, animal treatment, central nervous system, immunotherapy, therapeutic, ophthalmic, biomarkers, skin care, catalysts and other applications. Reliably and safely solving the toughest chemistry problems in partnership with its clients is the core purpose of Adesis. Trusted collaboration with exceptional chemistry teams. In Adesis hands, the science is not complicated.

Adient Medical is a medical devices company that specializes in absorbable devices that automatically vanish, eliminating the need for removal procedures.

Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. We're committed to staying at the cutting edge of protein-based therapeutic discovery to enable the highest quality IgGs, multispecifics, CARs and other modalities to allow our partners to have the most successful therapeutic programs possible.

ADInstruments is committed to providing innovative tools for research and education. Our company helps scientists and educators achieve their goals with our industry leading PowerLab and LabChart data acquisition systems. Since 1988, life science research has been and continues to be a key driver for innovation in our research product line. Today there are 40,000 ADInstruments data acquisition systems used worldwide in research, and in teaching. Our newest and most innovative product, Lt, takes education a step further with its cloud-based learning platform and 900+ pre-configured physiology, biology, chemistry, medicine, and nursing courses. ADInstruments is a brand synonymous with elegant research and education solutions tailored to suit, and our commitment to our customers is unmatched in our industry. #MakingScienceEasier

Admetsys is a biomedical technology company specializing in critical care automation. The company's flagship PrecisionOne system is the first fully automated glycemic control system and continuous blood diagnostics platform for hospital care. The company was founded to commercialize the next generation of medical automation technology: continuous real-time biosensing, robotics, artificial intelligence and learning algorithms, intelligent therapeutic delivery, and advanced data telemetry.

Since 1983, surgeons and neurologists have turned to Ad-Tech for Gold Standard products that help them deliver life-changing care to patients around the world. Our innovative electrodes are used to treat intractable epilepsy, in neurodiagnostics and neurosurgery. With devices ranging from intracranial electrodes for Long Term Monitoring (LTM) and Intraoperative Monitoring, (IONM) and a wide variety of device specifications, we manufacture the devices medical professionals count on for optimal care outcomes. We're humbled by the important role our products can play in the work of caregivers and the lives of their patients. That's why Ad-Tech products are registered and approved for use in more than 60 countries. All are manufactured in the United States. As an ISO 13485 certified company, we observe the highest standards of quality and an unwavering commitment to regulatory compliance. At Ad-Tech, surgeons and their patients always come first.

AdvanBio Inc., www.Advabio.com, a subsidiary of Autobio Diagnostics in the U.S is a fast-growing biotechnological company based in Irvine, CA. Established in 2021. We specialize in providing cutting-edge IVD Quality Control products & Reagents designed for a diverse range of analytes. In addition, we are committed to providing global partners with high-performance IVD Critical Raw Materials and services such as: • FDA Submission • Assay Development • Product Sales • New Technology/Biomarker Development We are committed to the advancement of medical laboratory technology and dedicated to the promotion of human health. We empower medical providers in making pivotal biomarker & diagnostic decisions with our portfolio of innovative technologies. #Advanbio#ADLM

Scientists today rely on advances in computer science, applied mathematics, and computational science, as well as high-performance computing and networking facilities, to increase our understanding of ourselves, our planet, and our universe. The mission of Computing Sciences at Berkeley Lab is to achieve transformational, breakthrough impacts in scientific domains through the discovery and use of advanced computational methods and systems and to make those instruments accessible to the broad scientific community. The Computing Sciences organization advances computational science throughout the U.S. Department of Energy's Office of Science research programs. Our greatest strength is our people. They specialize in solving scientific problems using expertise in computer hardware and software, computational science, applied mathematics, networking, and middleware services. Computing Sciences carries out its mission by operating two national user facilities — NERSC and ESnet — and by conducting applied research and development in computer science, computational science, and applied mathematics, the three essential elements of computational modeling and simulation. Combining computer and network operations with research and development provides tangible benefits to both the scientists who use our systems and their research programs. Just as our R&D programs benefit science, the needs of scientists influence the direction of our research. These two sides of Computing Sciences'​ work — systems and services, and research and development — are more than complimentary. Each enhances the quality of the other. Computing Sciences is comprised of three divisions: the Computational Research Division (CRD), the National Energy Research Scientific Computing (NERSC) Center Division, and the Scientific Networking Division, which manages the Energy Sciences Network ESnet.

Advanced BioMatrix provides innovative 3D matrix products, transforming science to a new level of discovery. We extract and manufacture highly purified, native, extracellular matrix proteins for tissue engineering, 3D bioprinting, cell culture, drug discovery and any other application with cells. Visit us at www.advancedbiomatrix.com or our 3D bioprinting page at www.bioprintabm.com

AB is proud to be the only U.S. based manufacturer of cochlear implants and equally proud to be a part of the larger Sonova group. At AB, success begins with a passion for hearing restoration and is driven by our global workforce of over a thousand employees. For more than 25 years, AB has removed limitations for those otherwise isolated from the world of sound. Always focused on bringing meaningful change through innovative technology, AB has set the standard for performance, lifestyle support, and access to sound in the field of cochlear implantation. Having implanted over 100,000 ears in over 130 countries and established a track record for developing high-performing, state-of-the-art products, our team of talented scientists, engineers, audiologists and other professionals are driven to succeed, work with integrity, and stay firmly committed to quality. Sonova companies include brands focused on hearing aids, cochlear implants, wireless communications, and clinical service. Together, we strive to create a world where everyone enjoys the delight of hearing and lives a life without limitations.Advanced Bionics is a global leader providing solutions for severe-to-profound hearing loss.

With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world’s most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients’ team – helping them advance today’s ideas into tomorrow’s medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.

Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals.

Advanced Cellular Dynamics (ACD) is a world-leader in the production, provision and application of novel cell-based assay systems. Our capabilities provide us with a unique capability to explore a variety of biological entities and systems. We have deep-rooted expertise in kinases, GPCRs, ion channels and transcription factors - to name a few. Those skills are applied to a variety of experimental systems that include (but aren't limited to) oncology, immunology and neurobiology. We also leverage these skills to provide our global clientele with contract research services. Whether you want to disrupt a specific gene in stem cells, or create a new biological cell-based assay in your tissue/cell line of choice, we have the knowledge and skills to help you succeed!

Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.

Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for the biotech industry and seamlessly integrate into both non-regulated and regulated GMP workflows ensuring increased yield, quality, and purity. Similarly, clinical labs worldwide rely on our products to provide high-quality results and optimize workflow efficiency. With products for clinical chemistry, microbiology and hematology labs, our innovative solutions enable the delivery of accurate and timely patient results to help improve health outcomes and help simplify workflows to support an increase in lab productivity. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. We are a global leader with products supported by a worldwide network of direct salespeople and distributors, with 24/7 technical support. Our direct presence is growing as we continue to expand the team with a continued focus on being the supplier of choice. Contact us if you are interested in joining a dynamic team! For more information, visit www.aicompanies.com.

With a complete platform of core trauma and extremity products, AOS has become a trusted leader with its entire focus on the orthopaedic trauma industry. Relying on the professional guidance of the four original founding partners, as well as the clinical expertise and training of skilled surgeon champions, AOS designs and manufactures innovative orthopaedic trauma products with intra-operative and postoperative clinical benefits. AOS’s products are distributed worldwide through independent distributors and agents. By continuing to build strong relationships with our valued distribution network and surgeon users, AOS continues to improve every aspect of the way we do business. Especially for our patients and their families worldwide.

Advanced Pharma - Miami is a dedicated Phase I­-IV Clinical Research Facility. With our 40,000 sq. ft. turnkey facility we house a 100+ bed capacity Phase I unit with three 6-­8 bed IPUs (Intensive Procedural Units) as well as our Phase II­-IV group experts. Our principals have participated in clinical trials since 1992 and our team has 50-­plus years of combined research experience. Our multi-­specialty Physician Investigators enable us to engage in many aspects of Phase I­-IV Pharmaceutical, Bio­tech and Medical Device Trials. Our team of experts is dedicated to sustaining safe, ethical, high-quality medical research so sponsors can exceed their deadline and patients can benefit from the development of new treatments and therapies. We pride ourselves on bringing efficiency, innovation and value to the clinical research process. Our strict adherence to protocol and GCP standards, along with our uniform delivery of quality data guarantees the most efficient and timely outcome in all trials. Our historical patient data confirms that we have outstanding recruitment and retention percentages in the upper 90's.

Serving the SynBio materials, foods and pharma industries with comprehensive facilities/equipment service programs, We help customers optimize their processes with the most cost effective systems, services, and processes to keep them running on schedule and in budget. Facilities/Equipment Performance Management Service Contracts Upstream Process Consulting - Bioreactor specification - Sensors, Sampling solutions - Automation - Integration Downstream Process Consulting - Filtration - Chromatography - Separations - Drying Calibration – instruments measuring -Temperature - Pressure - Flow - Mass - Optical - Volumetric - Dimensional NIST traceable "cradle to grave" calibration - Performance - Logging - SOP's - Records management Validation – IOQ generation, execution and reports OEM Post Sale Services Management - Installation - Calibration - Integration - On-site Services - Mail-in or Remote Service Center repairs - Warranty Record and Services Management Laboratory/Plant - automation, integration and maintenance Labor Services - field and contract service Equipment Sales - OEM supporting services in process design and performance service contracts - OEM Services Partners include;; Sonotec Non-invasive Flow Meters, BlueSens offgas Analyzers, APS Corp. Industrial Bioprocess Systems, Chemglass Labware, Hamilton Instruments, SecureCell Laboratory Automation

Advanced Radiation Therapy is the provider of AccuBoost. AccuBoost is the latest innovation in breast radiation therapy. The primary beneficiaries of the AccuBoost Technique are the breast cancer patients: who receive conformal radiation with better targeting, less toxicity, much less skin reaction, minimum exposure to the heart and lungs and a superior cosmetic result.

Advanced Resilient Biocarbon is a company that specializes in biocarbon production through licensed pyrolysis systems.

For more than 30 years, Advanced Solutions, a privately held company, focused on long-term investments in technology companies that deliver profound and positive engineering solutions for healthcare, manufacturing, workflow optimization, logistics and education. Companies include: Advanced Solutions Life Sciences, Power of Public Speaking, Expedient, and IDS Engineering. Advanced Solutions Design Software and Advanced Solutions PLM are now part of IMAGINiT Technologies

At AdventHealth, Extending the Healing Ministry of Christ is our mission. It calls us to be His hands and feet in helping people feel whole. Our story is one of hope — one that strives to heal and restore the body, mind and spirit. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies and hospice centers provide individualized, wholistic care. Our Christian mission, shared vision, common values and focus on whole-person health is our commitment to making communities healthier with a unified system: 50 hospital campuses and hundreds of care sites in diverse markets throughout nine states.

Advin Biotech is a FDA Registered growing corporation and manufacturer specializing in rapid diagnostics products for drugs of abuse testing with China and US based manufacturing facilities. Offering a complete line of one step drug tests for medical workplace and criminal justice professionals. Advin's 501k cleared products are intended for OTC, CLIA and professional use in cup, dip-card and cassette test formats. With full R&D and manufacturing capabilities located in our San Diego, California plant we are positioned to respond to the needs of partners and customers worldwide. We have the intra-company organic chemistry expertise to facilitate the design and synthesis of immunogens and the complementing ability to use the resulting immunogens to generate antibodies for the sensitive and specific detection of antigens and biomarkers. We encourage partnerships and co-development opportunities accordingly. Our short-term strategic goal is to augment our existing FDA cleared test menu with first-to-market, "organically-grown" assays targeted to fill the many gaps in the diverse toxicology market. Our long-term goal is to foster partnerships in the worldwide medical and forensic communities with a shared goal of providing affordable, accurate and actionable tests that fill unmet needs.

Advion is a manufacturer and supplier of mass spectrometers and analytics systems for life science and pharmaceutical sectors.

Aegea Biotechnologies, Inc. is a technology company that is developing a series of reagents, research kits and in-vitro diagnostic (IVD) products for molecular analysis based on novel, patented and proprietary nucleic acid chemistries and methodologies.

Aequor -- pronounced Acorn without the "n" -- means "The Sea" in Latin. Aequor's Founder discovered new chemicals in the ocean that are more potent and less toxic than anything known to kill bacteria and fungi -- including the antimicrobial resistant (AMR) Superbugs. PRODUCTS: Our platform includes "green" chemicals and products containing them for B2B sales and licensing: --Available now: 25 specialty chemicals - EPA/TSCA-approved --ingredients for consumer products to replace harmful biocides --proprietary formulations - sprays, washes, paints, coatings, etc.: --treatments for improving algae and yeast biomass production processes up to 40% in half the time for biofuels and renewable co-products --surface cleaners --water treatments --Pending EPA/FIFRA approval: 30 antimicrobials that are "green" and non-toxic for products and treatments making antibacterial, antifungal, antibiofilm and antifouling claims --Pending FDA approval : 30 new drug candidates The NIH offered Aequor free pre-clinical trials for 4 of the new drug candidates if we can deliver to them half-kilo samples. The DOD offered the same for up to 5 new drug candidates. SERVICES Aequor offers microbial and biofilm testing services for third parties seeking to determine efficacy of their formulations, devices, etc. UNMATCHED EXPERTISE Aequor's Founder Cynthia Burzell, Ph.D. - Marine and Medical Microbiology -- is considered a pioneer in Biofilms. She lectures internationally and offers educational training programs on biofilm and its impacts on the costs and operational inefficiencies in agro-industry, consumer, and healthcare sectors. UNMATCHED MODEL Aequor is a resident company at JLabs San Diego, raised $1.2M cash and is a Woman Owned Small Business, eligible for 5% of government contracts. For our in-house and virtual management team and updates, see our website. For further information: Marilyn Bruno , CEO - mbruno@aequorinc.com

Nasal breathing is a very important function of human life and any obstruction in the nasal airway also known as a congested or blocked nose, can dramatically impact the quality of life.The VIVAER treatment, performed in a doctor’s office, is a non-invasive procedure without any incisions. The patient'snasal valve area is gently reshaped using low-temperature radiofrequency energy with lasting results.

AeroFarmsis an indoor vertical farming company. They usea patented aeroponic growing system to grow produce.

From economic headwinds to talent complexities, the challenges facing North American industry are real. To rise to this moment, Aerotek® Inc. helps companies, and careers evolve. Aerotek provides staffing and services solutions in manufacturing, logistics, construction, aviation, facilities and maintenance. We partner with our customers to offer the expertise, solutions and people they need to rise to the challenges of North American industry. Our 12,600+ employees across 250+ offices work relentlessly to serve 180,000+ light industrial and skilled trades workers with 14,000+ employers every year. Let us rise to meet your challenges.

Aether's mission is to build a future of abundance for the human race. We believe that the machinery of nature can be reverse engineered to manufacture any arrangement of atoms desired, enabling the production of new products anywhere on earth.

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and harmful exosomes from blood utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Affera is a venture-backed medical device company founded by a seasoned team of leaders in the industry. We are developing an innovative system to treat heart rhythm disorders, a prevalent condition affecting millions of patients worldwide. Follow us as we share updates about our progress.

Affina Biotechnologies is dedicated to excellence in helping our customers develop measurements of activities, kinetics and affinities of interactions and concentrations of biomolecules. We offer a unique mix of label-free and label-dependent assay technologies supported by scientific and technical expertise and a wide range of instrumentation: Surface Plasmon Resonance (SPR) Light absorbance, luminescence, fluorescence polarization, time-resolved fluorescence Affina scientists will work with you on developing custom-built measurements and screens that are tailored to your requirements. Once a method is developed and validated we will help you transfer it to your facility of choice or perform it at Affina. The services listed are the major ones that we provide. If there is a type of measurement that can use our technologies and is not listed here we will be happy to work on it with you! Affinity and kinetics of molecular interactions Enzyme activity Total and active concentration

Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development. Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.

Affinity Life Sciences for over 10 years providing the highest quality services for Lyophilization, Reagent Manufacturing, Immunoassay test and more.

AG3 producesherbaceous perennials, grasses, sedges, bulbs, insectivorous, ferns and tropical varieties. The company uses tissue culture to produceand sellcloned plants.

Agathos Biologics is a biotechnology company pursuing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy. Discoveries in bioprocessing and genetic characterization and control have created an abundance of scientific possibilities that can help us all lead better lives. Our mission as the good science company is to create breakthrough products and services within a strong ethical and moral framework that benefit everyone. We believe in science that serves and have a relentless focus on serving our clients, employees, and society. For more information, please visitÂ

AgBiomeis usingknowledge of the crop microbiome and an extensive network of field-sampling partners to build a proprietary microbial strain collection that is both diverse and large—larger, in fact, than the major public strain collections. Unlike many programs, which only use metagenomics surveys, the AgBiome platform is focused on true isolated microbial strains, which provideinsight into the genomic composition of crop-associated microbes. The company uses this collection as a resource for discovering new biologicals and trait genes.Existing microbial classification systems based on 16S rDNA sequences or other fingerprinting technologies are imprecise—microbes that are classified as ‘the same’ often differ by hundreds of genes. AgBiome uses proprietary algorithms based on whole genome sequence to classify organisms in their collection. This allows the company to measure the true diversity of plant-associated microbes at the gene level—and genes determine function and performance. The company has also applied our whole-genome methods to their straincollection.

For nearly 20 years, AgBiTech has been on a mission to make pest management more sustainable and farming more profitable. As the world's leading producer of NPV-based insecticides, we apply our expertise in research, field development and state-of-the art manufacturing to bring our solutions to major row crops around the world. We manufacture all products in-house at our global headquarters in Fort Worth, TX. Our relentless focus on quality and efficiency, allows us to produce consistent and cost effective biological products that have established us as the market leader in NPV production and commercialization. For further information, visit www.agbitech.com.

AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from pre-clinical to commercial production, including our proprietary CHEF1TM Expression System for efficient protein production with CHO cells. Our company DNA drives us to provide innovative solutions to partner with our customers in helping them reach their goals and accelerate their projects at our cGMP-compliant facilities in the US, Europe and Japan, as well as to facilitate approval and manage spending during the product lifecycle. We forge exceptionally strong partnerships with our customers and we never lose sight of our commitment to deliver reliable and compliant drug substance. Visit www.agcbio.com to learn more.

In 1976 Alister Voller, Mike Clark, and associates reported the successful and sensitive detection of plant viruses by ELISA. Two years earlier, Voller, Engvall, Bidwell and Huldt developed the microwell ELISA plate. This technology arrived just in time to test and select plants grown by tissue culture and to assist clean plant programs using one-way pass-through propagation methods. The rapid exploration and acceptance of ELISA created an immediate need for optimized, validated tests, for kits, for quality controlled antibodies, enzyme conjugates and accessories. Agdia, Inc. was formed to meet this need. Agdia's first tests were developed for common potato pathogens, i.e., the viruses, PVX, PVY, PLRV, PVS, PVM, PVA and the bacteria, ringrot [Cms] and blackleg [Eca]. Next, a Testing Service was developed to help those who needed testing results but did not want to perform the tests themselves. The products and services were an instant hit. Agdia grew quickly as its products and services became known worldwide. In rapid succession many tests were developed for fruit, ornamental and field crops. And, significant advances were made in test formats and test type, including, the PathoScreen® test format, the potyvirus group test, membrane assays for viroids, nested PCR for phytoplasma, PCR virus group tests and ImmunoStrips®. All of this was possible only because a worldwide community of scientists and customers provided technology, biomaterials, plant samples and constant encouragement. Agdia's continuing focus on developing and performing tests for plant pathogens and dedication to confidential customer service and support have earned a special trust and place in the worldwide agricultural community. We value and treasure this trust. And, with each day, we dedicate ourselves anew to providing you with products and service that enable you to grow healthy crops with confidence.

Agena Bioscience® empowers research laboratories worldwide to deliver scalable targeted genomic data. Our advanced platforms deliver timely molecular insights in the areas of mutation profiling, liquid biopsy, pharmacogenetics, and more. Agena offers the MassARRAY® System, an open platform that provides researchers with insights through a highly multiplexed solution. Headquartered in San Diego, with offices located around the world, Agena Bioscience fosters a highly collaborative culture for both our customers and employees, encouraging diversity, creativity, and most importantly, innovation.

Agragene has developed Precision-Guided Sterile Insect Technology that will reduce grower's reliance on the 6 billion pounds of pesticides used on crops each year. Agragene is ready to deploy its first "Knock-Out" product in the field which targets spotted wing drosophila. The "Knock-Out" product will benefit crop growers in 3 key ways. 1) The product is much cheaper than the chemical pesticides used now, 2) scarce and expensive field labor is not required and 3) the resulting pesticide-free crop can be Organic-approved which increases grower's profits. Importantly, "Knock-Out" is non-toxic to bees, other beneficial organisms, the environment and humans. With many states and countries banning pesticides growers must look to safer and cheaper alternatives. Agragene has the solution.

Genuity was an early ISP (Internet Service Provider) focusing on commercial customers. It was among the pioneers to offer data center services at facilities with high Internet capacity. It was acquired by GTE/BBN. The company was made independent through the process of consolidating various companies to what is today Verizon.

AgriGro’s® formulations deliver plant nutrition along with a prebiotic concentrate, which significantly increases the growth of beneficial native microbial species. The company sells prebiotics for crops, livestock, gardening, golf, and wildlife. The company also makes a prebiotic formulation for treating organic waste or bio-solid residue.

AgriStart enables innovative early-stage businesses and SMEs to grow faster and with the confidence they have a scalable business model. We provide the expert advice and industry connections that fuel growth. We're on the lookout for those genuinely innovative ideas that once brought to market and adequately supported through collaborative partnerships, are industry changing and have global potential.

Agrivida is a biotechnology company focused on developing and commercializing a new generation of enzyme solutions to feed livestock more efficiently, reduce negative environmental impacts, and produce more healthful food for an expanding consumer population. Agrivida’s first product, GRAINZYME® Phytase, grows enzymes that are crucial for livestock’s health and well-being directly inside the animals’ corn feed. The enzymes improve feed digestibility, increase mineral availability, and reduce nutritional inhibitors within the animals. The traditional process for enzyme delivery is costly and inefficient. It requires enzyme additives to be administered alongside animal feed, and the process for producing the enzymes is complicated, generates excess waste, and requires tremendous energy. By growing necessary enzymes directly inside the feed, Agrivida eliminates the need for these enzyme additives, ultimately reducing costs to farmers, minimizing feed waste, and improving the environmental footprint of the entire process. Agrivida’s team is led by food and agribusiness industry executives and scientists with expertise in the fields of biochemistry, plant biology, molecular biology, and nutrition.

We help entrepreneurs form new teams and build AI-first startups. Apply on our website for $500k investment, up to $1M in free AI compute, and network of AI founders and researchers. We bring together world-class engineers, researchers, and entrepreneurs to create new companies together from scratch. From ideation to execution, we help generate ideas, find co-founders, secure pilot customers, integrate cutting-edge AI, and more. Our hands-on support guides founders through building, scaling, and raising millions in venture funding. In 6 years, we've backed 40+ companies now valued at $1B+, raising $220M+ and creating 700+ jobs. Our startups are transforming industries: improving immigrant communication (Yoodli), accelerating cancer research (Ozette and Modulus), enhancing legal efficiency (Lexion, acquired by DocuSign), turning smartphones into medical devices (PreemptiveAI), and so much more. Any VC can write a check, but what truly sets us apart is our unparalleled technical and AI expertise. With our heritage at the Allen Institute for AI—founded by Microsoft co-founder Paul Allen—we’ve been singularly focused on commercializing AI long before it became a buzzword. AI2 has 200+ PhDs, researchers, engineers, professors, and support staff—and is well known for its contributions to the A.I. research community including 600+ papers, 20+ best paper awards, and numerous products/open-source offerings including SemanticScholar, AllenNLP, and more. Our core team includes pioneers like Oren Etzioni, a leader in AI for over three decades, and our deep technical expertise means we don’t just back you financially—we help you build breakthrough products, navigate complex challenges, and accelerate your company’s growth. We're soon launching AI House in Seattle, a central hub for AI innovation. In partnership with the Mayor of Seattle and supported by Washington state, this space will serve as a central hub for the region’s AI community.

A.I. Analysis, Inc. is a medical software company specializing in the application of artificial intelligence (AI) to radiology. A.I. Analysis, Inc.’s first product is the Change Detector for Brain Imaging, a machine-learning based system that compares serial MR imaging studies and presents changes in the form of a color overlay superimposed on the anatomical images. The Change Detector saves radiologists time at the beginning of their reading — perhaps up to 10 minutes for diseases such multiple sclerosis. The Change Detector highlights the locations of changes and degree of those changes, so the radiologist can more quickly reach clinical judgments. Using the Change Detector, it may be possible for radiologists to detect changes months earlier than is possible with manual inspection alone, with greater reproducibility.

Aigen is accelerating the transition to regenerative agriculture. We're launching the world's first AI-driven, network connected robotic fleet, powered entirely by the elements. Aigen is building a future with no harmful chemicals in our food. Backed by NEA, GFC, AgFunder, Regen.vc, and Bessemer Ventures

Ainnocence is a next-generation biotech company with a fast, self-evolving AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for small-molecule, antibody, and other complex therapeutic modalities. This platform provides a computational screening capacity of up to 10^10 protein sequences or chemical compounds within hours. The end results are a shortlist of candidates with a very high wet-lab hit rate, and a dramatically reduced discovery time and cost. To learn more, visit ainnocence.com.

AirLife is the global leader in consumable breathing products, specializing in respiratory care, anesthesia, and patient monitoring solutions. AirLife has brought together the most trusted brands in anesthesia and respiratory care, such as SunMed, Salter Labs, Ventlab, Ethox Medical, Westmed, Vital Signs and Ballard. Our family of brands offers a product portfolio that spans the continuum of care from first responder to home care, with safety, patient comfort, and clinical performance in mind.

AIROS™ Medical, Inc. is a medical technology manufacturer, designer, and specification developer specializing in compression therapy. Our team of engineers, quality and regulatory experts, and clinical partners create medical devices that improve quality of life for patients battling lymphatic and venous disorders, including the AIROS 6 and AIROS 8 Sequential Compression Device systems.

Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.

AJA Labs is materials science and fiber innovation firm pioneering in dermotextiles and cosmetic textiles. We have brought to market "the fake hair of the future" under the brand mantle, Nourie, manufacturing and selling hair extensions made from biopolymers. Harvested in SOSV's IndieBio accelerator and NC State's Wilson College of Textiles, AJA Labs is where cosmetic efficacy, intellectual property, and sustainability intersect. Not only is our Raleigh-based team creating and defining a novel category in cosmetic haircare, but we are doing so through IP-backed platform technology that borrows the methods and means from time-release technology popularized in OTC pharmaceuticals. Each fiber of hair is wrapped in a nutrient rich cosmetic coating loaded with active ingredients you'd find in the Sephora skincare aisle to penetrate the hair shaft and scalp. Nourie's plant-based cosmetic performance fibers nourish your body during wear by releasing a cosmetic coating; it performs for you to address often overlooked beauty concerns while achieving style-forward hair looks. Much like the category-creating lab-grown diamond industry before it, AJA Labs approximates key properties of human hair including tensile strength, diameter, and biocompability. Currently undergoing human clinical trials for efficacy, AJA Labs proudly manufactures in the USA.

Ajinomoto is a global leader in the research, development, manufacture and sale of amino acid-based products for the pharmaceutical, nutraceutical, sports nutrition, health and beauty industries as well as food ingredients and consumer food products.

Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the Alerion™ Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material in under an hour, significantly expanding capacity of manufacturers. Akadeum is currently working with some of the largest corporations and forward-thinking leaders in the industry. The power of the Akadeum microbubble platform is an elegant and easy-to-use technology that can enable faster, more accurate, and scalable workflows to improve human health. Better Isolations. Healthier Cells.

3D substrate, drug-containing microparticle device, formulation services, polymer drug delivery

Akonni Biosystems is a molecular diagnostics company that develops, and manufactures at scale, sophisticated yet low cost genetic testing devices for complex infectious diseases like multi-drug-resistant tuberculosis (MDR-TB). Our approach is based on a revolutionary gel-drop microarray platform, along with associated instrumentation for high yield sample preparation and multiplex array imaging/analysis.

Akrivis solutions cool equipment and deliver cleanroom conditions in modular buildings and cabins. Specialist units delivering exceptional performance, outstanding reliability, and ultra-low energy usage.

Akrivita (formerly SeeTrue), a woman-owned company, specializing in microcapillary needles for precision microinjection. At AkriVita, we've developed the MultiPort Microcapillary Needle using advanced 3D printing and unique resin, ensuring precise and consistent needles. This innovative design eliminates recalibrations, reduces downtime and costs, and minimizes clogging. Our high-contrast needles offer consistent flow, improving the success rates of microinjection procedures. AkriVita provides biomedical scientists and healthcare practitioners with reliable tools that enhance outcomes, save time, and cut costs, enabling them to focus on advancing human health through discovery and innovation.

Akrotome Imaging, Inc. is focused on the clinical translation of cancer-targeted molecular probes into enhanced approaches for surgery and diagnostics, leading to improved outcomes and patient quality of life while positively impacting healthcare economics. Akrotome is a Delaware C Corporation with offices in Ohio, Indiana, and California. The company was first incorporated in 2008 and the current management team has been in place since May of 2012. The company's approach stresses the efficient use of capital, coupled with strategies that emphasize the fastest routes to the clinical market with the lowest regulatory overhead.

Alafair Biosciences is a privately-held, commercial-stage medical device company focused on the development of novel clinical products using its proprietary hydrogel technology. With a patent portfolio covering a broad range of clinical applications, Alafair is focused on building a robust product pipeline. Its products are distributed through a dispersed network of independent distributors across the United States.

Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.

Alator Biosciences is a privately-held company providing quality research products and custom manufacturing services located in Sun Prairie, Wisconsin minutes away from the heart of Wisconsin's biotech community and University Research Park.

The Genomics Core serves the Einstein scientific community by providing a broad range of services, utilizing current and emerging nucleic acid technologies. Single-cell assays, MPS, Microarrays, real-time PCR, Sanger sequencing and assay automation are available. The Core provides a number of technologies for genotyping DNA from humans or model organisms, varying from SNP (single nucleotide polymorphism) typing to targeted sequencing for variant discovery.

Alcala Labs was founded by a partnership between a healthcare attorney specializing in the defense of individual and institutional healthcare providers and a physician with one of the largest pain management practices in Southern California. The lab grew out of frustration with existing laboratory providers and the conviction that Alcala Labs could do better. Smaller labs were not scientifically up to the task and, in many cases, were simply dishonest about the services they provided. Larger labs were either unresponsive or subcontracted critical complex lab services to unaccountable third-party labs . Alcala Labs was built to react quickly to the needs of physicians who need to understand drug use and efficacy in their practices. The Alcala difference is accessibility to its physician customers, responsiveness to their needs and inquiries, and customizable lab testing. If a physician has a medical-legal question that arises from testing, he can immediately reach the company's healthcare attorney President. If a physician requires insight into how a particular test affects the course of a patient's care, she can engage in a dialogue directly with the lab's Medical Director. If there are questions about science and the development of new tests, our highly credentialed scientific team can be reached directly. Widely in demand among a variety of specialties, Alcala Labs is of especial importance to drug rehabilitation, pain management, and psychiatry practices. We're able to add assays as illicit "designer" drugs begin to appear, and our new pharmacogenetic department gives physicians the power to anticipate the right drugs and dosages to best treat their patients. Located in San Diego, Alcala is a laboratory of national reach and reputation. It is among the fastest growing labs in the country, dedicated to state-of-the-art science and the highest quality service.

Alcami is a pharmaceutical CDMO that offers contract development and manufacturing services for the healthcare and biotechnology industries.

Alchem Laboratories is a pharmaceutical company that specializes in custom organic synthesis, cGMP manufacturing, and analytical services.

We build and operate in-house pharmacies for safety net clinics, with a focus on STD clinics, Ryan Whites, and FQHCs serving patients living with HIV and Hepatitis C. We provide the entire physical, clinical, and digital infrastructure needed to operate and grow best-in-class 340B pharmacy programs. Our team has deep clinical pharmacy, technology, and operations experience. Together, we have spent 18 years in Africa building the largest HIV access program in the world, and we have set up, operated and scaled pharmacies that have dispensed over 25M+ prescriptions to patients across all 50 states in the US. After setting up your in-house pharmacy, we design and implement clinical pharmacy programs and deploy technology products that leverage your pharmacy to expand patient reach, improve clinical outcomes, and increase the financial impact of your 340B program. We are on a mission to serve safety net clinics and their patients. Drop us a line at hello@alchemyhealth.com.

Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by top-tier venture investors Athyrium Capital Management, Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures.

Alder Renewables harnesses the power of abundant and sustainable biomass to create a low-carbon to carbon-negative renewable platform.

Aldevron is proud to be part of Danaher. Aldevron is a leader in advancing biological science. Our custom development and manufacturing services have provided scientists around the world with the tools to make significant scientific advances. We provide high-quality plasmid DNA, proteins, enzymes, and other biologicals to help our partners achieve ground-breaking science.

Alere is now Abbott! Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

Alfa Wassermann Diagnostic Technologies is a provider of medical diagnostic instrumentation and reagents to the physician office, veterinary lab, and biopharmaceutical markets.

Algae-C is developing a platform for the sustainable and low cost production of plant-based ingredients. The companycreates designer microalgae that produce valuable ingredients for the pharmaceutical, nutraceutical and therapeutics industries.

Algae Systems is a full service algae to energy technology development and commercialization firm focusing on autotrophic algal solutions for the production of carbon negative high-BTU liquid fuels, water treatment and other high value products. Algae Systems was founded by a group of renewable energy veterans, NASA engineers, business executive consultants and IT experts. We are developing low-tech, highly scalable carbon-negative fuel production infrastructure that simultaneously treats wastewater and provides other services to industralized and developing economies.

We have broken the barrier to produce any microalgae on a commercial scale using a patented technology modular system. Our algal biomass is distributed as live, natural, high density, and of unequaled nutritional value. We partner with you to create a data driven knowledge network of best practices.

ARC specializes in mass culturing of sensitive marine and freshwater microalgae that are challenging to grow on a large scale. We are also experts in finding the proper medias for difficult to culture species and isolating species from wild samples. Our main group of focus are dinoflagellates, but we have recently expanded our services to include diatoms, such as Haslea sp., and freshwater species, such as the green algae Oophila sp. ARC also provides toxin analysis, DNA extraction and sequencing, photomicrographs, and HPLC pigment analysis. Feel free to contact us at arc.uncwilmington@gmail.com or view our website for service pricing and available strains.

Nature's solution for food's future. Engineering sustainable food solutions for all. As a food-tech company, Algama harvests the potential of algae to create food that's good for both people and the planet. Algama's goal is to feed 10 billion people by 2050, while preserving the planet and offering consumers additional and better choices in foods. Our story After consuming microalgae for numerous reasons, Alvyn and Gaëtan conclude that it was a viable solution with the potential to redefine our food system for good. Algama was founded in 2013. World leader in algae food Since its founding, Algama has been the world leader in microalgae food and is proud to have the support of world-class impact investors like Horizons Ventures, Blue Horizon Ventures, CPT Capital, Veginvest, Beyond Impact, Alwyn Capital. All the team is dedicated to innovate and make microalgae a key resources for tomorrow's daily food. Algama team We are focused on bringing microalgae-based foods to market, we are working hard to make our ingredients and products super tasty, affordable and widely available. We are expecting the team and we are looking for talents, innovateurs and entrepreneurs.

AlgenAir makes an air purifier that uses Spirulina to create oxygen and reduce carbon dioxide. According the company, one air purifier provides a benefit equivalent to 25 houseplants.

Our scientists redesigned plastic materials to harmonize with nature. Our patented Soleic® technology is the world’s first high performance, renewable, and fully biodegradable plastic material made from algae. Algenesis was founded in 2016 by three professors from UC San Diego, Dr. Stephen Mayfield, Dr. Micheal Burkart, and Dr. Robert Pomeroy. Together they combined their knowledge and background and worked their way into the polymer market where customers had an unmet sustainability need. Traditional petroleum plastics are responsible for a tidal wave of air, land, and sea pollution that is destroying ecosystems and harming wildlife. Soleic® technology was developed to address this global plastic pollution crisis. Our initial product line consists of soft foams for footwear and hard foams for surfboards. We continue to research new applications for Soleic® technology. Algenesis is also developing new technologies with exciting product applications across multiple industries

AlgEternal Technologies LLC will reduce human dependence on fossil hydrocarbons and create sustainable economic activity resulting in a healthier planet and improved quality of life for all, by harnessing the power of the PLANET'S PRIMARY PRODUCERS—ALGAE. MISSION: AlgEternal Technologies LLC will systematically apply microalgae as THE SUSTAINABLE INTEGRATED SOLUTION to the major existing and emerging issues facing our species, faster, more efficiently, and with greater environmental, social, and economic benefits.

Building a modern operating system for IVF, powered by artificial intelligence.

Aligen is a Pharmaceutical, Nutraceutical, and Cosmetic manufacturer that specializes in Softgels, Capsules, Tablets, Gummies, and Skincare Topical Creams.

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com

Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

AlivaMab Biologics is a biotechnology company based in San Diego, California, focused on therapeutic antibody discovery and development. The company provides integrated solutions to accelerate the creation of biologics, delivering fully human antibodies with a commitment to speed and reduced development risks. Their mission is to create efficient pathways for partners in the pharmaceutical and biotechnology sectors. The team at AlivaMab includes experienced professionals from leading global pharmaceutical companies, contributing to over 500 discovery programs and 35 clinical candidates. They utilize advanced technologies, such as the AlivaMab® Mouse platform, to generate high-quality antibodies and offer a range of services, including antibody engineering and target validation. AlivaMab collaborates with numerous top-tier pharmaceutical companies, with several of their antibodies currently in clinical trials.

AliveCor, Inc. is transforming cardiological care using deep learning. The FDA-cleared KardiaMobile device is the most clinically-validated personal ECG solution in the world. KardiaMobile 6L provides instant detection of Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with Supraventricular Ectopy, Sinus Rhythm with Premature Ventricular Contractions, Sinus Rhythm with Wide QRS, and Normal Sinus Rhythm in an ECG. Kardia is the first AI-enabled platform to aid patients and clinicians in the efficient detection of atrial fibrillation, the most common arrhythmia and one associated with a highly-elevated risk of stroke. AliveCor's enterprise platform allows third-party providers to manage their patients' and customers' heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies. AliveCor protects its customers with stringent data security and compliance practices, achieving ISO 27001 Certification, SOC 2 Type 2 Certification and HIPAA compliance attestation. AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers. For more information, visit alivecor.com.

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

We are the pioneers of allergy solutions. Allergy is the most common chronic disease globally and it has profound impact on people’s lives. More than 500 million people worldwide live with respiratory allergies, more than 200 million people have some sort of food allergy, and more than 100 million children are living with allergic rhinitis. These numbers are only expected to increase, and as a result, the need for allergy solutions is ever-growing. For more than a 100 years, ALK has been at the forefront of long-term allergy treatment. Building on our strong heritage, we are now stepping into the next 100 years with a mission to help even more people, with more solutions, more efficiently. We call it Allergy+. ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,900 people around the world. Our global headquarters is located in beautiful surroundings in Hørsholm, north of Copenhagen. Read more about ALK at www.alk.net

Founded in 1984, All American Pharmaceutical is a leading manufacturer of dietary, food and nutritional supplements. We specialize in producing private label and custom formulations for almost anything from general health and sports nutrition to anti-aging products and food products. All American Pharmaceutical has the capability to produce liquids, capsules, powders and tablets products from concept all the way to finished packaging. We are also the exclusive manufacturer and patent holders of two branded ingredients: Kre-Alkalyn® and Kre-Celezine® Formulating and producing effective, high-quality products is not as simple as mixing a few ingredients together and then dumping them into a bottle. Most people who hire a contract manufacturer don't even realize there are major differences between companies, regardless of price. Before hiring any manufacturer, you need to know what their quality standards and current certifications are, how quickly they can turn your products around and if they even have the capability to pull off your job in the first place. After all, your brand's credibility, integrity and hard-earned image are on the line. All American Pharmaceutical has been developing quality products for the past three decades. Over the years, we've listened to your needs and have responded to offer a variety of production and packaging capabilities. And we do it all in our cGMP certified, state-of-the-art 150,000 square foot facility located in Billings, Montana.

Allay Pharmaceuticals, LLC. has been helping pharmaceutical companies worldwide, bringing products to market - from concept to commercialization, assisting every step of the way.

Allegheny Health Network is an integrated health care delivery system serving the greater Western Pennsylvania region. More than 2,600 physicians and 22,000 employees serve the system's 14 hospitals as well as its ambulatory medical and surgery centers, Health + Wellness Pavilions, and hundreds of physician practice locations. AHN is a proud part of Highmark Health.

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers. The company was founded by scientists and other professionals with the goal of advancing discovery and innovation. Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge products at a reasonable cost, and providing excellent customer service in addition to the technical knowledge needed to facilitate their use. Our knowledgeable scientists and technicians are available to answer questions regarding any of our products. Over the past decade, Allele has become a reliable source for a wide variety of Molecular Biology reagents, superior fluorescent proteins, camelid derived nano antibodies (nAb), cellular reprogramming services and reagents, and immundiagnostic kits and various other products and custom services.

Allele Diagnostics, Inc., located in Spokane, WA, was established in 2014 to offer superior genetic testing services. We feel that high-quality testing, reporting, and services can be offered to you with quick results. We pride ourselves in being a laboratory that offers the genetic counseling services clinicians need in a genetic testing company. We combine this service with reliable, fast, accurate test results provided to you via user-friendly and conveniently accessible reports. At Allele Diagnostics, we are passionate about providing reliable answers as quickly and accurately as possible. We continuously strive to improve the efficiency of our workflow and improve the quality of our test results. We encourage feedback from our clients on how we can improve or assist in bringing your ideas into a clinical testing environment. Utilizing our extensive experience in genetic testing, we can work with you to develop solutions to the challenges you have previously experienced in receiving fast, accurate results. Additionally, we are always looking for new and better ways to provide answers to genetic questions and are continuously evaluating novel technologies to see how they can fit into our laboratory given the rapidly evolving clinical genetic testing space. Allele Diagnostics is a CLIA and CAP certified clinical laboratory committed to providing superior testing services for the best patient care possible. We are currently licensed in California, Florida, and Pennsylvania and are pursuing various other state specific licenses.

Allevi Develops 3D printers fof bioinks. Bioinks are materials that mimic an extracellular matrix environment to support the adhesion, proliferation, and differentiation of living cells. From GelMA to Collagen and from Hyperelastic Bone to Graphene, Allevi offers the widest range of material capabilities.

Allied Healthcare Products, Inc. is a leading manufacturer of medical gas construction equipment, respiratory therapy equipment, home healthcare products, and emergency medical supplies. Our products appear worldwide in a range of medical applications, including hospital care, sub-acute treatment, long-term care, home healthcare, and medical emergencies. Allied Healthcare Products, Inc. is a U.S. manufacturer of FDA approved respiratory medical devices and immobilization products with over 60 years of experience in the industry. Our products are produced in an ISO13485:2016 facility and we carry the capability to apply the CE mark to the products we produce. Allied manufactures transport ventilators, airway products, and immobilization devices under the Life Support Products (LSP) brand. For more information, please visit www.alliedhpi.com or www.ahp300.com.

Harvesting the power of Nature, Allied Microbiota develops advanced microbes to clean-up environmental contamination faster, more sustainably, and more cost-effectively than traditional remediation methods. Our products tackle the toughest contaminants like those from manufactured gas plants, chlorinated organics, and even emerging contaminants like per- and poly-fluoroalkyl substances (PFAS). We developed a heat-loving microbe called ThermO+ that breaks down contaminants at a fraction of the cost and significantly faster than traditional methods. Powered by heat and on oxygen, our microbes can clean difficult contaminants such as chlorinated compounds like polychlorinated biphenyls (PCBs), petroleum products, and dioxins from the soil, turning brownfields into greenfields. We don't bury the problem. We solve it. Site cleans ups can be expensive, but our technology makes this possible for companies, developers, and communities. We aim and strive to create cleaner, healthier, and productive areas around the world. Make Allied Microbiota your fast, affordable, and go-to solution for a cleaner tomorrow.

Health Products For You (healthproductsforyou.com) is a premium online health and wellness retailer. Celebrating our 20th year of delivering quality health care and healthy living products directly to your doorstep, we are committed to making a difference in the lives of our customers and the communities we are privileged to serve. Our 10+ health and wellness stores carry a wide array of products dedicated to women’s health and wellness, incontinence, ostomy, rehabilitation, mobility, respiratory, wound care, and more. Having developed relationships with the top 2000+ manufacturers over the past 20 years, we can provide our B2C and B2B customers with the ultimate streamlined purchasing experience, offering the best quality products at the lowest possible prices. Enter our #giveaway contest: https://www.healthproductsforyou.com/sweepstakes.html

Founded in 1994, AlloSource is a nonprofit leader in providing allografts that maximize tissue donation to help surgeons heal their patients. The company has grown into one of the largest tissue networks in the country creating more than 200 types of precise bone, skin and soft-tissue allografts for use in an array of life-saving and life-enhancing medical procedures. As a leading manufacturer of cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource’s products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO.

Allotrope Medical is committed to helping surgeons safely and easily identify the ureter during pelvic operations. The Houston-based company's first product –StimSite™–is designed to assist surgeons in the critical step of ureter identification in millions of operations performed every year. It received funding from Y-Combinator the Mountain View, CA based group that also invested in Door Dash, Dropbox, and Airbnb, and has been voted Top Innovation by a panel of expert surgeons at SAGES (Society of American Gastrointestinal and Endoscopic Surgeons). It also was the past runner-up in the MedTech Innovator contest out of over 600 companies from around the world, and took home top prize at the 2020 Texas A&M New Ventures Competition. Our vision is to advance smooth muscle stimulation technology as the standard of care to help improve minimally invasive surgical outcomes and drive healthcare efficiency. We are building a dynamic team of high performing, accountable, attentive individuals looking to serve patients, partners and institutions in focused surgical specialty markets.

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From academics and biotechs of every size to large pharma, we democratize access to foundational, pre-competitive biologics discovery technologies and services to enable drug discovery across six biologic modalities. When you partner with Alloy, you can: • Access our ever-growing stable of services and cutting-edge technology platforms to help you discover the best therapeutic antibodies against your targets • Unlock the therapeutic potential of T cell receptor (TCR) modalities through our fully integrated Keyway™ TCR Discovery service offering • Reach intracellular disease targets at the nucleic acid level with our novel AntiClastic™ ASO Format, which enhances the drug-like properties of antisense • Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Boston, MA, with labs in Cambridge, U.K.; Basel, CH; San Francisco, CA; and Athens, GA. We reinvest 100% of our revenue into innovation and access to continuously develop new groundbreaking platforms and protocols to make our collaborators more successful.

All Things Bugs manufactures and sells finely Milled Whole Cricket Powder for food production.

Allurion was founded in 2009 with one mission: end obesity. The Allurion Program combines medical, digital, and nutritional approaches and engages an entire team to jumpstart weight loss and form lifelong healthy habits. Allurion has already helped thousands of people around the world lose weight, develop lifelong healthy habits, and transform their lives, with over 100,000 balloons placed, and over 1,000,000kg lost worldwide.

Allvivo Vascular is a medical device company that develops biomimetic coatings for devices, offering dual function coatings with nonthrombogenic and antibacterial properties.

We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-friendly, reliable and accurate solutions. We achieve this through a culture of respect, dedication, empowerment and creativity.

Since 1987, Alpha Analytical, Inc. has provided full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is 6th largest environmental laboratory in the country, and is the largest environmental laboratory in the Northeast with services and support extending into New York,New Jersey, Ohio, Kentucky, and Michigan. Our core services include air, water and soil analysis, with particular expertise in the highly-specialized fields of emerging contaminants, sediment and tissue analysis and petroleum forensics. Please contact your Alpha technical sales representative to learn more about our capabilities, experience and certifications. Visit us on the web at www.alphalab.com.

AlphaBiolabs provides DNA testing to members of the public.

AlphaDERA Labs, LLC. is a full-service medical laboratory providing wellness testing, routine blood chemistry, prescription & illicit drug test including urinary tract testing, respiratory pathogen testing, and COV-19 antigen testing for healthcare facilities, clinics, and PCR Covid-19 testing for patients.

Alphalyse has pioneered the use of mass spectrometry analysis since 2002. Our scientists have completed over 5,000 protein characterization analyses, including forced degradation studies and over 400 LC-MS-based residual/host cell protein projects. Currently, we are the only CRO in the World certified to offer LC-MS-based MRM analysis under GMP for release testing. As a specialist contract research organization (CRO), we offer protein analysis services to support biopharmaceutical companies in developing and manufacturing patient-safe products such as mAbs, vaccines, recombinant proteins, and cell & gene therapies. You can count on us to work closely with you on developing well-characterized biologics by challenging and improving analysis methods using top-of-the-line mass spectrometry technology (LC-MS). Our comprehensive reports will allow you to carry out data-driven process development and regulatory documentation under ICH Q6B guidelines. Our services include analytical characterization of biopharmaceuticals, mass spectrometric peptide mapping, host cell protein analysis, and quantifying specific proteins in complex samples.

Alpha Medical Instruments,developer, manufacturer, Balloon flotation catheters, venous catherization, right heart, measurements, venous, pulmonary artery pressures, cardiac output

ATEC is a medical device company dedicated to revolutionizing the approach to spine surgery through innovation. ATEC’s Organic Innovation Machine™ is the greatest concentration of spine knowhow in the industry and committed to the creation of clinical distinction. Leveraging 100% spine focus and expertise, we seek to improve spine surgery by rethinking, redesigning and seamlessly integrating the technologies required from the ground up. The innovation that results from that process is being rapidly adopted because, like us, spine surgeons covet informatic and procedural sophistication that enables more predictable, more reproducible care. Our flagship technology, the Prone TransPsoas (PTPTM) Procedure, leveraged decades of experience to advance first-generation lateral surgery with a more familiar patient position and elevated neuromonitoring.   EOS imaging, the backbone of ATEC’s informatic ecosystem, provides radiographic imaging, enabling standing, full-body, global alignment assessments. We are further developing EOS technology to elevate spine care with unprecedented capabilities. Our vision is to be the standard bearer in spine. Visit our website for more information: www.atecspine.com

Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.

Zen Cart! : - Products for Cell Biology Products for Molecular Biology ecommerce, open source, shop, online shopping, store

Alphazyme was founded in 2018 by Christopher Benoit, Stephana Petrino and Chad Decker. Our experienced team has a track record of success and a passion for supporting molecular biology innovators. Our mission is to be the world’s premier partner for custom, industrial-scale, molecular biology enzymes. We are enzyme development and production experts, and partner with the manufacturers of nucleic acid therapies and detection platforms to develop and produce affordable, reliable enzymes which meet the specifications of the rapidly expanding market for custom DNA and RNA molecules, genomic medicines and genetic tests. Consistent quality, scalable processes, and compatibility with regulatory requirements are the hallmarks of our business.

Alpine Research is a Clinical Research Center that conducts clinical trials for major pharmaceutical companies.

AltheaDx, Inc. is a commercial stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx). IDgenetix® is AltheaDx’s PGx product test for depression and anxiety and is supported by a published/peer-reviewed Randomized Controlled Trial that demonstrated clinical utility over standard of care when physicians used the test prior to prescribing a medication.

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more. Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis. Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.

Aluna is designed to help you understand your chronic respiratory condition (such as asthma) and allow you to take control of your lung health. Using a combination of machine learning, our spirometer device and mobile app, you can now use the daily measurements to help you understand and manage your asthma.

At Alveo, we're on a mission to use our open, accessible, and actionable molecular detection platform to detect pathogens before they spread. Our portable, handheld, analyzer and cloud-based data analytics brings molecular detection out of the lab and into the field. Alveo's agile platform can be adapted to detect a wide range pathogens including viruses, bacteria, and fungi. Whether testing a patient at a pharmacy at the point-of-care, chickens pen-side at the point-of-need, or farmers testing crops in-the-field, Alveo's technology brings users real time data precisely when and where it matters most. Partner with Alveo today to bring the power of early detection to your industry. Know Sooner, Act Faster™.

Ambay Immune Sensors and Controls (AISC) is working to bring aboutá A revolution in early detection of diseasesá Speeding up the discovery process by developing new research kits and providing technical and professional services

Current methods for disposal and reuse of waste polymer materials areinefficient, low-value, and altogether broken. We believe that breakthrough science and engineering can deliver more efficient reuse of these materials.Ambercycle is developing chemical technology to produce conventional polymers, such as polyesters,from a variety of fibrous waste streams. Student startup out of UC Davis

AmberGen® is a biotechnology company and producer of Miralys™ spatial biology imaging solutions. Miralys™, also known as MALDI HiPLEX-IHC, is a new breakthrough method for targeted intact protein imaging that has unique multimodal imaging capabilities. First introduced in 2022, it has gained significant traction, including 8 of the top 10 pharma companies, as well as many of the world's premier research institutions. It is currently being used to study tissues for a wide range of diseases including cancers, Alzheimer's and Parkinson's diseases; and even COVID. Benefits include: - Drug/target co-localization on the same sample, same instrument - The ability to produce images that co-register small molecule lipids and metabolites as well as the intact targeted proteins. - The product's combination of fast, targeted, protein imaging (scan time as short as 45 min and 1cm2), ultra-high plex (10 to 100+), wide viewing area (up to 25 x 75 mm), and multi-modal capability make it an ideal technology for doing initial scans to identify regions of interest for later deep-dive analysis. - Miralys™ requires no dedicated instrument, and minimal investment to start using. It is used on MALDI Mass Spec Imaging instruments that your institution most likely already owns, such as the industry-leading instruments from our partner, Bruker Corporation.

At Ambient Biosciences, we are dedicated to being a true partner in your success. We bring the same spirit of versatility, transparency, and innovation to our customer relationships as we do to our technology. Our approach is to take the mystery out of biomolecule stabilization, making it an accessible and collaborative process that empowers you to feel confident about your products and assays.

Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics'​ scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers. Hiring Fraud Alert: Ambry/REALM IDx has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry/REALM IDx recruiter(s). If you've experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://realmidx.com/careers/recruitment-fraud-alert/ to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://realmidx.com/careers/.

AMD Biotech, Inc. was founded with a prime focus on the development of nano-magnetic bead technology and its capabilities. Through in-depth research and development, AMD Biotech, Inc. has established the unique technology and production system of nano-magnetic particles for array of products.

American CryoStem Corporation (CRYO) is a clinical-stage biotechnology company, developing and delivering autologous (own self) regenerative therapies to treat diseases and conditions with significant unmet medical needs. We are prioritizing research targets and biological drug candidates where the disease biology is understood, and where our suite of technologies has the potential to make a difference. We are currently focused on mitigating the deleterious effects of post-concussion syndrome: https://clinicaltrials.gov/ct2/show/NCT04744051 and Long COVID/ PASC: Post Acute Sequelae of SARS-CoV-2 https://clinicaltrials.gov/ct2/show/NCT05669261 Translating Technology into Therapeutic Treatments™ Our core proprietary "end-to-end" patented technology platform consists of the “Collection-Processing-Cryobanking and Delivery to Point-of-Care” of Adipose Tissue (AT) and Adipose-Derived Mesenchymal Stem Cells (MSCs). Our Platform is configured to produce large quantities of autologous mesenchymal stem cells for treatments as needed, "on-demand". Through a single tissue collection, an autologous master cell sample is manufactured and cryopreserved for a lifetime of personalized treatments. Naturally, pure and simple.™

American Dermatopathology Laboratory is the creative vision of Dr. H. Nicholas Shamma. They are a comprehensive, CLIA certified and independent laboratory, with a nationwide reach. As a physician owned lab focused on providing clinicians and their patients with reliable diagnoses of skin biopsies, they use state of the art processes and a high standard of care.

American Medical Technologists (AMT) is a non-profit professional association and certification agency founded in 1939. Based in Rosemont, Illinois, AMT is dedicated to credentialing allied health professionals and supporting their career development. The organization is recognized both nationally and internationally for its commitment to high standards, affordability, and lifelong professional partnerships. AMT offers a range of certification programs for various roles, including Medical Laboratory Scientist, Medical Laboratory Technician, Dental Assistant, Medical Assistant, and Allied Health Instructor. The organization also provides continuing education resources to help professionals maintain their certifications and advance their skills. Additionally, AMT advocates for the allied health profession, offering career guidance and resources for employers and educators to align training programs with industry standards. With a focus on integrity, excellence, and member support, AMT aims to be the preferred choice for allied health certification.

Red Cross Blood Services is a Hospital and Health Care company located in 78 Eastern Blvd Ste 3, Glastonbury, Connecticut, United States.

The American Society of Human Genetics (ASHG), founded in 1948, is the primary professional membership organization for human genetics specialists worldwide. The Society’s nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses and others who have a special interest in the field of human genetics. Our members work in a wide range of settings, including universities, hospitals, institutes, and medical and research laboratories. Our mission is to advance human genetics in science, health, and society through excellence in research, education, and advocacy. ASHG serves research scientists, health professionals, and the public by providing forums to: -- Share research results at annual meetings and in The American Journal of Human Genetics -- Advance genetic research by advocating for research support -- Enhance genetics education by preparing future professionals and informing the public -- Promote genetic services and support responsible social and scientific policies Connect with ASHG members and the broader human genetics community in our LinkedIn Group: https://www.linkedin.com/groups/142742

Amerigo is a distribution company providing essential supplies and services to the biomedical and life science research communities. Amerigo's founder has had more than 20 years of rich experience in the biomedical and biochemical fields and has established close contacts with key personnel in top international pharmaceutical and biotech companies, academic research institutes, and government research agencies. Amerigo's most valuable asset is a professional team, skilled at giving effective technical and customer support. Most of our employees own a graduate (Ph.D. or master) degree in life science, ready to understand customers' questions or concerns and provide individualized customer service with high standards. Our mission is to integrate premium product resources worldwide, simplify the search process for scientists, and provide the scientific community with the latest, professional solutions.

Amerilab Technologies is a pharmaceutical manufacturing company that specializes in developing, manufacturing, and packaging effervescent tablets and powders in stick packs and sachets.

Amethyst provides cGMP compliant, custom, creative, and cost effective services (4Cs) for FDA regulated activities to increase its customers' profitability, ensure compliance, and promote patient safety.

Amnio Technology is an industry leader in the development and manufacture of amnion-derived technologies. Amnio Technology manufactures high-quality, amnion-derived technologies for clinical use.

Amplicon independently validates all COVID19 IgM/IG Rapid Tests offered. In business since 1996, Amplicon proactively performs investigational research to confirm the claims of all manufacturers. Doing our due diligence is a critical part of bringing the best performing tests to Medical Professionals. To learn more, please visit https://covid19.ampliconexpress.com/

AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. To learn more about pulsatile intravascular lithotripsy, visit www.avspulse.com.

Amprion pioneers Testing for diseases associated with mis-folded proteins. Our flagship product - SYNTap is the assay used by the Michael J Fox Foundations Parkinson's Progression and Markers Initiative (PPMI) to define PD and DLB and its stages. Early diagnosis of synucleinopathies can help guide management, treatment and prognostic discussions. https://www.ampriondx.com

Amron International is a manufacturing company that specializes in high-quality diving, tactical, hyperbaric, and outdoor equipment with over 30 years of industry experience.

This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture. SCureClamp with iDOT's anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types, and wall thickness.

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. The Amsino product portfolio includes Sterile Water and Saline, IV Therapy, Waste Fluid Management, Respiratory, Urology, and Enteral Feeding products. Amsino products are distributed in the United States and more than 80 countries worldwide. Visit www.amsino.com for our complete product offering.

In neuroscience, where so much is yet to be explored, it’s crucial that scientists and researchers can devote their time to discovery. Through a partnership with a team of experts at Amuza, researchers gain access to precise tools that get data right the first time and opens the door to discovery. Amuza is a researcher-focused company. We provide instruments and support to improve productivity and outcomes for life science research and the quality of human life.

Amyris (Nasdaq: AMRS) is a science and technology leader in the research, development and production of sustainable ingredients for the Clean Health & Beauty and Flavors & Fragrances markets. Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence. Our ingredients are included in over 3,000 products from the world's top brands, reaching more than 200 million consumers. Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance™ clean beauty skincare, Pipette™ clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane. For more information, please visit www.amyris.com.

CenExel ACT is dedicated to performing medical clinical trials to find new patient therapies in unique areas, including Japanese-and Chinese-bridging studies. Our Phase I Clinical Pharmacology Unit is a 30,000 SF, state-of-the-art, 90 beds, clinical research center, and features: Private patient rooms and ward setting, State of the art entertainment 24-hour medical coverage, 7 days a week, On-site Surgery Suite (2 Procedure Rooms, 3 Recovery Beds), Emergency Room and Intensive Care Unit located close by In the clinical trials area, we ffer investigational therapies for indications such as Migraines, Insomnia, Chronic Pain, Osteoporosis, Hormone Replacement Therapy, Diabetes and much more. We offer new and existing therapies that manage conditions where other medical therapies may have failed. Each and every CenExel patients receive the highest quality medical care. We notify the patient's primary care physician of enrollment and ongoing status and provide a full report at the conclusion of each study. To learn more about working with us as a Sponsor or CRO for your clinical trial visit CenExel.com/ACT or call 714-774-7777.

Founded in 1996 in Cleveland, OH, Analiza, Inc. is a leading US based provider of high quality, affordable analytical services for physicochemical and ADME properties for early drug discovery markets. Adapting gold standard methods for compatibility with early drug discovery (throughput, sample requirements, turnaround time, and cost), Analiza developed the first automated, miniaturized, shake flask system for LogD in 1999. Since 2005, Analiza has provided over 150,000 solubility measurements, 45,000 LogD measurements and 2,500 pKa measurements. Analiza extends the in-house physchem and ADME profiling capabilities of small and large pharma and biotech alike.

Ananta has developed a centrifugal fluidized expansion (CentriFLEX) perfusion bioreactor that balances centrifugal forces with a continuous feed of fresh media. The CentriFLEX resolves a key manufacturing bottleneck in continuous cell culture. This instrument supplies fresh media, removes inhibitory cell waste, and prevents the loss of cell products.

AnaSpec, a subsidiary of Kaneka Eurogentec, is a globally recognized biotechnology company that manufactures and sells custom and catalog Peptides, Fluorogenic and FRET Assay Kits, Fluorescent Dyes, Amino Acids and more, for research use, drug discovery and diagnostic use. We also manufacture custom Peptide based starting materials for GMP applications. As a trusted and long-standing provider to the biopharmaceutical and diagnostic industries, academia, and governmental institutions, we aim to empower the scientific community in their endeavors to elucidate diseases and enhance health and well-being, through our quality proteomic products and services. Our team of experts strive for excellence with honesty and transparency on behalf of our customers. AnaSpec established in 1993 is certified to ISO 9001:2015.

We are experienced scientists, engineers, and business people working together to tackle a global challenge: detecting infection with COVID-19. Together, we are determined to help save lives by delivering rapid, precise, and inexpensive diagnostic tests. Our goal is to enable health care professionals to confidently provide lab-quality results in minutes instead of days so that patients can ​confidently know almost immediately whether they are positive -- or not. Our first product, The AscencioDx® Covid-19 Test and The AscencioDx® Molecular Detector, is designed to provide a precise diagnosis of COVID-19 in under 30-minutes (on average) instead of the 1-3 days that most testing services and physician offices now require for PCR testing. Using our patent-pending proprietary technologies, the AscencioDx diagnostic test is administered painlessly, in just seconds, with a lower-nasal swab. Our mission is to continue developing and marketing diagnostic test systems for diseases in addition to COVID-19 using our PCR- equivalent point-of-care diagnostic platform without the unnecessary delay, expense, or reliance on less-than-precise antigen testing. This is only the beginning. *The AscencioDx® Covid-19 Test and The AscencioDx® Molecular Detector have not been FDA cleared or approved, but have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

We are the curious. Ancestry®, the global leader in family history and consumer genomics, empowers journeys of personal discovery to enrich lives. With our unparalleled collection of more than 60 billion records from 88 countries, over 3 million subscribers and over 25 million people in our growing DNA network, customers can discover their family story and gain a new level of understanding about their lives. Over the past 40 years, we've built trusted relationships with millions of people who have chosen us as the platform for discovering, preserving and sharing the most important information about themselves and their families. Ancestry has over 1,300 employees in locations across the globe. Our headquarters is in Lehi, Utah and our offices are located in San Francisco, California; Lehi, Utah; Dublin, Ireland; Paris, France; London, England; Sydney, Australia; and Grafing, Germany. We are committed to our location flexible work approach, allowing you to work from where you want — in an office or from home or a hybrid of both (subject to location restrictions and roles that are required to be in the office). We will continue to hire and promote beyond the boundaries of our office locations, to enable broadened possibilities for employee diversity. We're passionate about using technology to create simple, useful, and delightful experiences that enrich lives and connect families and have accelerated product innovation to enable everyone to discover, craft and connect around their family story. Ancestry is continually looking for talented, hard-working and curious individuals who are passionate about bringing this mission to life. Sound like you? Join the curious. Visit https://careers.ancestry.com

Generate a Rapid DNA identification profile, anywhere, in less than 2 hours. FBI NDIS approved. Used around the world in public safety, investigations, disaster victim identification, sexual assault, booking, anti human trafficking, border control, counterterrorism, and environmental protection. The ANDE system is revolutionary with respect to its time to actionable result, ruggedization, complete end-to-end functionality, cost-effectiveness, and ease of use (so easy that a technical operator is not required).

Andelyn Biosciences is a gene therapy CDMO dedicated to Turning Hope into Reality™. Our capabilities span viral vector process and analytical development, adherent and suspension based GMP drug substance manufacturing up to 2,000L, as well as GMP plasmid process development and GMP manufacturing. We are located in Columbus, OH, USA. With more than 20 years of pioneering experience in viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with extensive expertise. We have produced GMP material for over 75 worldwide clinical trials in addition to over 450 cGMP clinical batches and more than 2,000 research-grade productions. Andelyn provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing, advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Our 180,000 sq ft clinical and commercial manufacturing facility comprises 16 upstream production suites for customization of new and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Andson Biotech is dedicated to advancing mass spectrometry workflows by enabling simple and fast sample-to-analysis workflows. Andson's DynaChip platform leverages advanced microfluidics packaged into an easy-to-use system to make sample prep for mass spec faster (and easier) for everyone. Our platforms are designed to be flexible - they couple with any commercial MS system for on-demand mass spec analysis with no expert training required. Our focus today is on improving sample preparation and workflow integration so that everyone can get more out of their mass spec.

Anellotech’s patentedBio-TCat™process produces 100% bio-based BTX (i.e. benzene, toluene and xylene) ‘drop-in’ aromatic chemicals, offering a solution to the lack of efficient, scalable processes for producing BTX fromrenewable, non-food biomass.In addition to BTX, Bio-TCat technology produces a heavier aromatics product, which can be used as bio-marine fuel, or can be upgraded to make diesel or jet fuel blendstocks.

Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we're dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix's Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.

AngioInsight, Inc. is a digital health company based in Ann Arbor, Michigan, specializing in artificial intelligence for cardiovascular diagnostics. Founded in 2018, the company develops AI-driven solutions aimed at improving the accuracy and efficiency of diagnosing and managing coronary artery disease (CAD). The AngioAI+ platform is a key offering, designed for real-time assessment during angiography. It provides actionable insights by detecting microvascular dysfunction and quantifying stenosis severity. Additionally, AngioInsight offers fully automated angiogram analysis, which processes coronary angiogram videos to support clinicians in making informed treatment decisions. The company's technology integrates seamlessly into existing clinical workflows, enhancing resource allocation and patient outcomes. AngioInsight has received significant funding, including grants and investments, to support its innovative approach. The company is actively engaged in clinical studies to validate its platform's efficacy, particularly in addressing diagnostic gaps in cardiovascular care. Its solutions are targeted at cardiologists and healthcare institutions that perform millions of angiograms annually.

For more than 160 years, Anheuser-Busch has been woven into the cultural fabric of the United States, carrying on a legacy of brewing great-tasting, high-quality beers that have satisfied beer drinkers for generations. Today, we own and operate more than 120 facilities and have more than 19,000 colleagues across the United States. We are home to several of America’s most recognizable beer brands, including Budweiser, Bud Light, Michelob ULTRA and Stella Artois, as well as a number of regional brands that provide beer drinkers with a choice of the best-tasting craft beers in the industry. From responsible drinking and emergency drinking water programs to industry-leading sustainability efforts, we are guided by our unwavering commitment to supporting the communities we call home. We are a company that believes our people are our greatest asset. We believe in the spirit of ownership because our employees take results personally and want to build something great together. We value talented employees who aren’t afraid to be bold, resourceful, and committed. At Anheuser-Busch, it’s not about what you studied or where you worked, it’s about what you can do. If you see yourself working for a company that allows you to excel at the pace of your talent, then a career at Anheuser-Busch may be for you. As America’s leading brewer, we are committed to finding innovative ways to continually improve. It's this kind of thinking that creates a unique work environment by rewarding talent, celebrating diversity and encouraging forward thinking. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status or any other characteristic protected by applicable law. For more information, visit www.anheuser-busch.com/careers.

BioDynamic Imaging delivers better drug assessment in three-dimensional (3D) living tissue samples, revealing a comprehensive phenotypic response that is more physiologically meaningful than from conventional 2D or monolayer screens. Our technique is label-free and probes up to 1 mm deep in living tissue to study drug response in heterogeneous tissue environments. BioDynamic Imaging converts all forms of functional cellular motions into contrast maps of cellular mechanisms of action.

Ani-Logicsmakes nutritional supplements, minerals, and attractants that can be added toto deer feed to attract deer and promote antler growth. These deer feed supplements providevitamins, chelated minerals,essential oils, and probiotics designed to optimizethe immune system.

Since 2016, AnimalBiome has helped tens of thousands of pet parents and veterinarians monitor and improve the gut health, and overall health, of companion animals around the world. See how we can help your pet or veterinary practice at animalbiome.com or animalbiome.vet (veterinarians only).

Animal Biotech Industries, Inc. is a private corporation that was established in 1990 to support the biomedical research community by supplying them with high quality post mortem tissues, organs and glands. To this end, ABI was conceived and is currently operated by scientific professionals who have dedicated themselves to producing superior animals and tissues as well as superior service.

Anitox works on protecting the food supply. By understanding how pathogens and other unwanted microbes occur, survive and thrive, the companydelivers commercially viable solutions in the areas of livestock and pet food production, feed milling and fermentation.

About Anju Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company's flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients' lives. Customer First Our mission is to always be a customer-first organization, powered by a passionate team, providing best-value life science solutions paired with an excellent customer experience to simplify the complexities of life science information management. Driving Impactful Results Anju solutions are used by large, mid-sized, and small pharmaceutical companies, clinical research organizations (CROs), and medical device companies as well as full-service medical marketing, market research, and communications agencies. Our technologies facilitate data flow between our solutions and seamless communication with third-party systems, providing a unique opportunity for our customers to leverage critical information and drive impactful results. Experienced Leadership Anju is a portfolio company of Abry Partners, which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across their active funds.

Annam Biosciences is a biotechnology company that focuses on developing transformative drug delivery technologies and drug candidates.

We are a team of experts providing pharmacometric service that involves the design, analysis and interpretation of data from pre-clinical and clinical trials, and drug development strategy. We continuously look for opportunities to innovate to transform drug development from a "box-checking" exercise into a science where novelty is the norm and not the exception. We provide our services with integrity. Leadership Anoixis Corporation is the leader in skilled pharmacometric service for breakthrough drug development. Expertise Our expertise is drawn from a broad knowledge base comprising drug development, pharmacometrics, clinical pharmacology, pharmaceutical science, pharmacy, drug evaluation and regulation, mathematical modeling and simulation, applied statistics, and academia. Experience Our extensive experience in pharmacometrics, drug development, clinical pharmacology, applied statistics, and consulting is reflected in our publications in peer-reviewed journals and presentations at numerous scientific meetings. Services We provide efficient and informative design and analysis of efficacy and safety studies, perform population pharmacokinetic modeling, population pharmacokinetic / pharmacodynamic modeling using pharmacometric knowledge discovery approaches, population modeling for dose selection, and clinical trial simulation. We design and analyze clinical pharmacology and biopharmaceutic studies, and provide strategy for knowledge-based drug development.

Founded in 2002, ANP Technologies, Inc. is an emerging nanobiotechnology company with a major focus on design, development, and marketing of innovative technologies. ANP Technologies, Inc. is a nanobiotechnology company with cutting-edge technology platforms focused on: • Specialty CRO for biological drug R&D • Biodefense and homeland security • Home/point-of-care diagnostic systems • Nanoencapsulation and targeted drug delivery and therapy

Anresco offers a full range of microbiological services including routine QA testing, FDA Detention Without Physical Examination (DWPE) testing, shelf life studies, inoculation challenge studies, validations of food safety programs (e.g. for compliance with HACCP), and FSMA mandated environmental testing. With decades of experience working with manufacturers, importers, product developers, and more, their microbiologists have the professional expertise to help ensure the safe consumption of all perishable food products.

At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page.

Antech Diagnostics, Inc., operates a network of veterinary diagnostic laboratories in the United States. It offers veterinary diagnostics services in the areas of chemistry, hematology and coagulation, endocrinology, serology and immunology, urine and fecal, therapeutic drugs, cytology and histology, and microbiology. The company provides laboratory medicine to veterinarians, as well as provides daily services to animal hospitals, zoos, and government agencies. Subject To: https://www.antechdiagnostics.com/privacy-policy , https://www.antechdiagnostics.com/terms-of-use

Antibodies Incorporated is a biotechnology company that specializes in manufacturing and distributing monoclonal and polyclonal antibodies, diagnostic reagents, diagnostic kits, and developing ImmunoAssays.

Antibody Research Corporation is a biotechnology company that specializes in offering custom antibody and protein services including monoclonal and polyclonal antibody development, gene cloning, in vitro antibody production, cell line engineering, and assay development.

Antibody Solutions is a privately held American contract research organization that helps biopharmaceutical companies advance their discovery of better diagnostics and therapeutics by delivering fit-for-purpose antibodies. The company provides comprehensive project management and technical support in a fee-for-service model. Antibody Solutions has expertise in immunology, immunochemistry, biochemistry, molecular biology, cell biology, transgenic animal platforms, flow cytometry, recombinant expression, and bioreactor technology. Antibody Solutions has served more than 500 clients, including all of the top 10 global pharmaceutical companies. Founded in 1995, the company is headquartered in Santa Clara, Calif. and works with clients worldwide. A leading developer of therapeutic, biomarker and critical reagent antibodies, Antibody Solutions provides elements vital for successful antibody discovery, including: Antigen design and generation Monoclonal and polyclonal antibody generation Monoclonal and polyclonal antibody production and purification Biological characterization (sensitivity, specificity, agonist/antagonist activity, internalization) Physico-chemical characterization (affinity, amino acid sequence, purity) Conjugation of antibodies and proteins Antibody engineering and recombinant expression Analytical methods development (ELISA, Flow Cytometry, PK/PD, ADA, Flourescence-Activated Cell Sorting) The company offers 24/7/365 online project management and tracking service.

Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.

Antigen Targeting & Consulting Service Incorporated (ATCS Inc), a biotech company formed in 2009, is dedicated in providing top-quality custom services for the development of vaccines and immunotherapies. The company specializes in targeting antigens to cell surface molecules on dendritic cells for vaccine development, as well as the development of PSMA-targeted PET imaging agents for improved diagnosis of prostate cancer. ATCS Inc also focuses on the translation of multi-antigen targeted off-the-shelf therapies for various medical conditions.

Anumana™ is harnessing industry-leading AI and translational science to decode electrical signals from the heart as never before, empowering healthcare providers to transform patient care throughout the cardiac clinical pathway. Serious cardiovascular diseases affect millions of people worldwide, often going undiagnosed until symptoms advance and patients deteriorate. Unfortunately, these conditions can remain undiagnosed until the patient suffers a life-threatening event. Innovations enabling earlier diagnoses could address this unmet medical need and empower healthcare providers to intervene with life-saving treatments. Anumana recently acquired NeuTrace and is leveraging the power of novel ECG-EGM-EMR integration for clinically valuable, actionable insights. With nference's proprietary nSights real-world evidence generation platform, built on data from leading health systems, we combine unparalleled longitudinal structured and unstructured electronic medical record data with diagnostic and interventional ECGs and EGMs. By applying AI techniques to these electrical signals from the heart, the company has uncovered clinically critical electrical signatures and patterns unrecognizable to the human eye. The resulting software products can be integrated into routine clinical practice for earlier disease diagnosis and in-procedure decision-making. Anumana's 75+ peer-reviewed publications and ongoing research show significant promise to detect and diagnose otherwise hidden conditions earlier and uncover actionable insights for valuable patient interventions. The opportunity to offer clinical decision support tools for each unique patient throughout the cardiac care continuum paves the way for precision medicine. Anumana strives to introduce a new standard of care in cardiac clinical care supported by reimbursement.

Are you ready for a transformative leap in small bowel capsule endoscopy? Meet ProScan, our cutting-edge AI Assisted Reading Tool meticulously designed to revolutionize the diagnostic process for patients suspected of small bowel bleeding. ProScan leverages advanced artificial intelligence algorithms to significantly reduce the time required for reviewing capsule endoscopy studies, enabling quicker and more precise diagnoses. It is meticulously engineered to expedite the evaluation of capsule endoscopy images, enhancing the timeliness of a diagnosis and initiation of therapy. Headquartered in Plano, Texas, AnX Robotica brings versatility in development and integration of multi-discipline technologies such as precise magnetic, robotic control, in house ASIC design, artificial intelligence, micro-optical imaging, image processing, and wireless transmission. With more than 200 patents granted or applications pending, and dozens of clinical papers published in major international journals, AnX Robotica, together with its sister companies, have become the leading companies in robotic capsule technology.

Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. Apath is the premier technology licensing company of research and development tools utilized to validate therapies for the hepatitis C virus, respiratory syncytial virus, Ebola virus, sindbus virus, West Nile virus, and permissive cell line technologies utilized in research surrounding influenza and SARS-CoV-2. We represent multiple academic institutions and commercial entities holding the fundamental intellectual property required for developing HCV and RSV Therapeutics, Antibodies, Vaccines, and SARS-CoV-2-related therapeutics.

Apeel's evolving technology stack is built on an unprecedented understanding of produce quality and shelf life. This has only deepened as the use of data and technology have given partners a powerful way to accurately and efficiently evaluate produce for ripeness, freshness, and other attributes. Apeel is developing science-backed, technology-supported solutions that help improve the produce experience on shelf.

Apex Medical Technologies is a healthcare company that specializes in non-latex elastomeric thin film dip molding, offering synthetic alternatives to replace latex-based products.

Aphena Pharma Solutions is a large pharma solutions provider focused on contract packaging, repackaging and manufacturing for the pharmaceutical, OTC, dietary supplement, animal health and medical device marketplaces. With over 25 years of experience in pharmaceutical packaging, Aphena was formed in 2011 by a family of well established companies (PrePak Systems, TestPak, Celeste and Integrated Pharmaceutical Packaging). The strategic alliance is now called Aphena Pharma Solutions. Aphena has five FDA registered facilities in the US and offers several capabilities to our customers. Aphena provides clients with a full range of solutions to address their pharmaceutical packaging and manufacturing requirements. With our continued investment in technology, advanced packaging systems and rigorous cost control, we can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the development of a product – including concept, manufacturing, packaging and distribution – we provide clients with services and solutions to help ensure a successful product launch. Our team of seasoned experts collaborates with clients and addresses every aspect of their product. We partner with clients to develop the solutions they need to succeed in a highly competitive marketplace, and we're committed to delivering an end result that is on schedule and cost effective.

ApiJect Systems, Corp. a medical technology company whose device development platform will make the safety and performance advantages of single-use prefilled syringes affordable. The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners.

API Pharmatech is focused on delivering Quality therapeutic products, satisfying Regulatory and Statutory necessities thereby, ensuring safety and purity to its products. We indulged in developing and manufacturing generic and innovative APIs and FDFs. Well capable of resources and expertise to pull out an API from development to commercial scale manufacturing, fulfilling all the required statutory regulations and inspections and involving in the development, manufacturing and marketing of the drug. API Pharmatech constantly updates its knowledge and identifies niche and complex APIs and FDFs which are technologically challenged.

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.

AppHarvest is a sustainable food company in Appalachia developing and operating some of the world’s largest high-tech indoor farms with robotics and artificial intelligence to build a reliable, climate-resilient food system. AppHarvest’s farms are designed to grow produce using sunshine, rainwater and up to 90% less water than open-field growing, all while producing yields up to 30 times that of traditional agriculture and preventing pollution from agricultural runoff. AppHarvest currently operates its 60-acre flagship farm in Morehead, Ky., producing tomatoes, a 15-acre indoor farm for salad greens in Berea, Ky., a 30-acre farm for strawberries and cucumbers in Somerset, Ky., and a 60-acre farm in Richmond, Ky., for tomatoes. The four-farm network consists of 165 acres under glass. AppHarvest is a public benefit corporation and a Certified B Corp.

Applied Biomics is a proteomics service company that provides top-quality, cost-effective, and full-line proteomics services to meet customers' research and discovery needs.

Applied Biosensors was established in 2013 to transform the production of life-saving medicines. The company has developed a biosensors and analytics platform for continuous monitoring of critical process parameters designed specifically for the biomanufacturing industry. The platform generates 1000X more process data in real-time compared to current off-line manual systems, and enables predictive analytics and models based on artificial intelligence and machine learning. Importantly, it is adaptable and scalable for any bioreactor: single use, glass or stainless steel, and it can be used in R&D and can scale up for GMP. Applied Biosensors mission is to provide its customers with comprehensive, high-quality solutions that improve productivity and process reliability thus resulting in superior biomanufacturing and life science products. For more information, visit www.appliedbiosensors.com

Applied Bio Tech Institute is a biotechnology company that develops animal-free health and environmental products, including oral vaccines, animal-free protein products, natural sweetener, and feed enzymes.

Applied Cells, Inc., was founded in 2018 in Silicon Valley to create revolutionary solutions to cell separation and enrichment products, which increase cell separation efficiently by changing how physics is employed in the process. We are supporting industry experts in Cell Therapy Development with MARS® immunomagnetic cell separation Platform. Our innovative, column-free, immunomagnetic cell iso

Applied NanoStructures is a premier supplier of AFM and SPM Probes as well as custom MEMS devices. The AppNano state-of-the-art MEMs foundry is located in the heart of silicon valley. The company was founded by Dr. Ami Chand who has worked in the NanoTechnology area for more than 20 years.

Get the professional care you deserve when you visit our ARC walk-in medical clinic. We specialize in treating acute illnesses and injuries without you having to make an appointment. You will receive the highest quality diagnosis with safe and effective treatments in a timely manner. We provide accurate and prompt lab work on site to ensure that you get the most appropriate treatment. You can also act as an important part of our research by volunteering as a study participant. ARC of Arkansas conducts Phase II-IV Clinical Trials, Registries and Health Outcome Studies which are aimed at finding new and better treatments for various medical conditions and diseases.

Applied Spectral Imaging (ASI) improves patient care through advanced image analysis. Founded in 1993, ASI is a global leader in the development of imaging and analysis platforms for pathology, cytogenetics, and life science research. ASI's GenASIs™ automated imaging platforms for pathology and genetic analysis provide advanced diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results. The GenASIs platform can be used with most brightfield or fluorescence microscope systems and supports manual and automatic scanning for a wide range of workflows and applications, to best suit the needs, size and budget of any lab. Our GenASIs HyperSpectral™ and HiSKY® platform created the field of hyperspectral karyotyping (SKY) and is still recognized today as the field's most advanced and productive platform. ASI's applications are US FDA cleared for BandView® (karyotyping), FISHView, SpotScan (for CEP XY, UroVysion®, ALK and HER2/neu FISH), and HiPath (for IHC Family: HER2, ER, PR and Ki67). ASI maintains comprehensive patent portfolios in the US, Europe, Japan and other countries. With thousands of Systems deployed worldwide, offices in the US, Europe and Asia, and a network of over 50 distributors, ASI also takes great pride in our outstanding record of service and support. We stand ready to answer your questions and assist you at all times.

Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases. ASC is a trailblazing CRO/CDMO committed to building a complete iPSC-Gene Editing platform for the production of iPSC-derived products for gene and cell therapy research and development. With the integration of our unique iPSC approach and IP-based site-specific large cargo insertion technology, TARGATT™, we (1) develop immune-compatible master iPS cell lines and (2) deliver large DNA fragments to pluripotent cells that have proven differentiation capabilities. We stand at the forefront of the iPSC-based therapy revolution delivering research- and GMP-grade iPSC solutions along with various downstream assay services. Current Offerings: • iPSC Cell Line Models: iPSC generation, CRISPR & TARGATT™ genome editing, differentiation • Cell Gene Product CDMO: TARGATT™ iPSC Platform for allogeneic cell therapy products/GMP iPSC reprogramming, cell banking, gene editing, and differentiation • Bioproduction: TARGATT™ CHO cell system for antibody screening and bioproduction/TARGATT™ HEK293 cell system for library/antibody screening • Animal Models: Custom and off-the-shelf CRISPR & TARGATT™ mouse models For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.

Applied Surgical Robotics is a MedTech company focused on developing robotic technology and SaaS software solutions to improve surgical precision.

Apprentice provides an all-in-one, cloud-native platform (Tempo Manufacturing Cloud) that is purpose-built for regulated industries, and covers a wide range of manufacturing use cases across multiple industry verticals. Within life sciences, Tempo accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. Apprentice is trusted by global manufacturing leaders across various regulated industries. Tempo users belong to organizations responsible for contract manufacturing, cell & gene therapy, CRISPR technology, biopharma, biotechnology and adjacent industries.

APTAGEN Labs is a biotechnology company offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery and therapeutics. Aptagen was formed in 2004. Operations began in 2006. Aptagen is located in Jacobus, PA, a suburb of York, beautifully surrounded by Lake Redman and conveniently situated off of Interstate 83. The facility is a forty minute drive from Johns Hopkins University and Hershey Medical Center.

AptaMatrix is a privately held, start-up biotechnology company headquartered in Syracuse, New York. The company's focus is to accelerate the rate of aptamer discovery using its patent pending High Throughput Screening of Aptamers (HTSA) approach in addition to developing its novel AlloSwitch™ sensor technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. AlloSwitches™, have demonstrated the ability to transduce molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. HTSA and AlloSwitch solutions are built on patented biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University. The HTSA approach leverages the high throughput capabilities of deep-sequencing technology. All sequencing activity is managed by our Genomics Division and conducted on our Illumina GAIIx platforms. Data analysis is supported by our in-house bioinformatics team. In addition to supporting internal research and development, our genomics division actively supports both academic and commercial deep-sequencing projects.

Every day, Aptar creates “a-ha moments” for its customers and their consumers and patients by continually bringing innovations to market that convert non-dispensing packaging into breakthrough product-dispensing systems, including those that give people more effective ways to put on their favorite fragrance, kids the opportunity to pour ketchup without making a mess and patients connected technologies that help them more easily adhere to treatment. Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. All of Aptar's current job openings are found at jobs.aptar.com. Job applicants should be aware of recruiting scams on the Internet and social media platforms. The scammers frequently use a company’s logo and photos or the names of its executives to give the appearance of legitimacy. The fraud targets job seekers and uses false and fraudulent offers of employment with legitimate employers, like Aptar, to steal from the victims. No applicant for employment with Aptar is ever required to pay any money as part of the job application or hiring process. In addition, Aptar’s recruiting staff sends email communications to job applicants from email addresses with the “@aptar.com” domain name only. To read more about recruiting fraud or to report an incident please see Aptar's Recruiting Fraud Statement. https://aptar.com/careers/recruiting-fraud-statement/

Apton is a California-based biotechnology company that manufactures and supplies single-molecule detection and sequencing imaging systems for clinical applications.

Aqtual, Inc. is a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology. Our mission is to revolutionize the treatment and management of these conditions by bridging the translational gap between groundbreaking research and practical healthcare solutions.

Aquatactics provides the following services related to fish health: Fish Health Products Veterinary + Regulatory Consultation Pathology Services Fish Health Education + Stockmanship Training Vaccination Protocol Design

Aquavit Pharmaceuticals, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies. We focus on personalized medicine to improve patient health and to maximize the efficiency of the medical community. At Aquavit Pharmaceuticals, Inc., we combine this strategic focus with a modern, diverse approach that enables us to pursue new specialty areas with significant unmet needs. Science personalized. Healthcare modernized.

Drug discovery remains an expensive and time-consuming process. Promising compounds proceed through clinical trials only to have many fail before FDA approval. Aracari Biosciences aims to simplify this process by more accurately and efficiently evaluating promising drug compounds in a human tissue-on-a-chip model prior to clinical trials. Our​ proprietary, Vascularized Micro-Organ (VMO) platform is the first to contain a 3D, perfused network of living, dynamic human blood vessels that deliver nutrients and drugs directly to tissues just as in the body. Ask about our oncology models that incorporate multiple human tumor types within the vascularized tissue or our blood-brain barrier model for testing trans-barrier transport of drug compounds targeting the brain.

Blending technology and science, we develop instrumentation to improve outcomes. Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research. Speed is essential for furthering our understanding of biology, and we believe in reducing the time needed to acquire high-quality data and obtain clear, high-quality results. By making advanced technologies accessible, we allow researchers to focus on the science, not the tool. Our goal is to develop innovative products that accelerate basic research, drug discovery, and manufacturing to advance healthy outcomes. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach. We strive to make the drug discovery process more efficient, reducing the time and bandwidth needed to screen compounds. By pairing fast, easy to use hardware with advanced artificial intelligence analysis algorithms, we aim to transform the drug discovery pipeline, allowing customers to fail faster.

We have invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Our proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct. To learn more, visit us at www.aralezbio.com Aralez Bio is a proud member of Cyclotron Road.

Aranscia unlocks the power of precision medicine by serving the needs of clinical professionals directly within the care workflow.

Arbor Assays is the first employee-owned life sciences company and is dedicated to advancing scientific discovery by providing innovative and reliable assay solutions. Our mission is to equip researchers and scientists worldwide with high-quality scientific tools and support their objectives with unparalleled customer service. Arbor Assays strives to be a trusted partner to our customers through our commitment to quality, integrity, and collaboration. As employee-owners, we are driven not by investor demand, but rather by a shared sense of responsibility to each other, our customers, our community, and our planet.

ADM unlocks the power of nature to enrich the quality of life. We're a premier global human and animal nutrition company, delivering solutions today with an eye to the future. We're blazing new trails in health and well-being as our scientists develop groundbreaking products to support healthier living. We're a cutting-edge innovator leading the way to a new future of plant-based consumer and industrial solutions to replace petroleum-based products. We're an unmatched agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. And we're a leader in sustainability, scaling across entire value chains to help decarbonize our industry and safeguard our planet. From the seed of the idea to the outcome of the solution, we give customers an edge in solving the nutritional and sustainability challenges of today and tomorrow. Learn more at www.adm.com.

ArcherDX is developing and seeking regulatory clearances for next-generation sequencing (NGS) diagnostics to help solve for the underutilization of targeted cancer therapies.

Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines.

Arconic Corporation, headquartered in Pittsburgh, Pennsylvania, is a leading provider of aluminum sheet, plate and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial, and packaging end markets. Keep up with us here to find out how we're helping to advance the automotive, aerospace, commercial transportation, industrial, packaging and building and construction markets. Social Media Disclaimer We welcome conversation on our LinkedIn page about anything relevant to Arconic and its products. We do ask that everyone follow a few simple guidelines: Please keep it professional and refrain from profanity, direct personal criticism aimed at Arconic employees or speculation about the company. Please do not post copyrighted or confidential material. Anything that violates these guidelines, Arconic policies, or that we find to be otherwise inappropriate for any reason may be hidden or removed.

Arctic Foam works with Algenesis to makesurfboards from polyurethanes isolated from algae.

Ardigen is a bioinformatics company that specializes in AI-driven solutions for drug discovery and precision medicine.

Aretech is a world leader in developing advanced rehabilitation technologies for improving function and independence. We offer robotic body-weight support systems for a variety of therapy needs. Our technology includes ZeroG 3D, ZeroG, Ovation, and Luminaire. ZeroG 3D is a 3-Dimensional BWS System for multi-directional, unrestricted movement within a 3D workspace. The ZeroG Gait and Balance System is for gait and balance training along a custom designed ceiling track. Ovation is an interactive treadmill for patients up to 700 pounds to walk on a treadmill with motivating goals and metrics. Luminaire offers dynamic body-weight support over a slat-belt treadmill. All our products are hand-crafted in the United States and designed for durability with an emphasis on quality.

Argon AI is a platform that allows biopharmacy and life sciences experts to conduct complicated, data-driven operations. They help life sciences companies automate their data-intensive workflows with unprecedented AI.

Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.

Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and regulatory approvals. With a growing number of successful therapeutic development programs, KEM® is an FDA-assessed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine. Ariana has developed Onco KEM®, the most advanced, clinically tested, oncology therapeutic decision support system. Founded in 2003 as a spin-off of the Institut Pasteur, Paris, France, the company operates a subsidiary in the United States since 2012.

Arima-HiC is a proximity ligation method that captures the three-dimensional organizational structure of chromatin, where genomic sequences that are distal to each other in linear distance can be closer to each other in the 3D space. The high-resolution, genome-wide map of interacting genetic loci that is generated from Hi-C data can then be used across multiple genomic applications including identification of promoter-enhancer interactions for gene regulation studies and scaffolding contigs for genome assemblies to define chromosomes de novo.

Cell-Free DNA Testing

Arizona Algae Products, LLC is a biotechnology company and algae producer in Holbrook, Arizona. We make use of proprietary production technologies and sustainable production methods to produce algal biomass and highly valuable oils from algae for use in food, dietary supplements and health products that enhance human health and improve the quality of life. We are on a mission to provide the world with the highest quality, sustainably-produced, vegetarian, omega-3 oils from algae. Omega-3 oils sourced from fish or krill raise concerns about over-fishing of our oceans or the reliance on whale food and its effect on the Antarctic ecosystem. Moreover, being animal-derived, these fish and krill oils do not fit well in a vegetarian or vegan diet. The algae we produce are sustainably grown in our own greenhouse in the high Arizona desert, using abundant sunshine, non-arable desert land and pristine saline water from the Coconino aquifer, which cannot be used for irrigation, as inputs. The oils from our algae are perfectly suited for vegetarian and vegan diets. Vegan omega-3 oils derived from flaxseed consist of ALA, which is difficult for our bodies to convert into the most important omega-3's: EPA and DHA. Instead, our algae produce EPA oil directly. Unlike other producers of algae who use outdoor raceway ponds, we grow our algae under controlled conditions in closed photobioreactors of proprietary design, resulting in the lowest possible contamination levels and the highest quality product.

Arizona Isotope Science Research Corporation (AZI), was formed in 2017 and specializes in nuclear medicine and the production of isotopes that are beneficial to medical research and treatment.

Arkansas Children's is the only healthcare system in the state solely dedicated to caring for Arkansas' more than 700,000 children. The private, non-profit organization includes two pediatric hospitals, a pediatric research institute and USDA nutrition center, a philanthropic foundation, a nursery alliance, statewide clinics, and many education and outreach programs — all focused on fulfilling a promise to define and deliver unprecedented child health. Arkansas Children’s Hospital (ACH) is a 336-bed, Magnet-recognized facility in Little Rock operating the state’s only Level I pediatric trauma center; the state's only burn center; the state's only Level IV neonatal intensive care unit; the state's only pediatric intensive care unit; the state’s only pediatric surgery program with Level 1 verification from the American College of Surgeons (ACS); the state’s only magnetoencephalography (MEG) system for neurosurgical planning and cutting-edge research; and the state's only nationally recognized pediatric transport program. Arkansas Children’s Hospital is nationally ranked by U.S. News & World Report in seven pediatric specialties (2022—2023): Cancer, Cardiology & Heart Surgery, Diabetes & Endocrinology, Nephrology, Neurology & Neurosurgery, Pulmonology and Urology. Arkansas Children’s Northwest (ACNW), the first and only pediatric hospital in the Northwest Arkansas region, is a level IV pediatric trauma center. ACNW operates a 24-bed inpatient unit; a surgical unit with five operating rooms; outpatient clinics offering over 20 subspecialties; diagnostic services; imaging capabilities; occupational therapy services; and Northwest Arkansas' only pediatric emergency department, equipped with 30 exam rooms. Generous philanthropic and volunteer engagement has sustained Arkansas Children's since it began as an orphanage in 1912, and today ensures the system can deliver on its promise of unprecedented child health. To learn more, visit archildrens.org.

ArkeaBio is a company focused on developing technology to reduce greenhouse gas emissions from the agricultural industry, specifically targeting livestock methane emissions. The company was founded on the premise that a simple vaccine could be a powerful tool in fighting climate change.

Arko Labs is a veterinary pharmaceutical company that specializes in developing and manufacturing industry-leading swine and turkey vaccines for commercial use.

For more than 50 years, ARKRAY has been committed to producing safe, reliable, effective products; from developing the world's first HbA1c Analyzer, to the first blood glucose monitoring system for Long-Term Care. Today, ARKRAY manufactures cost-effective diabetes care products and clinical chemistry equipment that are simple, convenient and easy-to-use, and also serves as a private-label blood glucose meter manufacturer for the world's largest retailer. ARKRAY prides itself on putting customer service first, with personalized training, industry expertise and on-going support.

Our mission is to decrease the quantity and severity of infections that cause human suffering through the creation and development of novel, targeted, antimicrobial therapies. Our lead technology, Veriox®, is a first-of-it's-kind, proprietary peracid/hydrogen peroxide based non-systemic antimicrobial agent. Our vision is to improve societal health by protecting humans, animals and the environment from harmful viruses and chemical agents. ArmiClenz™ (EPA registered disinfectant spray, cleaner/odor control) and ArmiVet™ (Topical wound, rash and hot spot care for animals) are two exciting new consumer brands that support our vision.

Since 1947, We have been the trusted source of crickets and feeder insects for the pet industry and fish-bait. We grow the Original Cricket Acheta Domesticus.

ARQGenetics offers custom-designed gene panels to provide accurate real-time gene expression data.

Arrayit develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function.

Arraystar is dedicated to empower research on regulatory non-coding RNAs (ncRNAs) and the epitranscriptomics, which have become the most fascinating and forefront areas of biomedical science research. Our innovative products, in-depth expertise, and strong bioinformatics in these areas have supported over one thousand high impact publications since our 2009 inception. Over the years, our client base has expanded to thousands of eminent research institutions all around the world. Go Beyond RNA With the discoveries of novel gene regulatory activities, non-coding RNA classes represent the fundamental biology going beyond coding mRNAs and encoded proteins as the focal point of the central dogma. The pursuit to uncover pivotal roles of ncRNAs in gene regulation, programming, and orchestration has attracted intense scientific interest with alluring opportunities of finding new disease regulators, biomarkers, and therapeutic targets. While the industry of gene expression analysis has long been predominantly covering only mRNAs, Arraystar is taking the lead in supporting scientific endeavor into the once hidden yet exciting world of non-coding RNAs: lncRNAs, circular RNAs, microRNAs, tRNAs, tRFs, tiRNAs, snoRNAs and more. As a newly unveiled layer of gene regulation, epitranscriptomic modifications of coding mRNAs and non-coding RNAs determine the molecular fates and profoundly impact cellular processes, such as RNA activities, splicing, export, stability and translation in disease and health. With rapid advances in the field and new methodology development, epitranscriptomics has come of age. Arraystar is in the best position to help your research into this omics dimension of not only mRNA, but also long and small ncRNA epitranscriptomics.

Arrow Dx is combining Nanotechnology and Artificial Intelligence (AI) to create an inexpensive, sensitive test to screen early for non-alcoholic fatty liver disease (NAFLD). Our aim is to provide physicians with an alternative to liver biopsy which detects the disease too late. We are working to solve the lack of rapid, reliable, point-of-care, and inexpensive diagnostic devices by bring faster, inexpensive and mobile testing for many other applications that require a rapid response (e.g., epidemic/pandemics, public health crisis, early diagnosis for rising complex non-communicable diseases, testing in emergency rooms). Our technology makes it more affordable for smaller healthcare providers such as Physician Office Labs (~100,000 in the U.S.), independent physicians and public health workers to access diagnostics due to our significantly lower cost as well as our portable, small compact size. Finally, we are also working to create a test for COVID-19 as well as other viruses, initially quantifying the virus in wastewater to help public health authorities and later to detect it in biological samples from individuals and patients.

Artera is a SaaS digital health leader redefining patient communications. Artera is trusted by 700+ healthcare systems and federal agencies to facilitate approximately 2.2 billion messages annually, reaching 100+ million patients. The Artera platform integrates across a healthcare organization’s tech stack, EHRs and third-party vendors to unify, simplify and orchestrate digital communications into the patient’s preferred channel (texting, email, IVR, and webchat), in 109+ languages. The Artera impact: more efficient staff, more profitable organizations and a more harmonious patient experience. Founded in 2015, Artera is based in Santa Barbara, California and has been named a Deloitte Technology Fast 500 company (2021, 2022, 2023), and ranked on the Inc. 5000 list of fastest-growing private companies for four consecutive years. Artera is a two-time Best in KLAS winner in Patient Outreach.

Arterys was founded to facilitate the global advancement of medicine through data, artificial intelligence and technology. Because a significant proportion of the world's medical data resides in medical images, Arterys set out to tackle several issues around the space, including the enormous workloads radiologists face, the lack of accuracy with many of today's tools, and the need for increased consistency across practices. The company was the first to receive FDA clearance for a cloud-based product with Artificial Intelligence, and currently has 8 FDA clearances, and is active in 118 countries. Arterys continues to focus on solving some of radiology's most pressing needs. We deliver the most comprehensive set of clinical AI solutions in the industry, built off a single platform and user interface that focuses on users with seamless workflow integration and a unified and optimized UI for every one of our applications. By making imaging diagnostics quantitative, intelligent and available, we empower healthcare organizations to improve physicians' experience, patient outcomes, efficiency, and reduce costs with cloud and AI. Arterys has offices in San Francisco, Calgary and Paris. For more information, please visit www.arterys.com. Follow Arterys on Twitter at @ArterysInc at https://twitter.com/ArterysInc.

Arthroventions™ is improving the quality of life for patients with joint disease by developing technologies that enable more effective joint care. Over 70 million Americans (1 in 5) have a form of joint disease. It impacts more people than cancer, there is no cure, and the longer and more active a lifestyle, we live the more likely we will experience it. At Arthroventions, we believe the synovial fluid is the key to diagnosing and treating the different types of joint disease, including Osteoarthritis and Rheumatoid Arthritis. Unlike other chronic diseases, such as cancer, there are no diagnostics assays that can differentiate between disease phenotypes or to predict drug responsiveness. This results in patients receiving ineffective treatments based on physician and payer preference. Our first product line is a Class I medical device that facilitates the aspiration/removal of synovial fluid from and the injection of therapeutics into the joint space, which it is estimated that 30% of these procedures miss the joint space. Our new approach reduces patient pain and decreases the probability of missing the joint space, thereby improving the delivery of therapeutics and patient comfort. Using our devices, physicians and providers can realize additional revenue with improved quality of care. Our products support all types of intra-articular injections, including corticosteroids, viscosupplementation, and new regenerative therapy products such as Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), and Adipose derived cells. Join us and take the first step towards more effective joint care.

Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment. Company status: * Working prototype * Feasibility study conducted * Four patents issued; two pending * Independent market validation with likely prescribers * Regulatory pathway established * Reimbursement codes identified This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.

Revolutionary speech therapy tools for parents and speech therapists. Simple to use & works twice as fast as traditional methods.

Artificial accelerates the pace of life science discoveries by making connecting and orchestrating labs easy with its cloud-based software platform, the Artificial Product Suite. As a vendor-agnostic platform, the Artificial connects with any native instruments, devices, databases, and informatics to provide a single, easy-to-use orchestration layer for the entire lab. Using Artificial, scientific labs can control and monitor their processes in real-time while capturing AI-ready data and keeping humans in the loop.

Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.

Artos helps clinical development and medical writing teams turn their data into regulatory submissions in days instead of weeks. Life sciences companies spend $13 billion and millions of man-hours each year on regulatory submissions for health agencies. At Artos, we build AI and software tools to shrink those timelines so that life-saving treatments can get to patients sooner.

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests. With more than 3,000 employees, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays. ARUP is an Equal Opportunity Employer M/F/D/V and supports a drug-free environment. Scammers have been posing as ARUP recruiters to target jobseekers using fraudulent email addresses and social media accounts. ARUP recruiters will only contact you with legitimate offers by calling from 800-522-2787 or 801-583-2787 or emailing from an address ending in @aruplab.com. Read our full fraud statement on aruplab.com/careers

ARVYS Proteins Inc. is a Contract Research Organization (CRO) that Specializes in Custom Protein Services for Drug Discovery and Life Science Research. Our strong integrated expertise in protein biochemistry, working experience with various recombinant expression systems and protein classes, up-to-date knowledge in protein technologies, enable us to become a reliable and resourceful partner for our clients. We help at any stage of a protein project. Our goal is to become your preferred outsourcing choice for Protein Services and we will work hard to earn your business. Maximize Project Success with Our Expert Protein Services! Protein Expression - generation of heterologous recombinant proteins in multiple expression systems. Fermentation & Cell Culture - bacterial, yeast, insect and mammalian biomass production for scale up processes. Protein Purification - homogeneous and well-characterized preparations save time, effort and resources. Protein Characterization - Customized design to address specific protein characterization goals. Functional Assays & Assay Development - Protocols with detection by UV-Vis, fluorescence or luminescence spectroscopy. ELISA Development - from selection of assay components to development of a working protocol. Protein Labeling & Conjugation - development of strategies to maximize functionality of modified proteins. Endotoxin Removal & Testing - expert service in less than 1 week. Antibody Development & Production - from generation of antigen to characterization of antibodies.

Arxspan provides cloud-based solutions to meet the scientific data management needs of leading life sciences, chemicals, and scientific companies globally. Arxspan offers ArxLab®, a suite of web-based scientific informatics applications, allowing scientists to record, manage, and share their research data​: * Notebook - Intuitive electronic laboratory notebook (ELN) optimized for collaborative models in current research environments * BioReg/ChemReg Registration - Configurable repository for registering unique chemical/biological entities and subsequent batches * Assay - Flexible system for registering assay protocol and result data * Inventory - Comprehensive tool for defining and managing chemical and biological compounds, reagents, equipment, and other items * Search - Robust decision support platform for querying, visualizing, and reporting data * Workflow - ArxLab Workflow allows users to create new work requests and to assign them to users and/or groups. The workflow management tool enables scientists to manage and prioritize all scientific projects, as well as to make procedure requests to internal colleagues and external partners. For more information, please visit our website at www.arxspan.com

Arzeda combines protein design, pathway design, HT screening and strain construction to create and improve designer fermentation strains for virtually any chemical. One example of their work is indeveloping new and improved enzymes to make rare sugars, natural sweeteners,and other oligosaccharides.

Headquartered in Houston, Texas, Ascend has nine global locations, including five fully integrated manufacturing facilities in the southeastern United States and an engineering plastics compounding facility in Europe, all dedicated to the innovation and safe production of nylon 6,6. With three of the world's largest chemical processing facilities, Ascend's materials form the building blocks for products used in everyday applications from apparel to airbags, cable ties to circuit boards and carpets to car parts. Ascend's 2,500 employees around the world are committed to making a difference in the communities we serve and leading the development of nylon 6,6 solutions that inspire everyone, everywhere, every day. Together, we're making a difference. Together, we're inspiring everyday.

The company supports cell and gene therapy manufacturing and process development projects from design through to clinical and commercial scale.

Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations

AscentGene is a biotechnology company that provides high-quality cell lines and protein services to the life sciences community.

CancerLinQ, a ConcertAI initiative, is a health technology company focused on improving quality of care, advancing biomedical research, and improving health outcomes for all patients with cancer. CancerLinQ's products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. We are bilingual by design: fluent in both the language of oncology and technology. As a trusted partner to over 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance cancer care and research. Learn more at www.cancerlinq.org.

Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.

Aseptica is a medical device development company focused on EDTA related products.

Aseptic Technologies develops, manufactures and markets equipment that guarantee optimal sterility assurance level and complies with latest regulatory requirements, while simplifying the validation and operation processes in the safest way. Aseptic Technologies improves the quality of aseptic operations by providing user-oriented and really innovative state-of-the-art equipment and services to the pharmaceutical industry.

Asimov's mission is to advance humanity's ability to design living systems, enabling biotechnologies with outsized societal benefit. The company is developing a synthetic biology platform from cells to software to design and manufacture next-generation therapeutics, including cell & gene therapies, through a combination of products, services, & collaborations. Founded by bioengineers from MIT and Boston University and headquartered in Boston, the company has raised over $200 million.

Aspira Scientific was founded by scientists coming from diverse functional areas (marketing, business development, R&D, manufacturing) with a common passion for science and quality. We believe in the power of human curiosity and the importance of scientific endeavors when applied to essential fields such as medicine, crop protection, materials, etc. Aspira Scientific strives to 1) provide highly cost-efficient research and development solutions while meeting the market-expected quality standards and 2) provide greater access to novel research tools through participation in a truly global innovation ecosystem. Through this collaborative relationship, we aim to foster a "thriving" research environment and deliver the next scientific breakthroughs for the betterment of humanity.

Aspira Women’s Health Inc. is transforming women’s gynecological health with the discovery, development, and commercialization of innovative testing options for women of all races and ethnicities, starting with ovarian cancer. Our ovarian cancer risk assessment portfolio is marketed to healthcare providers as OvaSuite℠, which includes OvaWatch℠, a non-invasive, blood-based test intended for use in the initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses for which surgical intervention may be either premature or unnecessary. With a negative predictive value (NPV) of 99%, OvaWatch allows physicians to confidently rule out ovarian cancer malignancy and choose the appropriate clinical management for the right patient at the right time. Ova1Plus® combines our FDA-cleared products, Ova1® and Overa®, to detect risk of ovarian malignancy in women with adnexal masses planned for surgery. EndoCheck℠, Aspira’s first-of-its-kind non-invasive diagnostic test for endometriosis, is currently in development. Visit our website for more information at www.aspirawh.com.

Aspire Biotech is a biomaterials Research and Development company focused on improving medical devices through the development of superior biomaterials.

Our vision is a world transformed by insect technology. Our mission is to harness the combined powers of technology and nature to pioneer the future of sustainable farming. We are creating tomorrow's traditions through breakthrough innovations that are in harmony with our largest stakeholder: our planet. We believe in technology that unleashes, rather than replaces, the incredible treasures of our natural world. We Aspire to a world that is abundant in planet-based nutrition that is better for people, pets and plants. Every company's culture is defined by its people and their actions. Who we are is the direct product of what we do and what we value. At Aspire, our culture is defined by the following attributes which spell the name of our company: • Audacity (we are competitive, innovative, and dream big) • Skill (we are competent, data-driven, and curious) • Passion (we are impact-centered, profit-minded, and market-driven) • Integrity (we are ethical, trusting, humble and candid) • Resilience (we face adversity and setbacks with fierce determination and collaboration) • Excellence (we aim to be world class in everything we do and believe generosity is a competitive advantage)

Since our inception in January of 2006, Assay Biotechnology has been a worldwide contributor of industry-leading antibody and assay technologies, fluorescent dyes, quenchers, recombinant proteins and synthetic peptides. Located in the heart of California's San Francisco Bay Area, we have strived to answer the global need for high quality assay kits and immunological reagents used in academic and pharmaceutical research that formulate the basis of healthcare. For the first couple years after our founding, Assay Biotech established itself as an antibody manufacturer, catering specifically to large corporations through OEM partnerships. Since then, we have been emerging as a prominent assay and antibody source, expanding our reach to millions of researchers in over 50 countries around the world. We are determined to become one of the world's leading assay development and manufacturing companies, providing a multitude of ready-to-use assays, immunological reagents, molecular detection modules and biomarkers to support the most arduous academic and pharmaceutical research endeavors.

Specialize in molecular and toxicology assays and technology.COVID-19: Molecular test, EUA (05/2020)

AstaReal produces astaxanthin from algae and is part of the AstaReal Group which is a wholly-owned subsidiary of Fuji Chemical Industries Co., Ltd.

At Asterra Labs, we are pharmaceutical scientists and industry veterans with a passion to innovate, develop, and manufacture a pharmaceutical-grade line of safe, beneficial wellness products and alternative medicines.

Astute Medical is a healthcare company that specializes in identifying and validating unique biomarkers to rapidly assess high-risk acute conditions and diseases, supporting healthcare professionals with useful clinical tools.

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. Visit atcc.org to learn more.

ATCOR develops innovative medical devices and digital solutions that help identify and reduce the risk of hypertension, cardiovascular disease (CVD), and other related vascular disorders. Early detection with SphygmoCor® technology allows clinicians to detect target organ damage and manage cardiovascular disease, Alzheimer's, kidney failure, and other vascular diseases. Using SphygmoCor® technology, researchers and clinicians are able to collect and assess clinically relevant digital vascular biomarkers to facilitate routine patient monitoring. These measurements shed insight into subclinical changes in the arterial system that demonstrate the efficacy of clinical trial therapies for chronic vascular diseases. Digital vascular biomarkers provide better prognostic and diagnostic information to target interventions—complementary and additive to—standard brachial blood pressure measurements. For over twenty years, major medical and research institutions have been using SphygmoCor® systems to improve therapeutics and treatment strategies for the world's most devastating chronic diseases. Leading pharmaceutical companies utilize ATCOR devices to collect primary, secondary, and safety endpoint data across all phases of global clinical trials. Playing an integral role in over 4000+ studies to date, our technology has been referenced in over 7000 citations in leading medical journals. ATCOR is a subsidiary of the Australian listed company Cardiex Limited (ASX:CDX) www.cardiex.com

At Athelas we're bringing simple, life-changing health care products and medical billing services to patients and providers around the globe. Athelas Revenue Cycle Management (RCM): Billing and reimbursement don't have to be painful. Athelas RCM delivers world-class service, maximizes reimbursements, and delivers actionable insights into the financial health of your practice. Athelas prides itself on end-to-end revenue cycle management. This means we cover all aspects of RCM besides simple submission - include denials, working A/R, research, and more as the backbone of your healthcare business. Athelas has powered revenue intelligence for hundreds of healthcare businesses, from small clinics to large health systems. Athelas Remote Patient Monitoring (RPM): We allow healthcare providers to monitor patient vitals like blood pressure, weight, and blood glucose without the patient ever having to enter a clinic, improving patient health and engagement, and reducing hospitalizations. We do this all through a beautifully integrated suite of devices and software tools that provides access to state-of-the-art technologies and groundbreaking AI powered analysis.

athenahealth strives to cure complexity and simplify the practice of healthcare. Our innovative technology includes electronic health records, revenue cycle management, and patient engagement solutions that help healthcare providers, administrators, and practices eliminate friction for patients while getting paid efficiently. athenahealth partners with practices with purpose-built software backed by expertise to produce the insights needed to drive better clinical and financial outcomes. We’re inspired by our vision to create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all. Our vibrant and talented employees spark the innovation and passion needed to accomplish our goals. We continue to expand our workforce with amazing people who bring diverse backgrounds, experiences, and perspectives at every level, and foster an environment where we each feel comfortable bringing their best selves to work. Our dedication to creating an exceptional workplace has been recognized with several prestigious awards. We've been honored as a 2024 Top Workplaces USA, named a Forbes 2024 America's Best Mid-Size employers, and celebrated as one of 2023 Glassdoor Best Large Companies to Work For. Additionally, we've been acknowledged as a 2023 Top Workplace in Austin, one of the 2023 Best Places to Work in Maine and a 2023 Top Workplace in MA by the Boston Globe. These accolades are a testament to our vibrant and diverse team that fuels innovation at athenahealth.

Athens Research and Technology, Inc. (ART) is a dynamic life science company and recipient of the Globe Award as Georgia's 2022 Exporter of the Year. Since our founding over three decades ago, we continue to proudly support the life sciences industry in the advancement of essential medical diagnostics and therapies. ART is renowned for defining the industry standard for native protein purification. We specialize in producing natural human and animal proteins critical to academic research and manufacturing in the Clinical Diagnostic, Cell Culture Media, and Standards/Calibration industries. Our custom purification programs support our long-standing distinguished industry partners as well as our growing base of inspired customers. Since 1986, ART products have been sought after by prominent academic researchers and biotech companies for high-impact research published in Nature, Science, & Cell journals. ART proteins have been crucial for Alzheimer's, Cancer, Cardiac, Pulmonary, and Covid-19 research. Envisioned by local physicians and a university of Georgia researcher, ART was one of the first Life Science start-ups to launch from the University of Georgia incubator. Since our inception, we have served as a model for success to many subsequent companies. We are committed to People, Purpose, & Proteins. People are at the core of our belief system. Our culture continues to attract great talent, developing the next generation of industry-leading Protein Chemists. Purpose is ingrained in our being, keeping quality proteins at the forefront of research for the world's most complex medical challenges. Our purpose overflows into the Athens, GA, community as we ensure the health and strength of our neighbors and the growth of our local economy. Proteins are the core of our success. After 36 years, our company holds a breadth of knowledge of proteins and purification processes, allowing us to purify even the most complex and least abundant proteins in the human body.

Founded in 1987, ATL, A Bureau Veritas Company, is a Scientific Sourcing Solutions Company. For more than 30 years, we’ve exceeded the highest expectations of the world’s most demanding customers in the Consumer Products, Pharmaceutical and Medical Device industries. ATL, A Bureau Veritas Company, has become a recognized leader in creating innovative sourcing solutions across the entire product life cycle, from discovery through commercialization. Our services range from standard rules-based testing to operating and managing entire scientific functions. We’re experts in the field of scientific sourcing. Across all levels of complexity, oversight and location, we transform cost-saving measures into strategic solutions. We can elevate your existing proficiencies and resources — all while protecting the critical continuity of business, knowledge and talent. Our capabilities include: Analytical Chemistry, Engineering, Life Science, Product Performance Testing, Product Safety and Regulatory, and Quality Assurance. At ATL, A Bureau Veritas Company, our unique solutions help maximize readiness, efficiency and productivity for our clients. We are committed to continue making “exceptional our ordinary” while delivering the science that makes life better. Careers At ATL, A Bureau Veritas Company, we don’t just do the science, we have the opportunity to transform organizations. We need people who want to grow with us and contribute directly to our clients’ success. As scientific sourcing experts, the largest and most respected companies in the world ask us to create innovative solutions to big problems. We have more input and influence, so we can have a significant impact on brand-name products and visible projects. And you can play a bigger role.

Atlantic Fish Company is working to make cultivate seafood. Cells are harvested from the fish and fed nutrients in a bioreactor. Scaffolding is used to give the cells a structure to grow on and produce the texture of a whole fish fillet. The end product is REAL seafood, grown directly from fish cells.

Atlas Data Storage is a technology company building end-to-end DNA data storage.

When it comes to solving our world's biggest problems, the answers can often be found in nature. The forest is a great place to begin. A lot goes on—between the dirt and the squirrels, and the mosses and the trees—but, what interests us most is what's happening just beneath the forest floor, where lies a hidden, entangled root system of fungi called mycelium. We've studied and become inspired by mycelium. We've learned there's a lot you can do with it—from textiles to building materials to packaging alternatives, even to food! Really tasty food. Guided by the wisdom of the woods, MyForest Foods is harvesting this new approach to meatless food—one that can sustain AND satisfy all types of eaters. Our mycelium is grown—not ground, so it actually feels like you're biting into a whole cut of meat. Our flagship product, MyBacon is the first of many plant-based, clean-label, mycelium-grown eats we have planned. Mycelium—MyBacon's star ingredient—is a complete protein with a naturally high nutritional profile, and it's what gives MyBacon its amazing texture. Our chefs brine each strip using a special recipe with minimal ingredients: flaked salt, cane sugar, natural flavors and beet juice for color. Add a little coconut oil for the perfect sizzle, and you're looking at a seriously meat-like bacon alternative, so reminiscent of the traditional bacon-y flavors and textures you love. Now that we've figured out how to create a sustainable supply of eats, it's our aim to pass the plate around the planet, honoring mycelium's potential to feed the future, one delicious bite at a time.

Founded in 2019, Atomo is a Seattle-based, food-tech startup improving coffee taste and confronting the climate crisis by reinventing coffee for tomorrow. They have reverse-engineered the coffee bean—producing outstanding espresso that tastes great and does good.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals

ATUM is an industry-leading provider of life science tools and solutions. Founded as DNA2.0 in 2003, we were a pioneer in the application of machine learning to synthetic biology and currently hold multiple patents covering several technologies, including our first-to-market Leap-In Transposase® platform. Our integrated offerings include Gene Design & Synthesis, Protein Production, Cell Line Development, and Master Cell Banking — all powered by our Leap-In Transposase® and machine learning platform. This means a streamlined path from sequence to Master Cell Bank (MCB) with just a click, ensuring efficiency, regulatory compliance, and innovative solutions tailored to our clients' needs. ATUM is privately held and is headquartered in Newark, CA.

Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company's revolutionary xvision Spine System® allows surgeons to see patients' anatomy as if they have "x-ray vision" and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states. Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine's Best Inventions of 2020. It was recently featured in The Economist documentary How will businesses use the metaverse? To learn more or schedule an xvision demo, visit augmedics.com.

August Schell Brewing Company is a food & beverages company based out of 1860 Schells Rd, New Ulm, Minnesota, United States. We make beer that is steeped with history, malted with integrity, hopped with innovation, fermented with perseverance, aged with experience, poured with expertise, laced with character, and consumed with celebrating all of life's victories.

Aurita Corp is a synthetic biology startup that creates a platform for 3D bioscience intended to provide personalized medicine and diagnostics, therapeutic solutions, and cell culture tools.

AustarPharma is a pharmaceutical company that specializes in drug delivery technologies.

AustinPx™, Pharmaceutics and Manufacturing, was founded to help developers realize the full potential of their drug candidates. There are many obstacles to bringing a drug to market, including poor bioavailability and accelerated timelines. That's where we come in. Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges and identify opportunities to do more, faster. As the inventors of the KinetiSol™ Technology - a next generation amorphous solid dispersion (ASD) technology for poorly soluble APIs - we look to disrupt the ASD industry with its smaller footprint, broader design space, and greener processing solution.

AuST is a medical device design, development, and manufacturing firm specializing in minimally invasive medical devices. We excel at collaborative development and have taken numerous products from concept to market using a process that focuses on rapid design iteration and ample clinical feedback. Our design expertise is supported by in-depth experience with quality management and US and European regulatory systems. We maintain a fully resourced product development lab and pilot production facility in Mountain View, California. We also maintain volume manufacturing capability in Salt Lake City, Utah. In addition to our development capabilities, we offer a number of novel technologies that can enhance device performance and manufacturability.

Research product distributor, Contract Services

Autocam Medical is a precision-machining contract manufacturer of highly engineered implants and instruments for surgical applications. Our product specialties include custom bone screws, bone plates and fixation devices; and perfect-fit complementary, surgical drivers, drill bits, taps and other rotary cutting instruments. We have decades of experience in every aspect of medical machining manufacturing, with specialties in CNC milling, turning, mill/turn and cutter-grinding of all surgical-grade materials, including titanium and other high-performance specialty alloys and plastics. Autocam Medical partners with customers to provide Design for Manufacturability consultation for precision-machined components, involving our engineering team early in the planning stage adds value to the entire process. Our in-depth knowledge of how medical devices work and interact gives customers an added competitive advantage.

AutoGenomics is a biotechnology company that offers an automated microarray based multiplexing molecular diagnostic platform to assess disease signatures with novel genetic biomarkers in the areas of women’s health, cancer and personalized medicine.

Autonomic Technologies is a medical device company that focuses on the development and commercialization of innovative therapies for autonomic disorders, particularly severe headaches.

Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

Autonomous Medical Devices Incorporated (AMDI), with its principal place of business in California, employs a world class team of engineers, scientists, clinicians, and manufacturing experts dedicated to the development and manufacture of point-of-care diagnostic devices using breakthrough microfluidics, protein engineering, and data/cloud connectivity. AMDI will launch its first products from its ISO:13485 certified 110,000 square foot facility in Santa Ana, CA.

AVACEN Medical is a healthcare technology company that specializes in noninvasive medical devices for pain management, offering drug-free alternatives for various chronic and acute conditions.

Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections.

Avance Biosciences is a leading CRO providing GLP & GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide. We provide customized solutions for cell and gene therapies testing including: ID testing by Sanger and NGS sequencing , next-gen sequencing on/off target assays, preclinical DNA & RNA biodistribution studies, mRNA Drug Product, Drug Substance and raw material testing including ID and...

NeoMed develops innovative enteral collection and delivery products supporting the specialized feeding and medication dosing needs of the low birth weight, neonatal and pediatric patient. We are committed to improve patient outcomes through product designs that meet safety, clinical, and regulatory guidelines while supporting cost containment objectives.

AvantGen is a biotechnology company dedicated in accelerating antibody-based therapeutics for their scientific partners by using innovative platforms. Based in San Diego, the fun and collaborative team is steadfast in this pursuit.

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Avazyme, Inc. a contract research solution provider, offering field and laboratory testing, product development, and expert consulting services to the agriculture and food industries. Avazyme's comprehensive services include food safety analyses for contaminants, pathogens, allergens, food quality and nutrition analysis, genetic trait testing, product safety, FDA Menu Labeling, pesticide residues, mycotoxin analysis, specialized studies for regulatory submission data packages, and a full spectrum of testing for product safety and product quality related to Industrial Hemp. Avazyme provides fast and reliable answers to ensure product safety and high product quality for consumable food, feed, cosmetics, nutraceutical Avazyme also offers comprehensive laboratory and "​in-brewery"​ services to craft breweries and local hops growers and maltsters. Most recently, Volker and his Avazyme team have been a strong supporter and testing partner for the fast-emerging Industrial Hemp Industry in North Carolina and the entire East Coast

AventaCell BioMedical Co., Ltd. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production. The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development. Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines. AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.

Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biologics and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit.

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in vascular access for hemodialysis patients. Our focus is to pursue unmet clinical needs by developing a minimally invasive, cost effective and efficient approach to vascular access. Founded in 2010 and headquartered in Orange County, California, we have developed the Ellipsys® Vascular Access System, an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous (AV) fistula for hemodialysis access. Over the past three years, the Ellipsys System has been used in clinical trials outside the United States. In December 2014, we received approval from the Food and Drug Administration (FDA) to begin a pivotal Phase III clinical trial in the United States through an Investigational Device Exemption (IDE). Patient enrollment for the trial was completed in June 2016. The Ellipsys System has received FDA approval and European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.

Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we’re dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix’s Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.

Aves Labs produces high-affinity, custom chicken IgY and other immunoreagents for biomedical research and antibody manufacturing.

As a primary turkey breeder, we are aware of our responsibility to both our customers and the environment. Investment and innovation are key to breed development, producing premium-quality turkeys of the future. Sustainability: Aviagen Turkeys is committed to developing breeds and adopting internal production practices that not only support cost-effective food production, but also supports social responsibility and environmental sustainability. Aviagen Turkeys is proud to be a leader in both new technologies and environmental stewardship. We will continue to supply the world with a valuable protein source while minimizing environmental impact and emphasizing conservation. Customer Support: Aviagen Turkeys provides support to ensure customers can maximize the genetic potential, efficiency and profitability within their systems. As well as attending many of the global poultry exhibitions to meet customers face to face, Aviagen Turkeys have previously held open days to help guide and support customers within the industry. Aviagen Turkeys provides an exceptional resource of information and expertise to customers, comprising of knowledge and experience gained from productions around the world to maximise the performance of the B.U.T and Nicholas breeds.

Avid Bioservices (NASDAQ:CDMO), is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology, biopharmaceutical, and cell & gene therapy industries. With over 30 years of experience, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Avid Bioservices positions are accessible via the Avid Bio Careers page at https://avidbio.com/careers/.

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Aviva Systems Biology specializes in providing polyclonal and monoclonal antibodies, ELISA kits, proteins, and custom services for research needs. We manufacture 24,000 validated polyclonal antibodies and offer nearly 20,000 ELISA kits. Our custom laboratory services include protein expression and purification, antibody development, and ELISA development, validation, and production. Our head office is in San Diego, CA, we also have an office in Beijing, China. Both locations provide scientific support assisting researchers with a variety of proteomic objectives. Aviva provides unique tools for research associated to unique species and targets. The company's products are relevant to 10,000 unique species, 10,000 cellular processes, and 5,000 protein pathways. Research Areas Transcription factors, cancer, cardiovascular, cell biology, DNA damage and repair, epigenetics, signal transduction, cell differentiation, stem cell biology , and many more. Specialties Western blot, immunohistochemistry, ELISA, custom protein expression

Axcess Surgical is a medical devices company that specializes in creating advanced surgical innovations for optimum results.

AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. We passionately believe that next-generation lumbar and cervical total disc replacement (TDR) technology will transform the lives of patients on a global scale. Led by an experienced surgeon team utilizing patented viscoelastic polymer technology, AxioMed is developing the next generation of artificial discs. Our Vision: Focusing on restoration of the natural function of the spine, AxioMed will enhance human health through research, innovation, development and service world-wide. AxioMed LLC is a KICVentures company. For all AxioMed jobs visit: http://www.kicventures.com/blog/careers/

AxisPharm is a San Diego based antibody drug conjugate (ADC) linker product and service provider. At AxisPharm, we focus on manufacturing novel ADC linkers, site specific molecular probes and advanced biochemical reagents. We also provide a variety of bio/chemical services worldwide, including custom synthesis and integrated drug discovery services.

Developing seamless neural interfaces.

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen’s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.

Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology. The Axonics Sacral Neuromodulation System™ is the first CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction (not available in the US).

Ayana Bio leverages cellular technology to produce bioactive ingredients that support health and wellness. Ayana Bio collaborates with global industry leaders in food and beverages, dietary supplements, sports nutrition, animal care, and cosmetics to bring standardized plant and fungal bioactives to market. We provide consumers with confidence in quality and reliability. Ayana Bio has partnered with Ginkgo Bioworks, a synthetic biology platform company that is redesigning the living world to solve some of the globe's growing challenges in health, energy, food, material, and more. Ayana Bio is backed by Viking Global Investors and Cascade Investment to democratize nature's bioactives in a way that is standardized, safe, and sustainably sourced.

Symphony Ayasdi is a FinTech company that specializes in AI-driven machine learning and data analytics solutions for financial services.

We believe good oral care is critical to everyone’s health and wellness. Dental professionals and consumers alike should have access to technologies that improve oral health. We are committed to the belief that these technologies should be proven effective through empirical evidence, have elegant & intuitive design, and be as minimally invasive as possible. At Azena, every insight is given a chance to develop, to be validated by science and clinical research, and to inspire the creative minds of our designers and engineers. We continually challenge ourselves to explore innovation for the betterment of oral healthcare. We base our innovation on the foundations of science and aesthetic design to create effectiveness, simplicity, ease-of-use, and overall appeal. With a focus on improving oral healthcare, we design, develop, validate, manufacture, and market world-class devices for both dental clinicians and consumers. We are continually searching for new solutions to enhance oral care. Our offerings are created at the intersection of where art, science, and technology meet.

Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world's leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. Follow us on LinkedIn. For more information, visit azzur.com

We work to find new uses for algae as sustainable, natural ingredients for food colorants and flavors; protein powders for plant-based meat; biostimulants to improve yield and quality in vertical farming and growth media to move cell-based food from the laboratory to the table. Based at The Plant in Chicago, BYAS has its own laboratories, production units, photobioreactors and access to a large anaerobic digester.

Baebies Inc. is a growth-stage medical device company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing for children and adults. Guided by the vision that everyone deserves to be healthy, we aim to deliver ‘Any test. Anywhere. To Everyone.’ We deliver millions of tests globally every year to save lives and make lives better. Baebies is a pioneer in digital microfluidics technology, which maximizes diagnostic yield from low-volume samples. Baebies is headquartered in Durham, North Carolina, and our products are used in central laboratories and point-of-care settings around the world. Over 20 million tests delivered, and counting. Every test is a chance to save a life. Our current pipeline of test panels on the multifunctional FINDER platform include molecular (Respiratory panel - Flu A, Flu B, RSV, and SARS-CoV-2, STI panel - CT/NG/TV), coagulation (anti-factor Xa, aPTT), and chemistry (G6PD).

Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako's comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako's in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession's principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.

Headquartered in Arizona, Banner Health is one of the largest nonprofit health care systems in the country. The system owns and operates 28 acute-care hospitals, Banner Health Network, Banner – University Medicine, academic and employed physician groups, long-term care centers, outpatient surgery centers and an array of other services; including Banner Urgent Care, family clinics, home care and hospice services, pharmacies and a nursing registry. Banner Health is in six states: Arizona, California, Colorado, Nebraska, Nevada and Wyoming.

Barrow Neurological Institute is a healthcare institution specializing in neurology and neurosurgery services.

BA Sciences is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2017 certified analytical laboratory located in Salem, NH. BA provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including: Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Impurities Testing, Advanced Therapeutics and Extractables & Leachables Studies.

Basepair is a next generation bioinformatics company. Through a combination of intuitive interfaces and modern architecture we are reimagining what a commercial platform can deliver to R&D organizations. We're on a mission to make genomic data analysis & visualization more accessible to a broader range of scientists so that the promise of precision medicine can become a reality. One of the biggest challenges preventing this now arguably lies not with how the data gets generated and processed, but who is able to perform the analysis and understand what the resulting data means. Limiting this work to a select few, whether through choice or more often because of technology restrictions, especially for routine analyses, leads to reduced efficiency in R&D teams, longer times to market for assay manufacturers and increased turnaround times in clinical settings. Unlike other more traditional alternatives, our philosophy is not to ask bioinformaticians to change the way they work by having to build workflows on our platform. Instead, once they are built and ready for sharing or production settings, Basepair can significantly improve and accelerate both scaling & deployment to colleagues, collaborators and customers wherever they happen to be in the world. To do this in a way that is adapted to the dynamics of the market today, we believe a bioinformatics platform needs to: 1) Leverage the compute and storage resources in a third party cloud account without the requirement of installing inside an organization's vpc 2) Facilitate the bundling of analysis with the sale of a kit or assay through easy white labeling and tokens/coupons 3) Support ever increasing sample volumes and application areas through an extensible architecture that scales to millions of records, enables complete sample provenance and reduces cloud costs Introducing Basepair…bioinformatics reinvented.

Base Pair Biotechnologies, Inc. offers rapid discovery of high quality aptamer (DNA- and RNA-based) affinity ligands. Aptamers have been successfully employed in virtually every application where antibodies are typically used. Aptamers have a number of potential advantages over antibodies, however, in a variety of applications. Base Pair Bio's aptamer discovery is powered by a patented, multiplexed approach to aptamer identification. This and other chemical enhancements result in better DNA affinity ligands. For more information, please visit www.basepairbio.com.

BASF Corporation is the largest affiliate of BASF SE and the second largest producer and marketer of chemicals and related products in North America. BASF creates chemistry for a sustainable future. They combine economic success with environmental protection and social responsibility.BASF Corporation operates more than 100 production and research and development sites throughout North America and operates Verbund sites in Geismar, Louisiana and Freeport, Texas. At Verbund sites, production plants, energy and material flows, logistics, and site infrastructure are all integrated.

Delivering actionable insights for the Life Sciences industry. Basil Systems leverages state-of-the-art AI and big data tools to provide precision insights, intelligence and analytics to support product innovation, regulatory strategy, quality management, post-market surveillance and competitive due diligence. Basil's instantly accessible, natural language interface delivers the latest news, alerts, and trends effortlessly, while putting fully customizable search, analytics, and insights right at your fingertips.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

BABEC provides assistance to Bay Area schools and equipsteachers with the technical skills and pedagogical knowledge to teach biotechnology.

Bay BioSciences provides high quality human biomaterials, fresh frozen human tissues, FFPE Tissue Blocks, bio fluids like whole blood from diseased and normal subjects, serum, plasma and other blood products. Bay BioSciences specializes in characterized and documented human bio-specimens for research and development projects and is a leading global biobank offering vital products and services facilitating breakthroughs in translational medicine, genetics, drug discovery, biomarker research, companion and molecular diagnostics.

Baylor Genetics offers a full spectrum of cost-effective, genetics testing and provides clinically relevant solutions. They offer whole exome sequencing, prenatal diagnostics, cytogenetics, molecular diagnostics, oncology, chromosomal microarray analysis, and over 30 enzyme assays. Along with these tests come interpretation services.

As the largest not-for-profit health system in the state of Texas, Baylor Scott & White promotes the health and well-being of every individual, family and community it serves. It is committed to making quality care more accessible, convenient and affordable through its integrated delivery network, which includes the Baylor Scott & White Health Plan, Baylor Scott & White Research Institute, the Baylor Scott & White Quality Alliance and its leading digital health platform – MyBSWHealth. Through 51 hospitals and more than 1,100 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care. Founded as a Christian ministry of healing more than a century ago, Baylor Scott & White today serves more than three million Texans. For more information, visit: BSWHealth.com.

Custom Manufacturing

The company providesservices inbioanalytic, molecular and cellbiology, in vitro and in vivo pharmacology.The company's capabilities include assay development and in vitro/in vivo pharmacologystudies forantibodies, small molecules, siRNAs, proteins, and gene therapy products.

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

The measure of our success is in what we achieve together. At BDO, culture is the first order of business. We succeed when we cultivate a conscious and caring corporate culture that puts people at the center of everything we do. In essence, the business of our business is to help people thrive every day. This mindset powers our growth by supporting the development of our people, the success of our clients, and the betterment of our communities. It means taking an expansive view of what's possible, and committing ourselves to achieving exceptional outcomes. At BDO, we are cultivating a culture where our professionals thrive in their work of providing middle market leaders with insight-driven perspectives and assurance, tax and advisory services, helping companies take business as usual to better than usual. BDO is the brand name for the BDO network and for each of the BDO Member Firms. BDO USA, P.C, a Virginia professional corporation, is the U.S. member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.

Beacon Clinical Research is a multi-specialty clinical research facility specializing in Phase I-IV clinical trials. In 2000, Beacon Clinical Research was established to offer patients the opportunity to enroll in clinical pharmaceutical trials. Participants are significant in contributing to the development of new innovative medications. Study participation potentially benefits the individual patient and contributes to the advancement of health care in our society.

Beaufort is a global CRO built around one purpose — helping life science companies improve and save lives through the rapid development and commercialization of innovative products. Our shared interest and commitment to your success drives our entire organization to deliver best-in-class clinical trial services, regulatory strategy and planning, data and business analytics, data management and statistics, and quality services. We are: ◈ MedTech Focused - Industry-leading expertise to streamline your clinical development. ◈ IVD Specialists - Two decades of extensive diagnostic experience. ◈ Results Oriented - Guided by efficient and adaptive clinical trial management. ◈ Partnership Driven - 94% of clients rate Beaufort higher than other CROs Our experience includes: ◈ 500+ Regulatory Submissions including 510(k)s, PMAs, IDEs and CE-Marks ◈ 4,000+ Clinical Study Sites Around the Globe ◈ 1,000+ Clinical Trials Across a Wide Variety of Indications and Testing Platforms ◈ 2,600+ Clinical Professionals in Over 50 Countries See how Beaufort CRO can accelerate your medical innovation -- and put our experience to work for you.

With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs more than 3,300 associates with more than 300,000 systems installed globally.

Beeflow creates nature based solutions to help farmers improve the impact of pollination in agriculture by leveraging scientific knowledge and technology. Pollination is critical to crop success as it sets the ceiling for crop yield and quality potential. Inefficient or lack of pollination can reduce crop yields, cause malformation and small-sized crops, contribute to fruit diseases and ultimately increase food waste.

Beeken Biomedical is an medical device company focused on the development, licensing and commercialization of wound care products. Beeken Biomedical introduces innovative and cost-effective technologies that rapidly stop bleeding and help protect wounds from infection. Beeken Biomedical is committed to improve solutions in wound care for healthcare professionals and consumers.

TheBEI ResourcesRepository is a central repository, established by the National Institute of Allergy and Infectious Disease, that supplies organisms and reagents, such asSARS-CoV-2, to the broad community of microbiology and infectious diseases researchers.

Purpose-built for organizations conducting clinical trials and observational studies, we leverage our AI-powered patient-matching platform and clinical expertise to optimize feasibility and speed up patient identification by extracting structured and unstructured data from electronic medical records (EMRs) that captures three times more trial criteria. Why: We believe sites are vital to the success of clinical trials. Empowering them to find the right patient for the right research at the right time is the focus of everything we do. What: We leverage our best-in-class technology and data expertise to detect more protocol-eligible candidates than traditional methods, so that site teams can focus on the parts of the job they actually love. How: We deliver an AI-powered software platform and support from clinical experts that enables our customers to find and match patients to available clinical research. With unbelievably fast and highly-accurate data extraction from electronic medical records (EMRs) we can capture three times more trial criteria - making trial participation more accessible and efficient.

Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, the materials we wear, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the development of breakthrough products and accelerate time to milestone and market. Come help us bring modern software to modern science. https://www.benchling.com/careers/

BenchmarkEA has sixteen years of operational experience in analyzing water, soil and sediment. The laboratory is owner operated and consists of two laboratory facilities and thirty employees. BenchmarkEA is headquartered in a new 7000 ft2 facility located in Palmetto/Bradenton, Florida and also provides service from a facility located in North Port/Port Charlotte, Florida. "Reporting results correctly the first time, on time." The laboratory is well equipped with automated instruments and data processing for analyses of weekly samples for metals, inorganics, THM's and VOC's. These analyses are routinely reported within a five working day time frame. The same analyses for special studies are typically reported within seven to nine working days. BenchmarkEA's strength is providing excellent routine service with the ability to also provide special services for the individual needs of our clients.

Benchmark Research, an Avacare business, has a track record of safety and expertise, having conducted more than 1,000 trials since 1997 at clinics located in California, Louisiana and Texas. Benchmark's superior team of motivated and focused investigators offers clinical trials experience in a wide range of therapeutic areas. Our knowledgeable investigators enthusiastically embrace clinical research and the opportunities that new therapies bring to the marketplace and patients. Dedication and experience aside, our investigators are also highly trained in GCP and FDA regulations.

The company helps customers' businesses become more sustainable and compliant while lowering their cost and/or optimizing their supplies of both water and energy.

We are an emerging technology company delivering unique cell analysis systems accommodating large multi-cellular spheroids and single cell analyses at 10 – 100x flow volume and event rates. The VelocytTM enables near total analyzed sample recovery for further re-analysis, dynamic cellular kinetic studies or repurpose to other workflows. We are also creating viable cell preserving, rapid enrichment technologies to purify specific cells for in vitro expansion to enable advanced immuno-oncology treatment or selectively isolate and further characterize specific circulating cells and disease states to develop higher precision diagnostics, guidance therapeutics and prediction of minimum residual disease. (The Velocyt is presently not approved by US FDA for in vitro diagnostic purposes)

Berkeley Yeast uses synthetic biology and process engineering to develop products with transformative impact on fermentation, particularly in the beer and wine sectors. With proven traction in these markets, and with support from government grants (NSF, NIH, USDA) and venture capital, we are expanding our research and manufacturing pipelines. Currently available products in the market give unprecedented control over flavors and improve production efficiency. And that's just the beginning. We are hiring—come join our team to build the future of fermentation. Learn more about our company and products here: Why Genetically Modified Yeast Could Be the Next Step in Beer's Evolution https://www.goodbeerhunting.com/blog/2020/1/13/yeast-of-eden-why-gmo-yeast-could-be-the-next-step-in-beers-evolution 6 Beer Industry Trends to Watch in 2022 https://daily.sevenfifty.com/6-beer-industry-trends-to-watch-in-2022/

3/21/23- Acquired IsoPlexis Corporation (Nasdaq: ISO) then renamed to create PhenomeX. On Aug. 17, 2023, PhenomeX and Bruker entered into a merger agreement. Berkeley Lights is a leading functional cell biology company focused on enabling and accelerating the rapid development and commercialization of bio-therapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain. Berkeley Lights’ Beacon® and Lightning™ systems and Culture Station™ instrument are for research use only. Not for use in diagnostic procedures.

It is Berkshire Sterile Manufacturing’s (BSM) goal to provide the safest sterile drug products possible for clinical use and small scale requirements. BSM will provide small scale sterile manufacturing services with highest level of sterility assurance and quality achievable through the use of the most modern technologies for sterile manufacturing, stringent quality standards and highly trained employees. BSM will also provide ancillary support to their clients’ drug productions such as analytical method development and validation, stability studies and formulation scale up.

At Best nomos we design products and solutions that help medical professionals treat a variety of cancers. We are best known for our innovations in IMRT and IGRT. As one of the newest members of the Best family of companies, our aim is to expand our product selection beyond imaging technology to become the Single Source Oncology Solutions provider of choice for our customers.

Novoste is the global leader in the field of vascular brachytherapy.

Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs. To learn more, visit www.betabionics.com. For safety information, visit: www.betabionics.com/safety.

Beta Hatch is industrializing insect agriculture within a regenerative food system. We make protein for plants and animals in a zero waste system using at our mealworm ranch in Cashmere, WA. Our circular production system uses waste heat from a neighboring data center to condition our insect grow rooms, in collaboration with the Washington Clean Energy Fund.

By shifting from animal to plant-based meat, we can positively impact four growing global issues: human health 💪, climate change 🌎, constraints on natural resources 🌱, and animal welfare 🐮. #GoBeyond

An innovation driven start up company catering to the unmet needs of the biomaterial community and medical device industry. With our state of the art research and development facilities in theUS and India, combined with our platform technologies derived from a family of novel and proprietary biodegradable polymeric biomaterials, we work with and for our customers to translate their demands into high quality products for a wide range of medical device and therapeutic applications in a cost effective manner. Our expertise lies in the area of absorbable polyurethanes, absorbable polymers derived from functionalized natural products, drug molecules and amino acids, adhesion prevention barriers, absorbable drug eluting stent coatings, tissue adhesive and sealant, medical device coatings, drug delivery, drug device combination, absorbable implantable devices and tissue engineering.

CELLINK is proud to be a part of BICO, the world's leading bioconvergence company. By releasing the first universal bioink in 2016, CELLINK democratized the cost of entry for researchers around the world and played a major role in turning the then up-and-coming field of 3D bioprinting into a thriving $1 billion industry. The company's best-in-class bioinks, bioprinters, software and services are trusted by the foremost academics in a range of applications, from 3D cell culturing to tissue engineering to drug development, and have been cited in over 700 publications. Furthermore, more than 1,000 laboratories, including ones at the top 20 pharmaceutical companies, are using these award-winning innovations. As part of BICO's bioconvergence revolution, CELLINK is dedicated to making the on-demand bioprinting of human organs and tissues a future reality and creating the future of health.

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company's pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. Bigfoot will be the first company to deliver a monthly subscription-based service leveraging a smart, connected insulin dosing platform to meet the needs of a diverse population with insulin-requiring diabetes. Bigfoot's investigational system is comprised of best-in-class proprietary and licensed components holistically and securely integrated, leveraging intuitive design, machine learning, and a mobile app running on an off-the-shelf smartphone, all designed to keep glucose levels in an optimal range. "The net result is a company that brings something unique to the table: a remarkable depth of knowledge and technical know-how combined with the personal motivation and direct patient experience necessary to really make a difference in this space." ---The MedTech Strategist, October 24, 2016

Big River Resources currently has four subsidiaries beneath it which include Big River Resources West Burlington, LLC; Big River Resources Galva, LLC; Big River Resources Boyceville, LLC; and Big River Resources Grinnell, LLC. These subsidiaries have facilities in West Burlington, Iowa; Monmouth, Ill.; Gerlaw, Ill; Edgington, Ill; Aledo, Ill; Galva, Ill.; and Grinnell, Iowa; Boyceville, WI; and, they consist of a 90 million gallons per year (mgy) ethanol facility, a 100 mgy ethanol facility, a 57 mgy ethanol facility, and 10.61 million-bushel capacity grain elevator sites. All are located on the Burlington Northern Railroad. The company also has an investment in Absolute Energy, LLC a 100 mgy ethanol facility in St. Ansgar, IA and is a majority shareholder and managing company of Big River United Energy, LLC a joint venture company in Dyersville, IA. The company has a 21-member board and employs 204 team members full time.

BillionToOne is a precision diagnostics company that quantifies biology to create powerful molecular diagnostics. They are focused on moving Prenatal Screening and Liquid Biopsy forward to improve disease detection.

binx health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining "convenient care" for the modern consumer. binx is developing a suite of offerings that service healthcare needs where people live, work and shop. The Company's io® platform is designed to offer rapid PCR-based results, up to 24-plex, from sample-in-to-answer in about 30 minutes, greatly accelerating today's multiple day standard-of-care central lab testing paradigm. binx is driving solutions to take place in retail clinics, supermarkets, primary care offices, and at home. It does it through a suite of mobile and digital offerings. binx health investors includes financial investors, Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors, Consort Medical (whose wholly owned subsidiary Bespak are the makers of the company's low-cost, proprietary multi-plex cartridges) and China-based Wondfo Biotech. binx health is a global company and has locations in Boston, MA and Bath UK. For further information visit www.mybinxhealth.com.

BioAgilytix is a biotechnology company that specializes in bioanalysis for the biopharmaceutical and life sciences industries.

At BioAI, we are developing world-leading machine learning technology to map the causal biology of disease, develop digital biomarkers, and identify novel drug targets, for the development of better medicine. BioAI’s PredictX Platform intakes your data and generates novel insights. PredictX is capable of ingesting a range of data types including: Digital Pathology, Multiomics, and Real-World Evidence. Using multimodal data and the most advanced AI methodologies, including In-silico phenotype projection and integrated deep learning, we can build predictive and prognostic models across a broad range of therapeutic areas. Founded by a group of friends who started by scribbling their ideas on a piece of paper, today we offer smart, innovative services to dozens of clients worldwide. Our team of experts has a proven track record in developing strategic partnerships with the Pharma industry and solving major challenges in R&D

A small, agile CRO. The primary function of the scientists at BioAnalysis, LLC is to provide a collaborative workspace that enables productive and effective solutions to the client’s problems. The traditional CRO model works well, however, at BioAnalysis, LLC we believe that collaborative interactions, communication and robust experimental design along with gold-standard quality results are the true value-added. The scientists of BioAnalysis, LLC possess a wealth of experience in characterization of therapeutic proteins, mAbs, and ADC (DARs), non-biologics (Polymers, PEO/PLA, nanoparticles), ICH/FDA regulatory applications, process development, and assessment of final biologic product formulations. Our subject matter expertise in the areas of Biophysics and Proteomics is showcased in over 70 peer reviewed publications.

Bioassay Sciences is an internationally recognized scientific and engineering consulting firm dedicated to the design, support and validation of bioassays. We use a platform approach to rapid bioassay development, systems suitability, parallelism and control. Bioassay Sciences has years of experience in the bioassay space and has worked with clients and regulatory agencies to achieve results in bioassay design and validation.

What We Do We focus on rapid, easy-to-use, lateral-flow immunoassays. We develop the crucial reagents, such as gold sols, gold conjugates, gold ribbon, etc. that are the backbone of any high-performance lateral-flow device. Superior reagents, coupled with our development and manufacturing expertise, yield superior assays. BioAssay Works, LLC powers the development of the finest rapid immunoassays. Utilizing our high sensitivity concentrated gold sols, high-performance gold conjugates, and our patented lateral-flow test platform, BAW develops and manufactures rugged lateral-flow tests that rival the sensitivity of ELISA. These tests can be read visually for quick positive/negative results or with simple instruments for more quantitative results. BAW offers a growing line of products that enable researchers and assay developers to create their own rapid assays. In addition, we are the assay-development partner-of-choice for both early-stage and established companies. We have the capability to manufacture and package your rapid assay, regardless of the volume required. BAW has developed a wide variety of assays for our clients, including assays for: Disease biomarkers In-process testing of pharmaceutical products Food allergens and agricultural targets Pathogens and toxins Veterinary applications Characterization and quantification of monoclonal antibodies

Bioblocks Magyarország Kft is a medicinal chemistry research organization that serves as a chemistry CRO focused on drug discovery and development candidates.

BioBQ is a cultivated meat company, workingto be the first in the world to offer cultured 100% beef brisket. The company is currently located inthe Austin Community College Bioscience Incubator.

We provide you with the best experts in the biopharma industry. Through our flexible, consultative approach, we'll align you with professionals with the expertise you need when you need them the most. From early clinical and device development to the post-market phase, we help you bridge your expertise gaps.

Biocare Medical LLC is an innovator in automated immunohistochemistry (IHC) instrumentation, and the full range of reagents for IHC and in situ hybridization (ISH; RISH) testing. Biocare pioneered multiplex IHC detection which accelerates turnaround time, increases instrument productivity and reduces reagent consumption and cost by 50% or more. Multiplex IHC allows pathologists to visualize more than one marker on a tissue at a time, allowing higher confidence for critical differentiation. Biocare's intelliPATH FLX is the only completely open, continuous random access IHC instrument available. The company’s customers come from clinical and research environments that do tissue based testing and include histology laboratories, pharmaceutical and biotechnology companies; CROs; and academic, government and military labs. Biocare Medical offers an expanding portfolio of products for the rapidly growing cancer and infectious disease diagnostic and research markets. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network. See biocare.net and slidestainer.com for more information. NOTE: Biocare Medical, the Biocare Medical logo, and intelliPATH are trademarks of Biocare Medical LLC.

Biocatalysts is a biotechnology company producing speciality enzymes at commercial scales for a variety of industries. Biocatalysts has used its wide range of technical, commercial and regulatory capabilities to develop #BiobasedValue for our customers. Established in 1983, Biocatalysts has been a member of the international BRAIN Group since 2018. Next to first-class research and development services for industry customers to create bio-based products and processes, the Group distributes specialty ingredients, like enzymes or bioactive natural products. Own fermentation and production facilities in Continental Europe, UK and the US, together with the associated biotechnological solution competency complete the value chain within the BRAIN Group.

BIO-CAT provides the very latest enzyme technology and custom formulations. Founded in 1988, our extensive range of products, from single-to-multi-enzyme blends, service various industrial, food, agriculture and other commercial markets. BIO-CAT is an FSSC 22000 certified facility in Virginia featuring state-of-the-art laboratories for scientific research, product development and on-site quality testing to better serve customers. BIO-CAT Microbials is an innovator in the field of biological solutions for a broad range of emerging and existing markets and industries. BIO-CAT Microbials is a GMP certified facility and a division of BIO-CAT, utilizing the latest enzyme technology in combination with microbes to produce products that are pioneering, more effective and of the highest quality for our customers’ applications.

BioCentriq is a premier contract development and manufacturing organization (CDMO) dedicated to advancing cell therapy. Since 2019, the company has specialized in GMP autologous and allogeneic cell therapies, offering end-to-end clinical-to-commercial capable services tailored to clients’ unique needs. Operating from two state-of-the-art U.S.-based facilities, BioCentriq provides a comprehensive range of services, including technology transfer and new technology evaluations, process and analytical development, cGMP manufacturing, quality control lot release, and stability studies. The company’s expertise spans diverse cell therapy modalities, such as T-cell (CAR-T, TCR), NK-cell, iPSC, and MSC-based products. With its proprietary LEAP™ manufacturing platform, BioCentriq accelerates service timelines while offering standardized and customizable solutions, including traditional fee-for-service, hybrid and person-in-plant operations, dedicated cleanroom capacity, and flexible service and contract arrangements. In addition to its technical capabilities, BioCentriq operates the Cell and Gene Therapy Experiential Learning Center, a training facility which provides hands-on and virtual instruction under the guidance of industry-experienced instructors and subject matter experts. The program has trained hundreds of participants, hosted major pharmaceutical companies, and integrates next-generation technologies and concepts into its curriculum including: Industry 4.0 and Lean principles, predictive analytics, augmented reality, and electronic batch record systems. Backed by GC Corporation, a South Korea-based leader in the healthcare, pharmaceutical and biotechnology industry, BioCentriq combines global expertise with a flexible working relationship, set to empower clients to develop and deliver cutting-edge, personalized therapies with unmatched precision and efficiency.

BioChain is the world leader in high quality processed bio-sample products and analysis services used in advancing translational medicine, companion diagnostics, and clinical product research and development. BioChain's products are available for DNA and RNA sequencing, PCR and RT-PCR, gene expression analysis, DNA and RNA purification, protein extraction and purification, protein expression analysis, and liquid biopsy studies. BioChain's One-Stop Services for Next Generation Sequencing (NGS), from clinical sample collection, sample preparation, sequencing to bioinformatics analysis, will revolutionize the industry. In addition to our world-class bio-specimen and sample preparation line of business, BioChain is moving into the clinical applications that offer clinical genomics diagnostics products and clinical trial services in cancer and reproductive health. BioChain is committed to achieving the Highest Quality products and services at highly competitive prices through our Continuous Process Improvement Initiatives. BioChain established a comprehensive quality assurance program to meet our customers' satisfactions as well as maintaining both ISO 9001:2016 and ISO 13485:2016 certifications for our in house production facilities. Innovation and Collaboration: As an industry leader, BioChain is always striving to innovate and collaborate with the world's leading Pharmaceutical, Bio Technology, and Health Care organizations. We have a strong in-house scientific team and actively seek research and business partnerships with industry innovators and leaders.

BioCheck develops and manufactures high-quality immunoassay kits for the worldwide healthcare markets in their cGMP and ISO 13485 certified facility in the San Francisco Bay Area. BioCheck also provides custom immunoassay development and contract manufacturing services to the diagnostic and research industries.

BioCircuit Technologies is a medical device company developing tools for the repair of nerve and other tissues.

Biocoat Incorporated develops and licenses biomaterial coatings for medical devices that are custom engineered to meet client design parameters. Its specialty is supplying lubricious hydrophilic coatings for medical devices. Our full-service coating solution includes industry-leading coating performance, high-touch customer service, and dip coating equipment that is specifically designed to maximize the coating process. HYDAK® Hydrophilic Coating Advantages * Exceptionally hydrophilic * Lubricious when wet, preventing trauma and tissue abrasion * Abrasion resistant * Very thin, flexible coatings can be applied * Biocompatible * Non-thrombogenic * Prevents adhesion of platelets, proteins, microorganisms * Carrier for bioactive substances to make o anti-bacterial surfaces o anti-thrombogenic surfaces

Biocrede is a biomedical technology company that develops innovative biomed-tech solutions to restore health, extend life, and reduce hospitalization length for patients worldwide.

For over 29 years, BioDot has developed proprietary, quantitative technologies for the dispensing of low volumes of fluids (picoliter to microliter) that meet the needs of industrial, life science, diagnostic, and medical products. BioDot is division of ATS Automation - Life Sciences Division On March 24, 1994, BioDot established itself as a company in Southern California with its patented BioJet™, "Drop on Demand"​, non-contact, dispensing technology. At that time, BioDot focused on using this technology to dispense discrete drops, or a series of drops to form a line. This quantitative, enabling technology was used predominantly in Lateral Flow Test or Flow Through Test applications in the diagnostic marketplace. Over the following years, BioDot expanded its expertise outside of dispensing, and developed lamination and cutting technologies. In parallel, it expanded its application abilities to enable scientists to utilize the quantitative dispensing and develop more sophisticated point of care tests, such as: - Glucose or other Microfluidic Sensors - Immunoblots or Allergy Tests - Cell, DNA, or Protein Arrays - Compound Handling In addition, BioDot developed modular workstations and enabled customers to work in either a "Batch"​ or "​In-Line"​ Approach, depending on their materials and processes, as well as short and long goals. Now, in our 25th year, BioDot continues to be a leading supplier of system tools for the research, development and commercialization of diagnostic tests. With our continuously expanding product portfolio, BioDot has marketed systems for the development and manufacture of Microfluidics. We also have systems for the Life Sciences and the Molecular & Point of Care Diagnostics. By expanding our global presence with entities in China and the UK/Europe, BioDot has a commitment to fully understand our customer's requirements, globally. #lateralflow, #biosensor, #labonachip, #biochip, #dispensing

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ employees and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline. For more information about BioDuro-Sundia, please visit our website at www.bioduro-sundia.com

With more than 25 years of molecular experience, BioFire Diagnostics, LLC (now bioMérieux) sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire® FilmArray® System. The FDA-cleared BioFire System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. Whether you’re trying to determine optimal therapy for a septic patient or pinpoint which respiratory pathogen is making a young child sick, the BioFire System can provide definitive answers—fast.

BioFluff is working to revolutionize the textile industry by pioneering a new era of plant-based alternatives to animal and synthetic derived materials. Their first product, Savian, is a plant based fur.

The heart of BioFluidica's CTC (Circulating Tumor Cells) system, is a highly efficient CTC capture bed, comprised of 50 to 500 sinusoidally-shaped channels. These channels are coated with antibodies, which isolate specific CTCs from whole blood. The antibodies are chemically immobilized onto the surfaces of the capture bed using BioFluidicas patented technology.

We are commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats.

BioForce Nanosciences, Inc. develops and commercializes nanotech instruments, consumables, and applications for the life sciences. For over a decade we've been a leading provider of consumable support products for atomic force microscopy (AFM). In 2005 we introduced our own flagship instrument platform, the Nano eNabler™ system. The Nano eNabler system is a molecular printer that rapidly and precisely delivers liquids to surfaces such as silicon chips in droplets that are ten billion times smaller than a drop of blood. This unique capability offers researchers in industry and academia a practical solution to problems they encounter when developing ultraminiaturized devices and methods, and creates opportunities for further commercialization of nanotechnology. For example, BioForce’s technology is being used to create biosensors and to study cell biology at the single cell level. Additional applications include printing proteins to guide neural cell growth, printing signaling proteins to study stem cell differentiation, “inking” of micro-stamps for soft lithography, and bio-functionalization of microfluidic devices.

Bioforcetech uses pyrolysis to convert organic waste like sewage sludge into biochar. Pyrolysis consists of treating materials with high temperatures in the absence of oxygen. This process neutralizes toxins and has a lower environmental impact than using landfills. Biochar is a type of carbon rich charcoal that can be used in multiple products. Bioforcetech uses biochar as a soil treatment, in inks, and in concrete.

BioForm Solutions is a San Diego-based contract research organization providing services for the analysis of probiotics in the supplement, food and beverage, cosmetic, and agriculture markets. BioForm Solutions offers industry leading, cutting edge flow cytometry assays developed exclusively by the BioForm team. These assays offer a broad spectrum of solutions for the analysis of probiotic samples in most formulations and are supported by a dedicated staff having over 20 years experience in flow cytometry. We strive to improve our customer's probiotic-based products, including accurately enumerating the viability of probiotics, determining packaging effects, and shelf life evaluation. We are passionate about providing the highest quality services at an outstanding value, along with superior customer service and technical support.

BioGrammatics Inc. is an industry leader in the heterologous gene expression of the single-cell, eukaryotic Pichia pastoris yeast. Our mission is to deliver detailed solutions within the research and development field. Specializing in high-quality products and contract services, BioGrammatics Inc. consistently demonstrates how expression is the language of life. We combine expert support services in custom strain construction, transcriptome generation and analysis, genome sequencing and analysis, small scale fermentation, and genome engineering, with a range of direct-to-consumer products. In addition to our proprietary Pichia GlycoSwitch® Strains, Vectors and Kits, we provide a multitude of other strains and competent cell batches, expression vectors, media, and reagents for research, industrial, and academic applications. To learn more about why methylotrophic Pichia pastoris is the right solution for you, please visit http://www.biogrammatics.com/ or connect with us at info@biogrammatics.com.

BioGX develops molecular products and provides partner-specified formulation and manufacturing services for molecular reagents on a platform of a partner’s choice. The company applies its proprietary platform-agnostic reagent technology to offer products and contract services across a variety of real-time PCR and Next Generation Sequencing platforms.BioGX SARS-CoV-2 Reagents for the BD MAX System - EUA 4/2020

BioHeights LLC specializes in business strategy for novel cell and gene therapies. We help companies, startups, and academic institutions.

BIOHM optimizes digestive health by combining good bacteria, good fungi and enzymes to break down digestive plaque, allowing for total gut balance. This allows BIOHM's 30 billion live active cultures to maintain, support, and promote the balance of the total microbiome in the digestive system.

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home. Learn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services or visit our website at BioIntelliSense.com. 

BioInvenu is dedicated to developing assay products and services by utilizing a novel cell-based protein-protein interaction assay technology, LinkLight™ technology. The LinkLight™ technology was originally invented in Sanofi-Aventis. The technology utilizes protein-protein interactions as the functional signal readout. Protein-protein interaction is an essential cellular process regulating signal transductions in a living cell. Specific protein-protein interactions define signal transduction pathways. Ligand-induced transient protein-protein interactions are therefore of particular interest as the intervention points for drug discovery. The LinkLight™ technology has been applied to G-protein coupled receptors (GPCR), nuclear hormone receptors (NHR), and receptor tyrosine kinases (RTK) by utilizing receptor and its signal adaptor interaction as the functional signal readout. Biologically relevant compounds that modulate protein-protein interactions can be identified with this highly sensitive, specific, and robust assay method. The technology has the potential for applying a broad range of drug targets that are difficult to tackle by existing methods. In addition to finding molecules that modulate protein-protein interaction signal cascades, the technology can be applied to protein-protein interaction drug targets by identifying molecules directly blocking protein-protein interactions.

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. Our award-winning dental lasers enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient-friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 36,200 laser systems to date in over 90 countries around the world.

BioLegend develops antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA.

Biolife, LLC is a privately-owned medical device company headquartered in Sarasota, Florida, that manufactures innovative healthcare and first aid solutions that improve patient outcomes and quality of life. All Biolife products are comprised of a powder with two main ingredients: potassium ferrate and a hydrophilic, or water loving, polymer. StatSeal devices for the healthcare industry are available in both powder and disc form; the disc is made of compressed powder that is encased in a white medical-grade foam. WoundSeal devices for the consumer and occupational health industries are available in powder form. All Biolife devices are manual pressure adjuncts and work via a two-step mechanism of action that occurs simultaneously to form a low pH seal or physical barrier over the wound, protecting it by letting nothing in or nothing out. The hydrophilic polymer rapidly dehydrates the blood and absorbs exudate, stacking up desiccated blood solids beneath to form a seal (scab). The potassium ferrate binds the blood solids and proteins together, adhering the seal (scab) to the wound to stop bleeding and oozing. Beneath the seal the pH is neutral, and the blood solids and proteins continue to stack naturally. Above the seal, the hydrophilic polymer exchanges protons for cations, resulting in desiccation and a pH of 2, creating a hostile barrier to microbial penetration. All Biolife devices work independently of the clotting cascade to create an occlusive seal over the wound or procedural site, while accelerating hemostasis. The low pH seal created by the powder helps reduce risk of infection and helps improve recovery time. The seal remains over the wound as the body's healing mechanism begins. As the wound heals, the scab is naturally sloughed off.

Formerly called Bioline, now acquired by Meridian Bioscience, as part of Meridian Life Science business unit, was founded in 1992 and based in London, UK. Meridian Bioscience is a fully integrated company with two business units dedicated to diagnostics and life science. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Meridian Life Science unit,with large-scale manufacturing capabilities and over 3500 products, provides the most comprehensive portfolio of raw materials for the clinical development of any immunological or molecular test. Our molecular reagents are used by biologists and other research scientists to perform test-assays and research in many fields from medical, biotechnology and marine biology to food and agriculture technology as well as forensic and environmental sciences, where life scientists have come to depend upon the outstanding quality and reliability of our reagents. We have developed and manufactured a portfolio of more than 300 reagents and kits, many of them proprietary, for molecular biology, cell analysis and nucleic acid and protein separation and purification. Meridian operates under an ISO 13485 quality system and is one of the world's few manufacturers of ultra-pure dNTPs, as well as a variety of enzymes and biochemicals.

Biolink LifeSciences is a premier contract research organization offering a comprehensive range of services including synthesis, characterization, formulation development, and analytical services for small to large molecules for nearly all dosage forms. Our strength resides with our highly experienced team in synthetic chemistry, analytical method development & validation and formulation development to solve difficult problems.

Biolog has the tools, services, and support to provide the microbial phenotypic characterization and polyphasic identification capabilities required to produce functionally relevant insights. Our products and services enable characterization of microbial and mammalian cells as well as identification of thousands of species of bacteria, yeast, and fungi. Learn more at biolog.com.

Our technology was developed by professors at a major University in the US. The formula uses an ingredient that is 100% natural and edible. In fact, the ingredient is already used in many food and beverage products for human consumption. The technology has been field tested by the USDA and has been proven to effectively kill the spotted wing drosophila, an invasive species that is currently decimating fruit crops across North America – costing the US fruit industry over $700 million annually. Key Technology Benefits: Fully field tested by USDA on spotted wing drosophila – 75% reduction in larvae First insecticide that uses an FDA approved GRAS ingredient that is edible by humans and pets Key ingredient both attracts and kills insects Slow acting which allows the insects to carry the insecticide back to the nest for complete extermination Could potentially eliminate the need for health warning labels on product packaging Could save up to $10 Billion in annual insect damage in the US Key ingredient is readily available and cost effective

ABOUT Biologics Consulting is a complete FDA regulatory and product development consulting firm for cell & gene therapy, biologics, pharmaceuticals, and medical devices. In the three decades since its founding, Biologics Consulting has become the go-to consulting partner for companies large and small seeking to bring innovative, safe, and effective products to market in the US. Our team of regulatory scientists, FDA consultants, and professional services staff has decades of industry and FDA experience that allows us to provide an unparalleled insider perspective for our clients. OUR DIFFERENCE The Biologics Consulting difference is all about the unique combination of regulatory expertise we have under one roof. Our team has depth of knowledge and breadth of experience across all product types and development pathways. This value proposition allows us to address the full scope of a client's regulatory and product development challenges from preapproval to commercialization. OUR EXPERIENCE AREAS - Biologics - Medical Devices - Pharmaceuticals - Biosimilars OUR SERVICES - CONSULTING – Regulatory, Product Development, Clinical Planning and Quality support. - SUPPORT SERVICES – Medical Writing, e-Publishing & Submissions, US Agent Services, Due Diligence OUR CLIENTS Our clients span the industry, from established multi-national pharmaceutical, biotechnology, and medical device companies to academic and research institutions. We also support small biotech and medical device start-ups. Since our founding, we have professionally services over 4,500 clients from 58 different countries.

Biologics Resources, LLC (BRLLC) is a Vaccines, immunotherapeutics and Biopharmaceuticals technology company.

Biolumen is a weight-loss and gut health company, on a mission to reverse the negative impact of the Western diet; like obesity, type 2 diabetes and autoimmune disorders. Biolumen's product, Monch Monch, is a highly functional cellulose matrix which entraps calories in the stomach.

Biolumina is a full-service, integrated agency delivering customized, data-driven solutions for oncology brands.

BioMarker Strategies has developed the proprietary SnapPath® Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath® is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP® Functional Signaling Profiles, created using the SnapPath® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath® and the Functional Profiles it enables are available for Research Use in preclinical studies in tumorgraft and other model systems, and in early clinical studies to assess pharmacodynamic changes in the solid tumors of individual patients.

Biomason is a unique biotechnology start-up manufacturing company with a natural process that will revolutionize the building and construction industry. Biomason employs natural microorganisms and chemical processes to manufacture biological cement-based masonry building materials.Biomasonmakes biocement by usingBacillus to hydrolyze urea. This process producesCO2, whichcombines with calcium ions to form calcium carbonate. This process binds particles of sand and rock together to make tiles.

BioMatrix International was established to vertically integrate product development for animal feed and horticultural additives. We create innovative products with an emphasis on developing novel and patentable technologies. Our products are customized to meet individual needs while minimizing environmental impact. We specialize in agricultural, companion animal, and aquacultural feed additives, as well as horticultural amendments.

Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time PCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The cutting edge platform performs to the gold standard used by the world's most advanced central labs but requires no lab equipment or special experience to use. The low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.

Biomerica, Inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The Company’s products are designed to enhance health and well-being, while reducing total healthcare costs. Biomerica primarily focuses on products for Gastrointestinal Disease, Diabetes and esoteric testing. The Biomerica InFoods® IBS product identifies patient specific foods that when removed may alleviate an individual's IBS symptoms. This patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve Irritable Bowel Syndrome (IBS) outcomes. The point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for which the company will seek regulatory approval. A billable CPT code that can be used by both clinical labs and physicians'​ offices is available for InFoods® diagnostic products. Since the InFoods® product is a diagnostic guided therapy and not a drug, it has no drug type side effects.

BiomeSense is a pioneering life sciences startup focused on harnessing the power of the gut microbiome to revolutionize personalized medicine. With our breakthrough technologies GutLab and MetaBiome, we are setting new standards in microbiome data analysis and interpretation, enabling unprecedented insights to understand & leverage the microbiome for human health.

Biomiga, Inc. is an innovative biotech research and service company based in San Diego, California. Our mission is to provide the highest quality laboratory products while maintaining the best possible service and support to our end-users. Our products maximize efficiency and cost-effectiveness through our cutting-edge technology and process. Biomiga owns the manufacturing process, enabling us to control both the quality of the products as well as the price. Our products are more reliable and effective while often costing less than half the price of our competitors. Biomiga can customize its products to meet a client’s exact specifications and requirements. Biomiga provides full service support to all our clients through the entire process. Our support and sales staffs are available for consultation 24 hours a day, 7 days a week. We stand behind all our products with a full guarantee. Our mission is to ensure our client’s satisfaction. Biomiga emphasizes on product development. Our R&D team is highly trained in the biological sciences to quickly develop new products. Our products have been proven to meet our clients' high demands with greater cost savings and effectiveness. EzgeneTM and ViraTrapTM are just some examples.

BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies.

At BIOMOTUM, we envision a world where all people have access to optimal mobility. Our mission is to optimize human mobility by providing intelligent and intuitive wearable systems, to a wide range of users in the medical and consumer markets. We empower individuals to live healthy and productive lives through the use of our clinically validated products. The Problem A person's ability to engage in physical activity, including activities of daily living, is essential to their health, independence, and general wellbeing. According to the CDC, approximately 50 million U.S. adults and children have a physical disability and are unable to engage in some activities of daily living or achieve a sufficient amount of physical activity. Mobility training is critical to improving mobility but there is currently no viable way to deliver a sufficient dose of active gait training. Our Solution The BIOMOTUM System addresses the need for individuals to be mobile while being able to engage in sufficient mobility therapy. It allows them to walk independently in the clinic, at home and in the community. Clinical trials have repeatedly demonstrated improvement in mobility outcomes in children with CP. As a smart device, it provides rehabilitation professionals and users activity data to facilitate progression and continued improvement in mobility. Our History BIOMOTUM was founded in 2019, by Dr. Zach Lerner, Dr. Ray Browning and Joe Lerner. The founders have been associates for many years. Drs. Lerner and Browning met in 2011 through a shared interest pediatric physical activity as a way to improve chronic diseases and have maintained collaborations since that time.

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research. Bionano also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through our Bionano Laboratories business, wey also offer OGM-based diagnostic testing services.

Since its founding in 1992 Bioneer Corporation has established market leadership in Korea for most of the products it manufactures. Bioneer has built its business by providing researchers with superior, high quality products at excellent value. Over the years, Bioneer has developed a broad range of unique products that provide total genomic research solutions for life sciences research including genomics, nucleic acid-based molecular diagnostics and gene therapy studies. Bioneer has extensive R&D experience in developing new drugs as well as the use of siRNA and drug delivery systems, and provides unrivalled service and support for such tools. For example, through the creation, development, and commercialization of the S. pombe deletion mutant library, Bioneer provides an innovative tool for improving the development of new drugs. The S. pombe library accurately predicts the toxicity of drug candidates for anti-cancer, Hyperlipidemia and also provides molecular level mechanism analysis of natural compound drugs. The company is headquartered in South Korea with an oligonucleotide manufacturing facility in the U.S., a regional office in China, and is supported by a network of distributors throughout the world. For more information, please visit www.bioneer.com.

Bionex’s mission is to realize the applications of bio-pharmaceutical and life sciences into commercial products and services that benefit human health. Strategically, Bionex engages in two areas of business activities. First, Bionex offers contract R&D services, from early-stage concept development, cGMP clinical supply manufacturing to full-scale commercialization, for bio-pharmaceutical products. Second, Bionex develops and out-licenses its own proprietary formulations, drug delivery technologies, and products related to medical, health food, and skin-care applications. Our expertise is focused on transdermal and transmucosal drug systems. We adopt a science-based, and yet pragmatic and out-of-box approach which often leads to fruitful outcomes, in time- and cost-effective manner. Bionex capabilities are its expertise in formulation science and analytical chemistry, full range of formulation/processing, analytical, and testing capabilities in cGMP facility, and well-connected network of industrial, academic and business consultants and advisors. Many of our in-house innovation R&D projects are funded by National Institute of Health (NIH), National Science Foundation (NSF), state grants and non-for-profit organizations.

Bionexus offers a comprehensive line of biomedical products and services for the scientific community.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients’ needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients' needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova's renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early stage research material generation to Process Development and GMP manufacturing, Bionova's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.

BioPAL is a biotechnology company that provides novel diagnostic tools to the life science community.

Biopartners Inc. is a global biosample management company with operational offices in the United States and Eastern Europe. It is based in Los Angeles, California. Biopartners Inc. provides comprehensive solutions to support scientific projects.

Biopeptide Company offers design, synthesis, and production of quality peptides using t-Boc/Fmoc solid phase and solution phase technology.

BioPet Laboratories is a biotechnology company specializing in animal genomics. BioPet offers multiple product and services: PooPrints®, the DNA Solution for Dog Waste; BioPet Life Plan™, an interactive canine health and wellness management tool with Breed and Allergy Testing; DNA Proof of Parentage, canine parentage testing certification; Travel Dog™, an elite club for dogs and their owners; and the DNA World Pet Registry®, a state of the art database to store canine genetic information. As the parent company of the PooPrints® program BioPet works with more than 7,000 multifamily properties worldwide. With more than 800,000 individual canines in their database, BioPet is becoming an industry standard for canine genetics. BioPet was the first to offer a ground breaking price point reductions and one of the fastest processing times in the canine paternity industry. Historically excelling in canine DNA offerings such as breed analysis, parentage verification, and DNA matching of fecal samples, BioPet continues to expand its offerings in genetics and forensics. *BioPet Laboratories is accredited to the ISO/IEC 17025:2017 standard*

Biophagy is a biopharmaceutical company, headquartered at The BioScience Center, Albuquerque, NM, USA. The company is focused on identifying drugs that modulate autophagy as part of a specific disease process in order to relieve patient symptoms. Biophagy is managing standard drug development programs in several therapeutic areas and is also developing an OTC/DTC kit that will focus on autophagy stimulation and measurement.

Biopharma PEG Scientific Inc. is a fast-growing worldwide company dedicated to developing and manufacturing of high-quality polyethylene glycol (PEG) products and derivatives, like Biotinylated PEGS, Monofunctional PEGS, Heterbifunctional PEGS, Homobifunctional_PEGS, Multi-arm PEGS, Fluorescent PEGS, Lipid PEGS,etc. Based on proprietary technologies, Biochempeg scientific Inc. is capable of supplying small to large quantities of high quality PEGs for customers worldwide, such as PEG Amine, PEG NHS ester, PEG Maleimide, PEG Azide, PEG DSPE, PEG DBCO, etc. Biochempeg scientific Inc. also provides custom synthesis of PEGs of various molecular weights (MW) and functionalities to facilitate and enhance growing industrial and academic uses. Biochempeg scientific Inc. is ready to help keep your projects on track with our high quality products and technical services.

BioPharm International® covers all aspects of biopharmaceutical development, analysis, processing, and packaging, as well as business strategies and regulatory issues. The print and digital editorial coverage provides technical and business insight and analysis for all biologic-based therapies including monoclonal antibodies, vaccines, biosimilars, protein therapeutics, cell therapies, gene therapies, antibody-drug conjugates, and other emerging therapies.

Biopico Systems Inc is a leader in the emerging field of interacting multiple organ systems or microphysiological systems technology. This technology will accurately recapitulate human physiology by engineering physiological fluidic flow and organ microenvironment.

BioQ Pharma is a specialty pharmaceutical company that focuses on setting a new standard of care for infusible drugs.

Research & Diagnostic Products. Bio-Rad is partnering with Biodesix on a test for SARS-CoV-2.EUA (05/2020) for a digital PCR molecular diagnostic test for SARS-CoV-2, the virus that causes coronavirus disease COVID-19. The 2019-nCoV CDC ddPCR Triplex Probe Assay is now authorized for use on the firm's QX200 and QXDx Droplet Digital PCR systems.

For over 20 years, Biorasi has been to go-to CRO (Contract Research Organization) for small to midsized biopharma companies, optimizing speed-to-market solutions across global clinical trials in oncology, neurology, dermatology, and cell and gene therapy. Our #OneTeam of leaders and clinical study experts focus on the qualities necessary to succeed in today's clinical trial industry – flexibility, reliability, and transparency. It is Biorasi's mission to be a catalyst for growth, innovation, and evolution in the field of clinical research – moving the industry forward while improving results for our partners and outcomes for their patients. Our culture is based on our strong commitment to building true partnerships with our sponsors. We approach all of our trials with urgency, commitment, and resolve. Biorasi is able to directly support studies in the Americas, Europe, and APAC. We have received multiple accolades including placement in the INC 500 and 5000 list of fastest-growing companies in America, Frost and Sullivan's Entrepreneurial Company of the Year for the CRO Industry, and the CRO Leadership Award from Life Science Leader magazine.

We provide services in genomics, statistics, and information technology. Our services include Bayesian analysis, bioinformatics, biomarker development, biostatistics, data management, data pipelines, data science, epigenomics, genetics, genome-wide association, imputation, microarray analysis, multiomics, next-generation sequencing analysis, pharmacogenomics, polygenic risk scores, predictive modeling, project management, proteomics, reproducibility, software development, statistical computing, statistical genetics, and statistical programming. We also developed the Smokescreen® Genotyping Array, advancing research into addiction and treatment approaches. Our highly-skilled transdisciplinary team of experts, carefully assembled from leading research universities and industry, has been solving our clients' research challenges for almost two decades. Extensive experience with a wide range of cutting-edge methods and technologies means we can help ensure your project's success, and provide high-quality deliverables on time and within budget. Whether you have a critical issue, need help with every aspect of a new project—including coordinating complex projects—or only one part of an ongoing project, we can work with you to develop the optimal solution to meet your goals and objectives. Our team can be an integral part of the collaboration, and provide full-service support for all the stages of your research journey. We follow all U.S. Department of Health & Human Services standards for the security of electronic protected health information (HIPAA-compliant). We believe in reproducible, reusable, transparent, and extensible research, and do everything we can to put those values into practice. We are prepared to use our internal computing environment, cloud-computing environments, or client-provided environments, if preferred.

AT BIOREP, WE MAKE PRODUCTS THAT ENHANCE - AND SAVE - LIVES. Beginning with our shared passion for health, we believe in making life better by innovating and developing new biomedical tools, and improving and understanding surgical techniques.

Our company is uniquely positioned with a multi-facetted experience team in biologics and biosimilars. BioSciencesCorp and its affiliates have the speed of small company with a depth of biologics experience from molecule selection to full commercialization.

The Biosero Green Button Go® suite of software products provides a unified way to design, dispatch, and schedule lab workflows, capturing and managing data all along and across all levels of operation.

We help scientists solve disease, develop drugs, and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Discover drugs tomorrow.

BioSkryb is a venture-backed startup bringing new solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system.

Our unique modular closure system is called the Xvivo System model X2. Many people dismiss it as simply another isolator. It does look like one and has glove access where necessary in the workflow. However, unlike isolators it has extensive plug-and-play modularity so it can enclose any production process. Less obvious but just as important, it can easily be reconfigured to quickly accommodate any changes or improvements to the process such as new equipment or automation, or as you need to scale

BioSpyder Technologies has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run. Assay content is flexible and customizable delivering unprecedented accuracy and sensitivity.with simplified data analysis that eliminates the need for bioinformatics. TempO-Seq assays deliver an easy to use solution for customers doing expression profiling for any species.

Biostage is a biotechnology company that focuses on developing organ replacement therapies using cellular scaffolds and tissue engineering.

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

BioSurfaces, based in Ashland, Massachusetts, is a life science company with deep leadership and a diverse team of specialists. The company's proprietary electrospinning technology known as Bio-Spun™ creates product solutions by engineering biology with synthetic cellular matrices for applications ranging from IVRT and delivery of bio-active therapeutics to medical devices and consumer health products. These materials can be made to form a variety of unusual and difficult-to-manufacture shapes while also demonstrating improved biocompatibility over other textile-based materials. The BioSurfaces manufacturing process also allows the incorporation of drugs or other bioactive agents directly into the nanofibers for localized release. BioSurfaces' technology is validated by leading organizations in pharmaceuticals, medical devices, life sciences, and consumer products.

BioSurface Technologies Corporation (BST) was founded in 1994 to provide biofilm reactor systems for evaluating and monitoring biofilm processes. BST is the sole licensed manufacturer of the Center for Biofilm Engineering Biofilm Annular Reactor, Drip Flow Biofilm Reactor®, Rotating Disk Biofilm Reactor, and the Center for Disease Control and Prevention’s CDC Biofilm Reactor®. BST is located in Bozeman, Montana, USA, near the Montana State University campus. BST has facilities for product assembly and manufacturing in our Bozeman facility. BioSurface Technologies strives to be the worldwide leader in providing innovative products for biofilm investigations. Follow us on Facebook and Instagram, too: @biosurfacetechnologies

BioTechLogic, Inc. is a biopharmaceutical and technology management firm with a unique, proven capability to rapidly and successfully bring products to market through the augmentation and optimization of a corporation's technical resources. We are a team of professionals with expertise in process development, BioAnalytical services, process validation, project management, quality assurance, regulatory submissions and Pre-Approval Inspection (PAI) readiness. Our quality by design (QbD) approach enables us to effectively provide product development support, including: development reports, design of experiments, technology implementation, critical process parameter evaluation, technology transfer and scale-up, and on-site third party contract manufacturing support.

Bio-Technical Resources provides contract services for microbial strain and fermentation process development including recombinant and classical strain improvement, microbial screening, bioprocess development and scale-up, and product recovery. Non-proprietary expression systems are offered for protein production. Experience with development of processes for biofuels, enzymes, pharmaceuticals, nutraceuticals, natural products, and products for agriculture.

BioTechnique is a contract manufacturing organization that provides standard and highly-customized cytotoxic and high potency sterile injectable liquid & lyophilized fill-finish services. Our state-of-the-art manufacturing facility is also equipped with a full-scale microbiology lab and offers regulatory affairs, laboratory, and project management support from investigational/clinical all the way through phase IV/commercial. Facility Capabilities: • Sterile injectable manufacturing & packaging for liquid & lyophilized products • Aseptic Vial Filling • Aseptic Lyophilization • Inspection • Formulation • Product Testing • Labeling/Packaging • Stability Storage • Process Design • Full service laboratory • Regulatory affairs support for product filings • Project management Product Capabilities: • Cytotoxics • Highly-Potent Compounds • Monoclonal Antibodies • Antibody Drug Conjugates (ADC) • Suspensions • Inactivated & Attenuated Live Vaccines Filling & Manufacturing Capabilities: • Grade A / ISO 5 Aseptic Filling Suite • 2mL to 100mL vials • 0.2mL to 100mL fill volume • Inline fill volume check weighing • Isolator • 13M2 Lyophilizer • Containment Unloading • Grade A / ISO 5 Capping • Post-Fill / Post-Lyo External Vial Rinse • Single-Use Disposable Manufacturing Train • Vial Inspection & Labeling • ICH Guideline Cold Storage • 2 to 8 ℃ • -20 to -70 ℃ • Stability Chambers & Warehouse Storage • Microbiology & Chemistry Labs

BTS is a bacterial growth media supply company specializing in the biological testing materials of the oil and gas industry. Our goal is to provide unparalleled service and bacterial growth media of the highest quality, manufactured and delivered in a time frame that meets the needs of the fast paced oil and gas industry. Our state of the art manufacturing facility is equipped to handle orders of any size to get you the bacterial growth media you need, when you need it.

BioTissue is the leader in innovative applications of human birth tissues for regenerative wound healing, aiming to improve patient outcomes. The company is committed to promoting regenerative healing through its birth tissue products.

BioTools is a world leader in providing instrumentation and services to pharmaceutical and biotechnology companies in several niche markets. We concentrate in the areas of biopharmaceuticals and chiral-organic drugs. Our unique products are used for molecular structure characterization from active ingredient to formulated finished products. We were the first company to commercialize two ground-breaking techniques in vibrational spectroscopy - Vibrational Circular Dichroism (VCD) and Raman Optical Activity (ROA). VCD is the most sought after technique for determination of absolute configuration of chiral molecules, including natural products and chiral API's. ROA is mostly used for structure characterization of glyco-proteins, proteins, viruses and nucleic acids. We are also renown for our expertise in the structure characterization of biologics. We pioneered commercial use of FT-IR for formulation and this year introduce a new ground-breaking integrated micro-imaging-Raman system. BioTools also offers contract services for characterization of chirality and biologics.

Biotricity is a global frontrunner in the realm of digital health. Our mission is to bridge the gap between patients and healthcare providers, ushering in a new era of care delivery that is both efficient and patient-centric. At Biotricity, we're not just transforming remote patient monitoring; we're redefining the very essence of healthcare itself. We are proud to offer award-winning health technology seamlessly integrated with state-of-the-art software. With over 100,000 patients placing their trust in us to improve their long-term cardiac health, we have solidified our position as a trusted healthcare partner. Biotricity's remote patient monitoring devices are designed to optimize patient and healthcare provider workflows. Our goal is to provide critical insights into a patient's health swiftly, resulting in faster treatment and improved outcomes. Our advanced hardware and software solutions enable accurate identification of cardiac problems as they occur, transforming the landscape of care for clinics and patients alike. Physicians can now access real-time data with reports in days, not weeks, while patients wear user-friendly, discreet monitoring devices, offering peace of mind throughout the process. At Biotricity, we firmly believe that the future of healthcare lies in connected medical devices that generate data leveraged by both physicians and individuals. We envision a healthcare ecosystem where these devices seamlessly integrate with big data, predictive AI, and machine intelligence, ushering in an era of better and faster analytics for superior care delivery. Join us as we continue to lead the way in digital health innovation, pioneering advancements that are not just transforming healthcare but also enhancing lives. Together, we are creating a healthier and more connected future. Biotricity's stock is trading under the ticker, “BTCY”.

BioTuring is an innovative bioinformatics company based in San Diego. Founded in 2016, the company has developed transformational bioinformatics platforms for sequencing data analysis, enabling scientists to gain valuable insights from biological data in an interactive, fast, and accurate approach. Its product portfolio now covers single-cell and spatial data analysis with BBrowserX, Talk2Data, Lens, BioVinci, and BioColab. BioTuring helps accelerate life sciences and nourishes computational minds.

BioVeritas upcycles excess biomass, like broken pasta, into clean label ingredients for the food preservation, animal & human nutrition, and industrial materials markets.

BioVision is now part of Abcam. BioVision is a privately held Life Science company headquartered in the beautiful San Francisco Bay area. Founded in 1995, BioVision specializes in the supply and integration of high quality imaging technologies to support research. In August 2021, Abcam acquired BioVision for $340 million, and it is now part of Abcam.

BioViva USA is dedicated to improving healthy human longevity through bioinformatics. The Biovault bioinformatics platform is contributing to health predictions and recommendations, precision medicine, and the discovery of novel biomarkers by applying state of the art computational methods on vastcollections of biological data.BioViva is partnered with Integrated Health Systems (IHS). IHS is an innovative company specializing in cell and gene therapy, aprivate care company supporting health professionals working with groundbreaking treatments and therapeutics to support healthy longevity. Theywork exclusively with regenerative medicine specialists targeting the aging process.BioViva is committed to:Bridging stakeholders with biotechnologyFacilitating the development of treatments and therapeutics through the BioViva platform, designed to be readily browsable by longevity researchers.Accelerating the path to human trials for life-saving gene therapies.Providing biotechnology companies, medical researchers, and patients access to one another, expediting research and development.The Biovault will continuously update user profiles, including changes in relevant biomarkers. BioViva is utilizing the latest machine learning algorithms to formulate hypotheses and validate findings, thereby paving the way for optimal combinatorial regimens addressing the root causes of the aging process.

Accelerate your research from pilot to pre-clinical phases. Rely on us to deliver the largest catalog of monoclonal antibodies formulated specifically for in vivo use and provide customizable antibody production services - backed by 25 years of experience.

Birchwood is a healthcare company that offers incontinence and wound care products to healthcare professionals and patients.

BiVACOR is a medical technology company that specializes in developing advanced artificial heart solutions.

Black Sheep Foods is a plant-based meat company that offers a delicious lamb alternative created using revolutionary technology and analytical chemistry, promoting environmental and health benefits.

BlinkRx is the world's first pharma-to-patient cloud that offers a digital concierge service for patients who are prescribed branded medications. Patients benefit from transparent low prices, free home delivery, and world-class support on this first-of-its-kind centralized platform. With BlinkRx, never again will a patient show up at the pharmacy only to discover that they can't afford their medication, their doctor needs to fill out a form for them, or the pharmacy doesn't have the medication in stock. We are a highly collaborative team of builders and operators who invent new ways of working in an industry that historically has resisted innovation. Join us!

Blood Centers of America, Inc., (BCA) is a cooperative representing community blood centers located throughout the United States. BCA members are independent, non-profit blood centers that provide over fifty percent of the nation's transfusion requirements. For more information: http://www.bca.coop

Bloodworks Northwest is an independent, community-based nonprofit organization with a tradition blending volunteerism, medical science, education and research to advance transfusion medicine and improve patient care. A recognized leader in transfusion medicine, Bloodworks serves patients in nearly 90 hospitals and clinics in the Pacific Northwest and provides tissue and transplantation support to 185 hospitals across the Northwest. Patients with leukemia, cancer, burns, hemophilia and traumatic injuries also depend on Bloodworks research. With your help, we're bettering our community drop by drop.

Specializing in Creating and Improving Biosensors with Synthetic Biology. Winner of LymeX Diagnostics Prize

Blue California is a science-based solutions provider and manufacturer of clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products. For more than 25 years, Blue California has built a strong reputation for creating value in these diverse natural product and nature-inspired industries. We develop novel materials and new clean, green production methods to ensure the successful commercialization of products to companies with global reach. The three divisions of Blue California are Specialty Ingredients, which is dedicated to clean and natural nutritional ingredients. FineCap™ Novel Delivery Systems, the new generation microencapsulation for simplified manufacturing and excellent performance. Sensegen®, the flavor and fragrances comprised of expert perfumers and flavorists to help create clean and sustainable product innovations.

At Blue Evolution, we are revolutionizing sustainability by harnessing the power of seaweed to create innovative solutions for a better tomorrow. As a leader in ClimateTech, we develop cutting-edge products that span biostimulants, animal feed, biomaterials, nutraceuticals, and cosmeceuticals. Our climate-smart biorefinery, powered by renewable energy and green chemistry, transforms seaweed into high-value outputs that drive decarbonization, enhance climate resilience, and promote sustainable growth. We collaborate with leading research institutions and indigenous communities worldwide to advance our mission of creating a regenerative future. Our patented processes and pioneering research set us apart, positioning Blue Evolution at the forefront of sustainable innovation. Join us in leading the charge toward a more sustainable, resilient, and prosperous world.

Bluegrass Community and Technical College (BCTC) is a member college of the Kentucky Community and Technical College System. As one of the two largest colleges in our system, BCTC transfers more students to four-year universities than any other college in the state. It awards certificates, diplomas, and associate degrees in more than 40 career and technical programs with day, evening, and online classes serving more than 16,000 students annually at seven campuses. Customized workforce training serves more than 500 businesses annually. BCTC provides excellence in learning and service with caring, experienced professors, helpful staff, and excellent facilities and a focus on student success. The college sustains strong partnerships with our communities to improve economic vitality and quality of life in the region. BCTC MISSION Bluegrass Community and Technical College (BCTC) transforms the Bluegrass Region—one student, one employer, and one community at a time. With students at the heart of our mission, BCTC supports student access, success, and completion of educational goals through comprehensive services, high-quality career and technical education for workforce skills, transfer education for baccalaureate degrees, and life skills development.

Blue Heron has been collaborating with some of the most brilliant minds in the industry to create millions of complex genes using our proprietary GeneMaker® multi-technology platform. We are the first gene synthesis company founded and solely operated in the USA. Our only location in Bothell, Washington subjects us to strict U.S. standards for Intellectual Property (IP) Policy and ensures every contract for each customer is confidential. Because of our simple flat rate pricing, we deliver what no other company can provide — the assurance your project will proceed as quoted. Utilizing high grade reagents and proprietary technology we produce DNA of the utmost quality. Our aptitude for projects involving unusually long or difficult sequences allows clients to eliminate errors, risk, and costs that are simply no longer a necessary part of the research process. Blue Heron Provides: - Dedicated Customer Service - Simple Pricing - Easy Ordering - Strict Client Confidentiality - Guaranteed Turnaround Time - Sequence Design - Synthesis of Genes up to 50KB - Complex Genes (hairpins, repeats) - 100+ IP free Expression Vectors - Free Codon Optimization - Free Archiving Publications Citing Blue Heron Biotech Gene Synthesis: http://www.blueheronbio.com/assets/documents/citations/BlueHeronBiotechCitations.pdf

Blue Ocean Barns is an established industry partner, collaborating with innovative cattle farmers and food companies. Our feed supplement, Brominata™, is made from a proprietary variety of Asparagopsis seaweed. Designed for optimal integration on-farm, Brominata™ delivers a cow’s required daily intake of iodine, eight essential amino acids, and other valued compounds. Blue Ocean Barns provides simple solutions with immediate impact for customers striving to meet the evolving demands of 21st century beef and dairy production.

Blue Planet Ecosystems builds, develops and operates modular LARA (Land-based Automated Recirculating Aquaculture) systems for sustainable seafood production in extreme environments. We help farmers, agriculture businesses and future entrepreneurs to diversify their farming methods in the face of climate change.

Blueprint Genetics is a genetic diagnostics company focused on inherited diseases. We provide world-class genetic diagnostics and clinical interpretation for hereditary diseases. We are passionate about changing peoples’ lives through development of groundbreaking solutions that take genetic diagnostics from niche to mainstream. Our global team of innovative and motivated people are working at the forefront of genetic knowledge, AI and other areas of life science. Our team consists of more than 20 nationalities working as geneticists, data analysts, laboratory technicians, client service specialists, genetic services consultants, software developers and marketing specialists. Today, we work with customers in over 70 countries and push to make genetic knowledge easier to access for the medical community. Our comprehensive and cost-effective genetic tests support healthcare professionals around the world in providing the best care for patients and families with rare inherited diseases.

Bluestem Biosciences, Inc., is designing biology with the end in mind, to enable existing infrastructure in the Midwest for industrial biology. We are leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the sustainable production of chemicals and materials. Bluestem Biosciences was Co-Founder by Billy Hagstrom, Tyler Autera & Jared Wenger in January 2022. Bluestem is based in Omaha, Nebraska CREATING TOMORROW'S RENEWABLE CHEMICALS INDUSTRY CREATED FROM ORGANISMS, NOT OIL

BMG LABTECH is a leading developer and manufacturer of microplate reader instrumentation with a wide range of measurement methods. Microplate readers are used in the pharmaceutical and biotech industries, as well as in academic research establishments, for both basic research analysis and high-throughput screening. We focus solely on microplate readers and offers the most diverse selection of optical detection systems in conjunction with integrated liquid handling equipment. Our exceptional worldwide sales and support network is committed to bringing you innovative microplate reader technology with the reliability and quality that you expect from BMG LABTECH. The highest priority at BMG LABTECH is to have satisfied microplate reader customers! We succeed at this goal by not only offering excellent microplate readers but also providing personal customer support that not found at larger companies. Our support centers have teams of microplate reader development specialists ready to work with you and your applications to get the most out of your microplate reader. This close working relationship allows BMG LABTECH to completely understand your needs and to help develop our instruments to meet the changing needs of the microplate reader market. Imprint: https://www.bmglabtech.com/legal-notice/ Privacy Policy: https://www.bmglabtech.com/privacy-statement-linkedin/

We are a one-of-a-kind resource built for the future of life science research​. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries​ ISO-certified Biobanx biospecimen inventory ​ ACRP and CCRA-certified clinical research services​ CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow's therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.

BOC Sciences provides a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. We are committed to providing our customers with the best products and services at the most competitive prices. Given diverse packing options for most of our chemicals, you are welcome to order the desired compounds in any quantities from a few mg to several kg along with all the relevant technical reports. We sincerely hope that our unremitting pursuits of excellence, success, and professionalism will add immense value to your research and development projects!

Bolt threads usesproteins found in nature to create fibers and fabrics with both practical and revolutionary uses, starting with spider silk. The company also develops materials from mycelium, the vegetative form of mushrooms. One application is a form of vegan leather called "Mylo."

Bond Pet Foods is using fermentation technology to produce ingredients formeat proteins like chicken, turkey, beef, pork and fish for use in pet food.

MISSION Bonneville Labs’ is creating a global life science ‘hard tech’ community empowered to go forward, faster. We provide comprehensive and supported environments enabling companies to focus on discovery and outdistance the conventional. BONNEVILLE LABS There’s no need to start from square one. Bonneville Labs is an adaptable workspace that eliminates operational barriers and reduces the cost of development through shared services and pre-negotiated discounts. Backed by years of industry experience, we manage laboratories and services so members can focus on their science. BONNEVILLE LABS COMMUNITY BENEFITS Headquartered in Berkeley, California, Bonneville Labs features flexible lab space from single benches to dedicated suites, lab equipment, streamlined operational support that includes Environmental Health and Safety training and oversight, purchasing services, facilities support, meeting rooms, community lounges, kitchens, high-speed internet, and events. BONNEVILLE COMMUNITY Small teams don’t have to worry about the setup and maintenance costs of a traditional office. They can work like larger organizations at a fraction of the cost in a workspace that can accommodate their needs as they grow. Large companies looking to expand benefit from our streamlined workspace model - sidestepping the costs of building it out, operating it and the long-term liability - while gaining access to pioneering talent. Bonneville Labs’ dynamic environment facilitates cross-pollination while nurturing a unique bio-community that connects innovators from across the broader life sciences community.

With 30 years of expertise, Boster Bio is committed to producing high-quality antibodies and ELISA kits at the best value for researchers worldwide. Our global distributor network extends beyond 30+ countries and delivers rigorously validated antibodies, ready-to-use kits, and reagents that have received over 60,000 citations. At Boster, our customers' research is our priority. Our mission is to help customers achieve their research goals so that they can stay on the cutting edge of research. To honor our customers' goals, we choose to uphold high quality standards by manufacturing our antibodies and ELISA kits in our very own facilities from start to finish for strict monitoring, efficiency, and optimization. Let us become your partner in research. Get better results with Boster. For more information, please visit www.bosterbio.com.

Since its founding in 1987, BA Sciences has been a trusted provider of high-quality analytical testing services to life science companies worldwide. With a commitment to excellence, compliance, and innovation, the company has established itself as a premier analytical testing services provider in the industry. Originally located in North Reading, Massachusetts, BA Sciences moved its operations and headquarters to its current home located in Salem, New Hampshire. The footprint of the HQ laboratories facility started at 30,000 square feet but has since expanded to over 60,000 square feet, and there are additional laboratory and office facilities located in Framingham, MA and Morrisville, NC.

For nearly 30 years, Boston BioProducts (BBP) has been dedicated to providing buffers and solutions for life sciences research, diagnostics, and biomanufacturing. Learn how you can quickly develop your next buffer formulation: https://bostonbioproducts.com/custom-formulations/

Boston Clinical Trials (BCT) is a leading medical research center based in Boston, MA. BCT works with the top Pharmaceuticals on clinical studies in the areas of Dermatology, Gastroenterology, Internal Medicine, Neurology, Psychiatry, Sexual Dysfunction, and Urology. Our mission is to conduct safe and effective clinical trials to advance the development of new medications and therapies.

Boston Heart Diagnostics is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and reports and integrated customized lifestyle programs that have the power to change the way clinicians and patients communicate about disease and improve heart health. Boston Heart looks beyond the “good” and “bad” cholesterol assessment that conventional labs provide to give a more complete and individualized picture of heart health. Founded by renowned cardiovascular researchers and led by seasoned lab and diagnostic executives, Boston Heart is one of the fastest growing health companies in the country. For more information on Boston Heart Diagnostics, please visit www.BostonHeartDiagnostics.com Current Career Opportunities Visit our website for a complete list of career opportunities: http://www.bostonheartdiagnostics.com/about_join.php.

BIB is a full service CDMO partner offering cGMP and non-GMP mammalian, microbial, gene therapy and cell therapy services.

We are part of bess group (www.bessgroup.com), a group of dynamic and developing companies, headed by our holding company bess AG (Berlin, Germany). It is our vision to provide life sciences products of high value yet cost-effective, enabling us to become market leaders in as many of our medical fields as possible. Though much has changed at Boston Medical Products over the past 39 years, one thing remains constant: our commitment to deliver the world's finest specialty surgical products - products that clinicians rely on and patients can trust. Founded in 1980 by three physicians - including world-renowned ENT surgeon William W. Montgomery, M.D. - as a way to make Dr. Montgomery's original innovations widely available, Boston Medical Products continues to be driven by his life-long commitment to superior patient care. Over the years since our beginning, we have expanded our line of products with innovations from some of the world's leading physicians, health care innovators, and opinion leaders. Boston Medical Products today develops, manufactures and sells many different types of specialty products that meet the exacting needs of clinicians specializing in Otolaryngology, Pulmonary Medicine, Respiratory Therapy and Speech Pathology. In the established patient oriented tradition, Boston Medical Products has developed an educational website www.trachs.com as a service to provide patients with the very best products and resources for their laryngectomy and tracheostomy needs. It is a website where you can not only find the products you need for your care and comfort, but information and support that will help you make decisions and improve your quality of life.

Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development, manufacturing and distribution of US- quality medicines – across therapeutic areas. From our nerve center in Riyadh, we leverage the expertise, daring creativity, and unwavering determination of our international leadership team to provide customers with end-to-end, efficient, single-point-of-contact access to our diverse portfolio of world-class biogenerics. We do this because lives depend on it.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

L'Alliance Boviteq (LAB) inc. is an embryo transfer centre located in Saint-Hyacinthe, Québec, Canada, about 50 km east of Montréal. It is a very unique enterprise highly specialized in the production of bovine embryos using both in vivo and in vitro technology. LAB is linked to The Semex Alliance and is an important part of its research and development program. Research and development (R & D) LAB has a significant involvement in research and development in order to provide state-of-the-art technologies in reproduction to our customers. This involves the investigation and application of new technologies in bovine reproduction in order to provide the cattle breeding industry with the tools needed to produce superior genetics such as sexing of embryos, freezing sexed embryos and production of embryos from in vitro fertilization of oocytes. Our scientific and professional staff work in close collaboration with government and university researchers in order to bridge the gap between basic and applied research. Besides owning and housing livestock, LAB has well equipped laboratories and competent personnel, thus providing opportunities to undertake research projects with other organizations. Services to breeders LAB offers breeders a wide variety of services such as conventional embryo collection, in vitro fertilization as well as treatment of repeat breeders. LAB is the privileged place for breeders who wish to get specialized services for their donor cows. TYPE OF SERVICES AVAILABLE ·Housing of donor females ·Collection and freezing of embryos ·Embryo sexing ·Oocyte recovery and in vitro fertilization ·Recipients on site to produce guaranteed pregnancies ·Ultrasonography to confirm early pregnancies and foetal sexing ·Treatment of repeat breeders HEALTH STATUS Our installations can provide housing of leucosis positive donors, as well as maintaining the status of leucosis free donors. Our recipient herd is free of leucosis, neospora and BVD. LAB is accredited by Agriculture and Agri-Food Canada for embryo export to the EEC and other markets. Achievements in R & D include: -First heifer born from a split embryo and first identical twin in 1990 -Numerous calves resulting from embryos produced by in vitro fertilization (IVF) -In vitro fertilisation of oocytes collected on farm and transported to LAB -Embryo sexing by molecular probe, including sexing of IVF embryos produced at LAB -Freezing of sexed embryos -Embryo culture -Ultrasound technology, including fetal sexing -Improvement of superovulatory response PRODUCTS AVAILABLE ·Frozen embryos, quality 1 and 2 ·Sexed frozen embryos ·Heifer calves, 3 to 9 months of age Contact us by phone (450-774-7949) or fax (450-774-1740) for a list of embryos or calves for sale.

BrainCool Inc is an innovative medical device company that develops, markets, and sellsleading medical cooling systems for indications and areas with significant medical benefitswithin the healthcare sector. The company focuses on two business segments, Brain Coolingand Pain Management.

Generic Pharmaceuticals

Bridge to Life was founded with the mission of improving organ transplants through licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, we continue to explore emerging science and preservation technologies.

We are an investment banking and venture capital advisory firm that focuses on the healthcare industry. We have relationships with corporate partners, venture capitalists, hedge funds, family offices, and HNWI internationally. We represent companies and venture capitalists in biotech, pharma, diagnostics, devices, and imaging. BUSINESS DEVELOPMENT We listen to clients' goals for financing and do deep research for the right financial partner that includes family offices, angels, venture capitalists, hedge funds, and small funds. We provide personalized venture capital and investment banking advisory services. We keep the number of companies from one to three. We put together co-lead investors to help make the transition go smoothly. We represent multiple companies and venture capitalists in foreign countries looking for a foothold in California and the U.S. We work with U.S. companies looking for relationships internationally. We understand cultural differences and can help bridge the gap of communication on deals. FINANCE Expertise at targeting financial partners internationally. We create extensive relationships with private funding sources—from family offices to strategic angels. We build solid associations with healthcare and technology venture capitalists throughout the world. We comprehend the complexity of creating tranches in an investment. We work with lead investors and help put international syndicates together. We represent venture capitalists and individual companies and we understand the key points of closing deals STRATEGY We understand how to create materials that synthesize the company's strengths and message. We work with multiple CEOs and help design winning and concise pitches while providing personalized assistance on each call with investors and find areas that can be improved. We research influencers and non-profits in the scientific community that can help sway financiers' opinions. We analyze the current venture market for your company and find out which other companies in your space are getting financed and why. We design multi-tiered strategies of creating associations with the best financial partners.

Boston's Brigham and Women's Hospital (BWH) is an international leader in virtually every area of medicine and has been the site of pioneering breakthroughs that have improved lives around the world. A major teaching hospital of Harvard Medical School, BWH has a legacy of excellence that continues to grow. With two outstanding hospitals, over 150 outpatient practices, and over 1,200 physicians, we serve patients from New England, throughout the United States, and from 120 countries around the world. The BWH name is a reflection of our history. In 1980 three of Boston’s oldest and most prestigious Harvard Medical School teaching hospitals - the Peter Bent Brigham Hospital, the Robert Breck Brigham Hospital, and the Boston Hospital for Women – merged to form Brigham and Women’s Hospital. As a national leader in improving health care quality and safety, we have helped to develop some of the industry’s best practices including computerized physician order entry (CPOE) to prevent medication errors. The CPOE is now a nationally-accepted safety practice. The BWH Biomedical Research Institute (BRI) is one of the most powerful biomedical research institutes in the world and the second largest recipient of National Institutes of Health (NIH) funding among independent hospitals in the United States. BWH has long had great success in research as measured by the number of important discoveries made, the size and scope of its research portfolio and the volume of publications annually. BWH is a training ground for physicians, nurses, and allied health professionals. We have 1,100 trainees in over 140 of the most sought after training programs in the world, and also host Harvard Medical School students in rotations throughout our programs. As our global health services expand, our clinical trainees have rich opportunities to contribute and learn in challenging environments around the world. Brigham and Women's Hospital is an EEO, AA, VEVRAA Employer.

We believe a world yearning for hope and joy needs the graduates of Brigham Young University—disciples of Jesus Christ who are driven by love for God and His children and who are prepared to serve and lead. This preparation demands a unique university model: at BYU, belief enhances inquiry, study amplifies faith, and revelation leads to rich understanding; at BYU, helping students develop their full divine potential is central to both our teaching and our scholarship. As the flagship higher education institution of The Church of Jesus Christ of Latter-day Saints, BYU strives to be among the exceptional universities in the world and an essential university for the world.

Brightseed is a pioneer in biosciences and artificial intelligence (A.I.) that illuminates nature to restore human health. Brightseed’s proprietary A.I., Forager®, accelerates bioactive discovery, biological validation and ingredient formulation from years to months, rapidly revealing new connections between nature and humanity. Through Forager® and clinical evaluation, Brightseed partners with organizations across the consumer health continuum to offer insight into the world of bioactives and health solutions. Brightseed produces branded, proprietary, clinically proven bioactives that are sold to leading dietary supplement, food & beverage CPG, specialty nutrition and medical food companies for incorporation into health beneficial consumer products. Visit www.brightseedbio.com to learn more.

BrightSpec is an innovative life science tools company with a range of instruments that tap the power of molecular rotational resonance (MRR) spectroscopy. MRR enables the rapid, unambiguous molecular ID and quantitative analysis of mixtures, without separation, no chemometrics, and with no reference sample required. Not only can BrightSpec MRR complement other techniques such as Mass Spectrometry or NMR, in many cases MRR can solve problems not possible by these methods. For instance, MRR can easily distinguish between isomers (compounds with the same atoms but a different arrangement) or identify the exact site of deuteration of a molecule as well as quantify the number of each in the sample. BrightSpec is in the process of working with leading pharma, biotech, and academic players to develop breakthrough methods that will enable important advances in discovery. The company is also working with major chemical, oil & gas, consumer products, security, and environmental players to bring innovative solutions to these applied markets. The work is supported by research from a growing number of academic institutions as evidenced by a rising number of publications using BrightSpec instruments. BrightSpec builds on decades of federal and academic work in more than 110 research groups around the world. The technique was developed foremost in astrochemistry research. Using breakthrough technology developed by Brooks Pate at the University of Virginia, BrightSpec made this powerful technique of practical use by making the instrument significantly faster, cheaper, and easier to use. MRR spectra capture the unique set of rotational resonances, a fingerprint specific to a given molecular structure. These can be calculated theoretically based on quantum mechanics and are highly resolved. Isomers, isotopologues, diastereomers and enantiomers can be distinctly identified.

BrightWave makes photobioreactors designed to provide the ideal growth environment, whether your goal is maximizing overall growth rates and densities, maintaining cultures at set parameters, or applying stress factors to enhance metabolite production. The photobioreactors control lighting, pH, temperature, and nutrient delivery.

BroadPharm is a leading customer-focused biotech company. We are dedicated to manufacturing and supplying high-purity PEG Linkers, Click Chemistry Tools, ADC Linkers, PROTAC Linkers, Drug Delivery Lipids, and Labeling Reagents to our clients worldwide. Founded in 2009, BroadPharm takes our customer needs as our highest priority. We have over 8,000 PEG Linkers, Click Chemistry tools, ADC Linkers, Lipids, Fluorescent Dyes, and Nucleosides. In addition to our broad catalog selection, we also offer IP-protected custom synthesis and bio-conjugation services for our clients in the pharmaceutical and biotech industries. We provide timely technical support to address our client's needs and offer technical advice for the best use of our new products. With our strong expertise in modern chemistry along with innovative and novel Lipid & PEG technology supported by state-of-the-art equipment, BroadPharm can help our customers accelerate their research through cost-effective and efficient solutions.

Brooks Applied Labs was formed in 2015 through the merger of the two industry-leaders in the field of specialty trace metals analysis and metals speciation: Brooks Rand Labs & Applied Speciation and Consulting. Today, Brooks Applied Labs provides Meaningful Metals Data and Advanced Speciation Solutions to hundreds of projects worldwide, and we are very dedicated to staying in our niche. Many members of our staff, from the Sample Disposal Technician to our CEO, are seasoned veterans in the world of ultra-trace metals analysis and metals speciation. Together we work to provide thoroughly ultra-clean and pre-tested sampling equipment, fast turn-around-time options, high-quality validated data, and custom reporting packages at competitive prices to ensure that our clients receive the data and consulting they require to make critical decisions.

Right from the beginning, more than sixty years ago, Bruker has been driven by a single idea: to provide the best technological solution for each analytical task. Today, worldwide, more than 9,700 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. Bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems, and maintain a strong reputation amongst its customers. As one of the world's leading analytical instrumentation companies, Bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever-complex analytical questions. Bruker - Innovation with Integrity. Privacy Policy: https://goto.bruker.com/LI-Bruker-PrivacyPolicy Imprint: Bruker Corporation 40 Manning Road Billerica, MA 01821, USA Contacts: - Phone: +1 978-663-3660 - Fax: +1 978-663-5585 - Email: pr@bruker.com

Bruker Spatial Genomics, Inc, (formerly Acuity Spatial Genomics, Inc.) provides a groundbreaking platform for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s jebFISH™ technology empowers researchers to directly visualize genome organization and 3D chromatin architecture of individual cells, directly in situ. The company’s transformative PaintScape™ platform, powered by jebFISH technology, breaks through challenges of multiplexed, direct imaging of the genome in nuclei and makes it possible to gain critical insight into cell programming and transcription regulatory programs that drive cell type, state, and function. Directly seeing changes and disruptions of genome organization will elucidate mechanisms of disease and its progression especially in disease systems like cancer. Bruker Spatial Genomics, Inc. is part of Bruker’s strategic investment in spatial biology and its initiative to develop and expand emerging spatial analyses technologies. The PaintScape platform joins the portfolio of high-performance Bruker Spatial Biology platforms that empower researchers to delve deeper and advance discovery in life science and translational research.

Bryllan is a contract manufacturing company that specializes in producing potent and cytotoxic compounds meeting US FDA and global regulatory standards.

BSK Associates (BSK) provides consulting engineering and testing for clients with projects ranging in size from small to complex, in both natural and built environments. Celebrating over 49 years, BSK is employee-owned, and has grown to a staff of nearly 200 with offices, laboratories, and sample drop-off locations throughout Northern and Central California. Since 1966, BSK has been closely involved with the earth sciences and construction materials. We apply this knowledge and experience to meet the needs of client industries including agriculture, commercial/retail, education, energy, healthcare, aggregate/mining, transportation, manufacturing, water, telecommunications, and local, state and federal agencies.

Gust is the global SaaS platform for founding, operating, and investing in scalable, high-growth companies. Gust’s online tools help entrepreneurs start, run, and fundraise for companies and provide deal flow and relationship management for investors. As the world’s largest community of entrepreneurs and early-stage investors from 191 countries, Gust pioneered the equity funding collaboration industry and is the official platform of the world’s leading angel investor federations and venture accelerators. More than 500,000 startups have already used Gust to connect with over 70,000 investment professionals. Gust powers the official online hubs of the world’s largest innovation ecosystems including New York City (Digital.NYC), Boston (StartHub.org) and London (Tech.London).

BTS Research is a Contract Research Laboratory that delivers cGMP/GLP biological services to clients in the pharmaceutical, biopharmaceutical, biotech, academic research, medical devices and related industries.

Buck Institute for Research on Aging is a biomedical research institute focused on studying the aging process and its effects on health.

Buffalo Brewing Company is a craft brewery that specializes in small batch hand crafted beers, offering an intimate tasting room and large beer garden.

Butterfly’s mission is to create access to valuable clinical insights using innovative ultrasound technology, made simple with artificial intelligence, to benefit all patients worldwide. Through the delivery of high-quality, affordable, easy-to-use, intelligently connected ultrasound, Butterfly Network enables better clinical decisions through better information and insight at the point of care. With Butterfly, seeing is knowing – in the hospital, community, or home.

Market opportunities created by evolving legislation legalizing recreational use of cannabis is generating a significant need for advances in rapid and accurate drug testing technology. Buzzkill Labs is developing next generation technology that will combine patented noninvasive sample collection methodology with scientifically validated laboratory detection and quantitation technology. Buzzkill Labs products will address the growing need for:SAFETY IN THE WORKPLACESUSPECTED IMPAIRED DRIVING BY LAW ENFORCEMENTFAST AND ACCURATE TESTING BY MEDICAL AND DRUG TREATMENT CENTERS

Byrne Dairy is a fourth generation, family-owned producer and distributor of Greek Yoghurt, Conventional Yogurt, Sour Cream, Milk, Cream, Ice Cream and a variety of other dairy products. Byrne Dairy currently has four manufacturing facilities including a Fresh Dairy Plant and Ice Cream Plant located in Syracuse, NY and a Cultured Plant located in Cortlandville, NY.

C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.

C4 Imaging develops innovative medical devices that enable clinicians to personalize patient treatment through accurate image-guided procedures. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within an implantable, biocompatible shell. C4 Imaging's first product is the Sirius™ MRI Marker, which will be used to facilitate seed localization during the treatment of prostate cancer. The Sirius™ MRI Marker will allow physicians to accurately locate seeds within the complicated anatomy of the prostate and the surrounding critical structures, utilizing a single post-implant MR imaging procedure. C4 Imaging's goal is to improve quality assurance by allowing post-implant seed localization to be performed with MRI alone, eliminating the need for computed tomography in assessment of prostate brachytherapy.

Cadence Biomedical, a commercial-stage medical device company headquartered in Seattle, Washington, is committed to working with healthcare professionals, patients and caregivers to advance neurorehabilitation. The company's primary commercial product, Kickstart®, is a neurorehabilitation device designed to accelerate a recovery to walking in stroke, multiple sclerosis, spinal cord injury patients and in individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. For more detail, please see www.cadencebiomedical.com.

Clinical Assay Innovation (CAI) Biosciences is a consulting firm focused on providing expertise and guidance in the development of Laboratory Developed Test (LDT) and In Vitro Diagnostic (IVD) assays in the areas of Next Generation Sequencing (NGS), Real-Time Polymerase Chain Reaction (qPCR), Immunochemistry, and Clinical Chemistry. Our mission is to provide our clients with best in class assay development services and to insure successful implementations of their projects.

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.

Cairn Biosciences discovers new medicines by mapping multiscale cell dynamics. Our proprietary COMPASS™ discovery platform unlocks exclusive routes to novel targets and drugs by navigating uncharted, complex and dynamic disease biology. Using COMPASS, our diverse, multidisciplinary team of experts in drug discovery, disease biology, engineering and computation is pioneering a new drug discovery paradigm that utilizes our innovative simulations of living biology to deliver better therapeutics. We are initially orienting COMPASS to the exciting challenge of discovering new drugs that overcome acquired resistance to targeted cancer therapies. Cairn \​'kern\ a stone beacon marking the direction of a trail.

CairnSurgical, Inc. is a clinical stage medical device company developing patient-specific surgical guides using patient imaging data and state-of-the-art 3D printing technologies. CairnSurgical's Breast Cancer Locator System enables precise tumor localization and excision, and has been tested in both single-arm and randomized clinical trials. The Breast Cancer Locator is considered an investigational device in the U.S. and is limited by U.S. law to investigational use only. It is not approved for sale in any region.

Caladan Bio is a Brooklyn-based startup specializing in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. The company's first product, the Caladan 250, is a high throughput benchtop bioreactor system that leverages AI and machine learning to enable advanced data capture and increase throughput. Caladan Bio is focused on revolutionizing the way biotechnology research is conducted by creating lower-cost, cutting-edge bioreactors and advanced software.

Cala kIQ is a healthcare technology company that specializes in digital therapeutics and medical devices.

CalChem Synthesis is a Contract Research Organization (CRO) serving as an outsourcing partner for the biotech and pharmaceutical companies and research institutions. The company mission is to provide high quality non-GMP chemistry services to the chemical community and to maintain customer satisfaction. Our services are based on the belief that our customers' needs are of the utmost importance and we are committed to meeting those needs. The experience of CalChem's team in synthetic organic chemistry and process research and development ensures that all projects are delivered with highest quality standards and on time. CalChem is located in the heart of "Pharma Corridor" in Torrey Pines, San Diego. Our leadership team has over 45 years of combined experience in different sectors of drug discovery and development in pharma industry. If you are located in Southern California, benefit from our services in your backyard and discuss progress of your projects in face-to-face meetings with our chemists on a weekly basis. For national and international clients, progress reports can easily be discussed by conference or video calls. We would welcome the opportunity to earn your trust and deliver you the best services in the industry. With our experience in pharmaceutical contract research and development, we ensure that your projects will be handled smoothly and in your best interest.

Caldera Medical is a medical device company solely focused on women's health with a commitment to our mission of "Improving the Quality of Life for Women!" We develop, build and market best in class surgical products for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Working closely with surgeons to help those here at home, as well as women around the world, through our humanitarian programs to give them the access to the education and treatment they deserve. Mission - To Improve the Quality of Life for Women Vision - To be the Global Leader in Women's Pelvic Health Values "C4"​ - Care / Collaborate / Challenge / Create

Founded in 1991 as Lucid Technologies, Inc. and later Lucid, Inc., Caliber I.D. offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber I.D.Õs Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

The California Animal Health and Food Safety Laboratory System (CAHFS) is the backbone of California's warning system that helps to protect the health of California's livestock and poultry. CAHFS serves the people of California by safeguarding the public health with rapid and reliable diagnoses for animal diseases including those affecting humans. CAHFS operates in partnership with the California Department of Food and Agriculture, UC Davis, veterinarians, and livestock and poultry producers. CAHFS provides quality services that protect animal health and performance, public health and the food supply.Located on the University of California, Davis campus, the Davis laboratory provides livestock, equine and avian necropsy, histopathology, immunohistochemistry, electron microscopy, toxicology, serology, microbiology and virology testing on site. Specialty services for equine performance chemistryand pharmacology are also located at the Davis facility.CAHFS Davis offers:American College of Veterinary Pathologists board certified diagnosticiansAmerican College of Veterinary Microbiologists board certified microbiologistAmerican Board of Veterinary Toxicology board certified toxicologistExperts in poultry/avian, horse, cattle, pig, llama, alpaca, sheep, goat, exotics and wildlife diseasesForeign animal disease trained diagnosticians on siteComprehensive reports which include gross examination, histopathology and testing in other disciplines as neededNational Poultry Improvement Plan approved site for Salmonella, Mycoplasma and Avian Influenza testing

Climate change, deforestation, forced labor and many other issues are putting the world's chocolate supply at risk of collapse. The time is now to build a cleaner and better future of food. We are developing the newest plant cell culturing technologies in order to create a new supply of chocolate that is scalable, sustainable and better for the planet.

California Department of Fish and Wildlife's mission:To manage California's diverse fish, wildlife, and plant resources, and the habitats upon which they depend, for their ecological values and for their use and enjoyment by the public.

California Institute of Technology - Caltech is an educational and research institution that focuses on science, technology, and engineering.

CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites' commitment to real world solutions. Rely on us to confidently progress from site selection to study close-out and accelerate life-changing therapies. Get more value from your clinical trials with CenExel.

Calysta is a world leader in cellular agriculture, creating protein without limits via a patented fermentation platform that uses no arable land, plant or animal products. As the world's demand for healthy, sustainably produced food continues to grow, Calysta's family of ingredients – FeedKind, FeedKind Net Zero, and Positive Protein – are ready to meet the challenge. Powered by renewable energy, Calysta's protein products can preserve biodiversity and contribute to improving the global nexus of water, energy and food security.

Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today. Founded in 2016, Calyxo is led by executives and investors with a strong track record of commercializing paradigm-shifting solutions in the field of urology. Our team features some of the most talented, high-achieving and brightest minds in the medical device industry who are compelled by a desire to make a difference in kidney stone care. We are proud of our collaborative, diverse, fun and dynamic culture. We drive our actions based on our core values which we call ‘F.I.T to WIN.’ Find Joy: We celebrate wins and enjoy the journey! Integrity: We are truthful, honorable, and reliable. Transparency: We share what’s going on in our business. We are open, honest and have a clear communication across our organization. Win as a Team: We are earnest collaborators. We hold ourselves and each other accountable.

CAMAG is the world leader in High-Performance Thin-Layer Chromatography. We provide high-end instruments, tools and concepts for TLC/HPTLC. Additionally, we support our clients with training, technical and contract laboratory services. Wherever complex substance mixtures are analyzed (e.g. herbal, environmental or forensic samples), TLC/HPTLC often is an excellent alternative to GC and HPLC. Moreover, it has proven value as a solid quantitative analysis technique in quality assurance of food, pharmaceuticals and other industrial products. Since 1961, CAMAG is dedicated to the development and manufacturing of instruments, software and consumables for all steps of the TLC/HPTLC procedure. Our products are truly Swiss made and have an excellent reputation throughout the world.

Innovative spine and medical technology company Camber Spine is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology. Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, we are making quantum leaps in the spinal fusion market. Our patented OLIF system and procedure – with its less complicated, simpler approach to treating complex spinal pathologies – is poised to change the way spine care is delivered. Camber Spine now has 20 products with 510(k) clearances and over 28 active or issued patents, including two award-winning, highly innovative and IP protected device platforms that support faster spinal fusion and recovery: ENZA® (MIS Integrated Interbody) spinal fusion implants; and SPIRA® OA (Open Architecture 3D printed) spinal fusion and orthopedic implants. Our 27,000 sq. ft. state-of-the-art facility just outside Philadelphia features meeting facilities, office spaces, a mechanical test lab with full prototype shop and an expanded double cadaver lab.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.

Cambridge Technologies is an independent owner-operated custom vaccine company working with veterinarians and livestock producers to provide solutions to animal health problems. We use cutting-edge molecular diagnostic and manufacturing techniques to manage the entire custom vaccine process and to provide you with the best possible solutions for managing emerging health problems. Diagnostic and research scientists work in a modern laboratory specializing in personalized service. Techniques including metagenomics, genetic sequencing, qPCR, culture, sensitivity and serology will be employed as needed to precisely determine the right isolates needed for vaccine production. Research scientists alongside the diagnosticians keep Cambridge on the cutting-edge of isolate identification and characterization. Cambridge Technologies vaccines are formulated and produced at our USDA-licensed 37,000-square-foot manufacturing facility featuring a state-of-the-art fermentation suite. The vaccine production team has extensive experience in diagnostics, R&D, quality control, regulatory affairs, and both commercial and custom vaccine production. Vaccines from Cambridge Technologies are truly customized to the customer’s needs, including a range of adjuvant choices, label options, and SoliDose implant delivery in bovine products.

Canaery is a neurotechnology and SaaS data company on a mission to introduce the world's first enhanced working animals and unlock the hidden world of scent. By building a networked database of detectable odors, Canaery can revolutionize border and transportation security, medical screening and health diagnostics, and invasive pest inspections to make a safer, healthier society.

Welcome to the Cancer Center of Southern California. Contact us today to schedule an appointment with a leading oncology expert in Los Angeles!

Cancer Research And Biostatistics (CRAB)® is a non-profit organization whose mission is to help conquer cancer, and other diseases. Since 1997, CRAB has supported over 300 clinical trials in partnership with foundations, universities, pharmaceutical and biotech companies. Past project experience has ranged from phase I to phase III, registration, staging, and prevention trials. CRAB provides a constellation of services that can help with concept creation, trial conduct, and regulatory submission or publication. Dr. Antje Hoering serves as President and CEO. Dr. John Crowley, co-founder with Dr. Cay Crowley, is Chairman of the Board of Directors. CRAB believes that collaboration accelerates outcomes. CRAB has long-standing partnerships with several cancer research organizations, including the SWOG Cancer Research Network, The Hope Foundation for Cancer Research, and SWOG Clinical Trials Partnerships. SWOG is one of five National Cancer Institute (NCI) supported members of the National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). CRAB and Fred Hutchinson Cancer Research Center make up the SWOG Statistics and Data Management Center (SDMC). CRAB is also an integral collaborator with the International Association for the Study of Lung Cancer (IASLC) since the late 1990s, publishing analysis for over 200,000 lung cancer cases in the 7th and 8th editions of the Staging Manuals. CRAB currently serves as the Independent Analysis Center for Friends of Cancer Research's ctDNA for Monitoring Treatment Response (ctMoniTR) Project. In this project, CRAB receives data from the pharmaceutical and diagnostic partners, coordinates input from collaborators, harmonizes and pools data, and analyzes the pooled data to meet the project's objectives. Message us to learn how we can support you in your next clinical trial, or partner with you, to continue to make strides in preventing and curing cancer.

Canopy Biosciences, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.

Cantata Bio is enabling researchers and clinicians to solve tomorrow’s most challenging scientific problems through novel, multiomic approaches that unlock access to genomic and metagenomic information at unprecedented levels. Combining propriety technologies with platform solutions, services, and cutting-edge bioinformatics and software, our unique approaches are solving complex problems, including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, metagenomics, and microbiome analysis. Our customers are positively impacting the fields of epigenetics, developmental biology, cancer research, evolutionary biology, infectious disease, and more. Cantata Bio is based in Scotts Valley, California and Cambridge, Massachusetts. For more information on Cantata Bio, its technology, and offerings, visit www.cantatabio.com.

Embracing Innovation: Transforming Hyperbilirubinemia Management with CoSense ETCOc Technology. The CoSense® ETCOc Monitor performs a non-invasive, bedside breath test using a nasal cannula, and identifies hemolysis and neurotoxic risks from rising unconjugated bilirubin, aiming to prevent hemolytic HB and Kernicterus. Grounded in extensive research, peer-reviewed studies, and neonatology expert endorsements, CoSense® revolutionizes neonatal care by enabling precise, customized interventions, including vigilant monitoring and effective phototherapy, setting new care standards in neonatology.

Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.

CapsoVision is a medical device manufacturer based in Silicon Valley, USA. We are engaged in the development of innovative capsule endoscopy (CE) solutions that empower physicians, streamline clinical operations and enhance patient experience. Our novel small bowel capsule endoscope CapsoCam Plus® is the only CE system with a 360° field of view, no capital equipment, and a state-of-the-art CapsoCloud® cloud-based software for efficient image review and analysis.